0000021665-20-000007.txt : 20200501 0000021665-20-000007.hdr.sgml : 20200501 20200501074017 ACCESSION NUMBER: 0000021665-20-000007 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 65 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200501 DATE AS OF CHANGE: 20200501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 20838361 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 10-Q 1 cl-3312020x10q.htm 10-Q Document
2false--12-31Q12020000002166576000000840000000.850.871215 0000021665 2020-01-01 2020-03-31 0000021665 cl:A0.000Notesdue2021Member 2020-01-01 2020-03-31 0000021665 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000021665 cl:A0.875Notesdue2039Member 2020-01-01 2020-03-31 0000021665 cl:A0.500NotesDue2026Member 2020-01-01 2020-03-31 0000021665 cl:A1.375NotesDue2034Member 2020-01-01 2020-03-31 0000021665 2020-03-31 0000021665 2019-01-01 2019-03-31 0000021665 2019-12-31 0000021665 2018-12-31 0000021665 2019-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000021665 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000021665 cl:UnearnedCompensationMember 2019-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000021665 cl:UnearnedCompensationMember 2018-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2018-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-03-31 0000021665 us-gaap:TreasuryStockMember 2018-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000021665 us-gaap:RetainedEarningsMember 2018-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-03-31 0000021665 us-gaap:CommonStockMember 2018-12-31 0000021665 us-gaap:TreasuryStockMember 2019-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000021665 us-gaap:CommonStockMember 2019-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommonStockMember 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2020-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2019-12-31 0000021665 cl:UnearnedCompensationMember 2020-01-01 2020-03-31 0000021665 cl:UnearnedCompensationMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000021665 cl:UnearnedCompensationMember 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2019-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000021665 us-gaap:CommonStockMember 2019-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 2019-09-19 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:CustomerRelationshipsMember 2019-09-19 2019-09-19 0000021665 cl:HelloProductLLCMember 2020-01-31 2020-01-31 0000021665 srt:EuropeMember cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:TrademarksMember 2019-09-19 0000021665 cl:NigeriaJointVentureMember 2019-08-15 2019-08-15 0000021665 srt:NorthAmericaMember cl:HelloProductLLCMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 0000021665 cl:NigeriaJointVentureMember 2019-08-15 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:CustomerRelationshipsMember 2019-09-19 0000021665 cl:HelloProductLLCMember 2020-01-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:OtherIncomeExpenseNetMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:NonServiceRelatedPostretirementCostsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:RestructuringAndImplementationRelatedChargesMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-03-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000021665 2017-07-31 0000021665 2019-04-01 2019-06-30 0000021665 srt:MinimumMember 2020-03-31 0000021665 2015-09-01 2015-09-30 0000021665 2019-04-30 0000021665 srt:MaximumMember 2020-03-31 0000021665 2005-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2020-01-01 2020-03-31 0000021665 us-gaap:SalesRevenueNetMember 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentAssetsMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:LongTermDebtMember 2019-12-31 0000021665 us-gaap:LongTermDebtMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:FairValueInputsLevel2Member 2020-03-31 0000021665 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommodityContractMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-03-31 0000021665 us-gaap:DebtMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember 2019-01-01 2019-03-31 0000021665 us-gaap:DebtMember 2019-01-01 2019-03-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2020-03-31 cl:case cl:country_and_territory iso4217:USD iso4217:USD xbrli:shares cl:Dividend cl:appeal cl:segment iso4217:EUR xbrli:shares xbrli:pure


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 10-Q
_________________________
 (Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from________ to________ .
Commission File Number: 1-644
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
Delaware
13-1815595
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
 
300 Park Avenue
 
 

 
 
New York,
New York
 
 
10022
 
(Address of principal executive offices)
 
(Zip Code)
 
(212) 310-2000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $1.00 par value
 
CL
 
New York Stock Exchange
0.000% Notes due 2021
 
CL21A
 
New York Stock Exchange
0.500% Notes due 2026
 
CL26
 
New York Stock Exchange
1.375% Notes due 2034
 
CL34
 
New York Stock Exchange
0.875% Notes due 2039
 
CL39
 
New York Stock Exchange

NO CHANGES
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒  No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
 
 
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
Class
 
Shares Outstanding
 
Date
Common stock, $1.00 par value
 
856,528,455
 
March 31, 2020




PART I.    FINANCIAL INFORMATION


COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Income
(Dollars in Millions Except Per Share Amounts)
(Unaudited)
 
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
$
4,097

 
$
3,884

Cost of sales
1,632

 
1,597

Gross profit
2,465

 
2,287

Selling, general and administrative expenses
1,473

 
1,365

Other (income) expense, net
40

 
43

Operating profit
952

 
879

Non-service related postretirement costs
21

 
25

Interest (income) expense, net
36

 
40

Income before income taxes
895

 
814

Provision for income taxes
147

 
214

Net income including noncontrolling interests
748

 
600

Less: Net income attributable to noncontrolling interests
33

 
40

Net income attributable to Colgate-Palmolive Company
$
715

 
$
560

 
 
 
 
Earnings per common share, basic
$
0.83

 
$
0.65

 
 
 
 
Earnings per common share, diluted
$
0.83

 
$
0.65







See Notes to Condensed Consolidated Financial Statements.

2




COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Comprehensive Income
(Dollars in Millions)
(Unaudited)
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net income including noncontrolling interests
$
748

 
$
600

Other comprehensive income (loss), net of tax:
 
 
 
Cumulative translation adjustments
(355
)
 
26

Retirement plans and other retiree benefit adjustments
16

 
12

     Gains (losses) on cash flow hedges
18

 
(5
)
Total Other comprehensive income (loss), net of tax
(321
)
 
33

Total Comprehensive income including noncontrolling interests
427

 
633

Less: Net income attributable to noncontrolling interests
33

 
40

Less: Cumulative translation adjustments attributable to noncontrolling interests
(16
)
 
5

Total Comprehensive income attributable to noncontrolling interests
17

 
45

Total Comprehensive income attributable to Colgate-Palmolive Company
$
410

 
$
588



See Notes to Condensed Consolidated Financial Statements.

3


COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Balance Sheets
(Dollars in Millions)
(Unaudited)
 
March 31,
2020
 
December 31,
2019
Assets
 
 
 
Current Assets
 
 
 
Cash and cash equivalents
$
854

 
$
883

Receivables (net of allowances of $84 and $76, respectively)
1,551

 
1,440

Inventories
1,301

 
1,400

Other current assets
542

 
456

Total current assets
4,248

 
4,179

Property, plant and equipment:
 

 
 

Cost
8,167

 
8,580

Less: Accumulated depreciation
(4,680
)
 
(4,830
)
 
3,487

 
3,750

Goodwill
3,559

 
3,508

Other intangible assets, net
2,822

 
2,667

Deferred income taxes
179

 
177

Other assets
775

 
753

Total assets
$
15,070

 
$
15,034

Liabilities and Shareholders’ Equity
 

 
 

Current Liabilities
 

 
 

Notes and loans payable
$
255

 
$
260

Current portion of long-term debt
255

 
254

Accounts payable
1,216

 
1,237

Accrued income taxes
485

 
370

Other accruals
2,232

 
1,917

Total current liabilities
4,443

 
4,038

Long-term debt
7,336

 
7,333

Deferred income taxes
415

 
507

Other liabilities
2,535

 
2,598

Total liabilities
14,729

 
14,476

Shareholders’ Equity
 

 
 

Common stock
1,466

 
1,466

Additional paid-in capital
2,623

 
2,488

Retained earnings
22,481

 
22,501

Accumulated other comprehensive income (loss)
(4,578
)
 
(4,273
)
Unearned compensation
(1
)
 
(2
)
Treasury stock, at cost
(22,104
)
 
(22,063
)
Total Colgate-Palmolive Company shareholders’ equity
(113
)
 
117

Noncontrolling interests
454

 
441

Total equity
341

 
558

Total liabilities and equity
$
15,070

 
$
15,034




See Notes to Condensed Consolidated Financial Statements.

4



COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Cash Flows
(Dollars in Millions)
(Unaudited)
 
Three Months Ended
 
March 31,
 
2020
 
2019
Operating Activities
 
 
 
Net income including noncontrolling interests
$
748

 
$
600

Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
 

 
 

Depreciation and amortization
133

 
128

Restructuring and termination benefits, net of cash
(30
)
 
5

Stock-based compensation expense
16

 
17

Deferred income taxes
(99
)
 
53

Voluntary benefit plan contributions
—

 
(102
)
Cash effects of changes in:
 
 
 
Receivables
(211
)
 
(145
)
Inventories
29

 
(32
)
Accounts payable and other accruals
220

 
44

Other non-current assets and liabilities
(38
)
 
37

Net cash provided by operations
768


605

Investing Activities
 

 
 

Capital expenditures
(82
)
 
(71
)
Purchases of marketable securities and investments
(42
)
 
(27
)
Proceeds from sale of marketable securities and investments
16

 
—

Payment for acquisitions, net of cash acquired
(351
)
 
—

Net cash used in investing activities
(459
)
 
(98
)
Financing Activities
 

 
 

Principal payments on debt
(1,200
)
 
(1,774
)
Proceeds from issuance of debt
1,188

 
2,076

Dividends paid
(373
)
 
(366
)
Purchases of treasury shares
(220
)
 
(399
)
Proceeds from exercise of stock options
297

 
71

Net cash provided by (used in) financing activities
(308
)
 
(392
)
Effect of exchange rate changes on Cash and cash equivalents
(30
)
 
2

Net increase (decrease) in Cash and cash equivalents
(29
)
 
117

Cash and cash equivalents at beginning of the period
883

 
726

Cash and cash equivalents at end of the period
$
854

 
$
843

Supplemental Cash Flow Information
 

 
 

Income taxes paid
$
128

 
$
149


See Notes to Condensed Consolidated Financial Statements.

5



COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Changes in Shareholders’ Equity
(Dollars in Millions)
(Unaudited)
Three Months Ended March 31, 2020
 
Colgate-Palmolive Company Shareholders’ Equity
 
 
 
Common
Stock
 
Additional
Paid-in
Capital
 
Unearned
Compensation
 
Treasury
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)(1)
 
Noncontrolling
Interests
Balance, December 31, 2019
$
1,466

 
$
2,488

 
$
(2
)
 
$
(22,063
)
 
$
22,501

 
$
(4,273
)
 
$
441

Net income
 
 
 
 
 
 
 
 
715

 
 
 
33

Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
 
 
 
(305
)
 
(16
)
Dividends ($0.87/per share)*
 
 
 
 
 
 
 
 
(738
)
 
 
 
(4
)
Stock-based compensation expense
 
 
16

 
 
 
 
 
 
 
 
 
 
Shares issued for stock options
 
 
133

 
 
 
164

 
 
 
 
 
 
Shares issued for restricted stock units
 
 
(15
)
 
 
 
15

 
 
 
 
 
 
Treasury stock acquired
 
 
 
 
 
 
(220
)
 
 
 
 
 
 
Other
 
 
1

 
1

 


 
3

 
 
 
 
Balance, March 31, 2020
$
1,466

 
$
2,623

 
$
(1
)
 
$
(22,104
)
 
$
22,481

 
$
(4,578
)
 
$
454


Three Months Ended March 31, 2019
 
Colgate-Palmolive Company Shareholders’ Equity
 
 
 
Common
Stock
 
Additional
Paid-in
Capital
 
Unearned
Compensation
 
Treasury
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)(1)
 
Noncontrolling
Interests
Balance, December 31, 2018
$
1,466

 
$
2,204

 
$
(3
)
 
$
(21,196
)
 
$
21,615

 
$
(4,188
)
 
$
299

Net income
 
 
 
 
 
 
 
 
560

 
 
 
40

Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
 
 
 
28

 
5

Dividends ($0.85)/per share)*
 
 
 
 
 
 
 
 
(734
)
 
 
 
(2
)
Stock-based compensation expense
 
 
17

 
 
 
 
 
 
 
 
 
 
Shares issued for stock options
 
 
33

 
 
 
49

 
 
 
 
 
 
Shares issued for restricted stock units
 
 
(13
)
 
 
 
13

 
 
 
 
 
 
Treasury stock acquired
 
 
 
 
 
 
(399
)
 
 
 
 
 
 
Other
 
 


 


 
1

 
(5
)
 
 
 
 
Balance, March 31, 2019
$
1,466

 
$
2,241

 
$
(3
)
 
$
(21,532
)
 
$
21,436

 
$
(4,160
)
 
$
342


(1) Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,467 at March 31, 2020 ($3,134 at March 31, 2019) and $3,128 at December 31, 2019 ($3,155 at December 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,122 at March 31, 2020 ($1,026 at March 31, 2019) and $1,138 at December 31, 2019 ($1,038 at December 31, 2018), respectively.

* Two dividends were declared in each of the first quarters of 2020 and 2019




See Notes to Condensed Consolidated Financial Statements.

6

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


1.
Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission (the “SEC”).

2.
Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

3.
Recent Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This new guidance is effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, FASB issued ASU No. 2020-03, "Codification to Financial Instruments." This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323) and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This new guidance was effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.


7
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326)” Codification Improvements to Financial Instruments-Credit Losses (Topic 326). Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This ASU introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.

8
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



4.
Acquisitions

Hello Products LLC

On January 31, 2020, the Company acquired Hello Products LLC, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.

The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:

Receivables
$
11

Inventories
13

Other assets and liabilities, net
(4
)
Other intangible assets
200

Goodwill
131

Fair value of net assets acquired
$
351



Other intangible assets acquired include trademarks of $155, which are considered to have an indefinite useful life, and customer relationships of $45, which have a finite useful life. Goodwill of $131 was allocated to the North America segment.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company expects to finalize the purchase price allocation no later than the first quarter of 2021.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.

Laboratoires Filorga Cosmétiques (“Filorga”)

On September 19, 2019 (the “Acquisition Date”), the Company acquired the Filorga skin health business for cash consideration of €1,516 (approximately $1,674), which included interest on the equity purchase price, plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. Filorga is a premium anti-aging skin health brand focused primarily on facial care. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses, including by expanding its portfolio in premium skin health.

9
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)




The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:
Cash
$
30

Receivables
53

Inventories
70

Other current assets
18

Other intangible assets
1,051

Goodwill
923

Other current liabilities
(67
)
Deferred income taxes
(276
)
Noncontrolling interests
(90
)
Fair value of net assets acquired
$
1,712



Other intangible assets acquired include trademarks of $774, which are considered to have an indefinite useful life, and customer relationships of $277, which have an estimated life of 14 years. Goodwill of $923 was allocated to the Europe segment. The Company expects that goodwill will not be deductible for tax purposes.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company continues to evaluate potential contingencies that may have existed as of the acquisition date and expects to finalize the purchase price allocation no later than the third quarter of 2020.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.

Nigeria Joint Venture

On August 15, 2019, the Company acquired a 51% controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited, for $31.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.



10
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



5.
Restructuring and Related Implementation Charges
    
The Company’s restructuring program (the "Global Growth and Efficiency Program"), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program's three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions, and optimizing the global supply chain and facilities. There were no restructuring and implementation-related charges incurred for the three months ended March 31, 2020.

For the three months ended March 31, 2019 restructuring and implementation-related charges are reflected in the income statement as follows:
 
Three Months Ended
 
March 31, 2019
Cost of sales
 
$
11

Selling, general and administrative expenses
 
4

Other (income) expense, net
 
13

Non-service related postretirement costs
 
1

Total Global Growth and Efficiency Program charges, pretax
 
$
29

 
 
 
Total Global Growth and Efficiency Program charges, aftertax
 
$
22



Restructuring and implementation-related charges in the preceding table were recorded in the Corporate segment as these decisions were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance.

The following table summarizes the activity for restructuring accrual:

 
 
Three Months Ended March 31, 2020
 
 
Employee-Related
Costs 
 
Incremental
Depreciation 
 
Asset
Impairments
 
Other
 
Total
Balance at December 31, 2019
 
$
26

 
$
—

 
$
—

 
$
74

 
$
100

Charges
 
—

 
—

 
—

 
—

 
—

Cash payments
 
(15
)
 
—

 
—

 
(15
)
 
(30
)
Charges against assets
 
—

 
—

 
—

 
—

 
—

Foreign exchange
 
(1
)
 
—

 
—

 
—

 
(1
)
Other
 
—

 
—

 
—

 
—

 
—

Balance at March 31, 2020
 
$
10

 
$
—

 
$
—

 
$
59

 
$
69




11
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



6.    Inventories

Inventories by major class are as follows:
 
March 31,
2020
 
December 31,
2019
Raw materials and supplies
$
329

 
$
305

Work-in-process
46

 
49

Finished goods
976

 
1,056

       Total Inventories, net
$
1,351

 
$
1,410

            Non-current inventory, net
$
(50
)
 
$
(10
)
              Current Inventories, net
$
1,301

 
$
1,400



7.    Earnings Per Share

For the three months ended March 31, 2020 and 2019, earnings per share were as follows:

 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
Basic EPS
$
715

 
856.9

 
$
0.83

 
$
560

 
862.0

 
$
0.65

Stock options and
restricted stock units
 
 
1.5

 
 

 
 

 
1.2

 
 

Diluted EPS
$
715

 
858.4

 
$
0.83

 
$
560

 
863.2

 
$
0.65



For the three months ended March 31, 2020 and 2019, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 20,965,110 and 21,980,033, respectively.


12
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



8.
Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2020 and 2019 were as follows:
 
 
2020
 
2019
 
 
Pretax
 
Net of Tax
 
Pretax
 
Net of Tax
Cumulative translation adjustments
 
$
(320
)
 
$
(339
)
 
$
27

 
$
21

Retirement plans and other retiree benefits:
 
 
 
 
 
 
 
 
Net actuarial gain (loss) and prior service costs arising during the period
 
2

 
1

 
(1
)
 
(1
)
Amortization of net actuarial loss, transition and prior service costs (1)
 
17

 
15

 
17

 
13

Retirement plans and other retiree benefits adjustments
 
19

 
16

 
16

 
12

Cash flow hedges:
 
 
 
 
 
 
 
 
Unrealized gains (losses) on cash flow hedges
 
25

 
20

 
(2
)
 
(2
)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
 
(3
)
 
(2
)
 
(4
)
 
(3
)
Gains (losses) on cash flow hedges
 
22

 
18

 
(6
)
 
(5
)
Total Other comprehensive income (loss)
 
$
(279
)
 
$
(305
)
 
$
37

 
$
28


(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.

9.
Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three months ended March 31, 2020 and 2019 were as follows:

 
Three Months Ended March 31,
 
Pension Benefits
 
Other Retiree Benefits
 
United States
 
International
 
 
 
 
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
Service cost
$
—

 
$
—

 
$
4

 
$
4

 
$
6

 
$
4

Interest cost
19

 
23

 
5

 
5

 
11

 
11

Expected return on plan assets
(27
)
 
(26
)
 
(4
)
 
(5
)
 
—

 
(1
)
Amortization of actuarial loss (gain)
11

 
13

 
1

 
2

 
5

 
2

Net periodic benefit cost
$
3

 
$
10

 
$
6

 
$
6

 
$
22

 
$
16


For the three months ended March 31, 2020 and 2019, the Company made voluntary contributions to its U.S. postretirement plans of $0 and $102, respectively.


13
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



10.
Income Taxes

The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Acts (the "TCJA").

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company has now determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes.

Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company now believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26.

11.
Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $175 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.


14
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $118. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. There is one case currently on appeal at the administrative level. In the event the Company is ultimately unsuccessful in this administrative appeal, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. In April 2019, the Company lost another administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $49, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.


15
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



Competition Matter

Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of March 31, 2020 of such competition law matters pending against the Company during the three months ended March 31, 2020 is set forth below.

▪
In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of March 31, 2020 and December 31, 2019, there were 121 individual cases pending against the Company in state and federal courts throughout the United States. During the three months ended March 31, 2020, five new cases were filed and five cases were resolved by voluntary dismissal or settlement. The value of the settlements in the quarter presented was not material, either individually or in the aggregate, to the period’s results of operations.

The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.


16
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



12.
Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
929

 
$
853

Latin America
889

 
889

Europe
675

 
602

Asia Pacific
633

 
700

Africa/Eurasia
252

 
240

Total Oral, Personal and Home Care
3,378

 
3,284

Pet Nutrition
719

 
600

Total Net sales
$
4,097

 
$
3,884



Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

17
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
 
 
 
Oral Care
44
%
 
48
%
Personal Care
20
%
 
19
%
Home Care
18
%
 
18
%
Pet Nutrition
18
%
 
15
%
Total Net sales
100
%
 
100
%

Operating profit by segment was as follows:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Operating profit
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
258

 
$
249

Latin America
248

 
232

Europe
154

 
151

Asia Pacific
161

 
189

Africa/Eurasia
56

 
46

Total Oral, Personal and Home Care
877

 
867

Pet Nutrition
203

 
164

Corporate
(128
)
 
(152
)
Total Operating profit
$
952

 
$
879



Corporate Operating profit (loss) for the three months ended March 31, 2020 included a charge for acquisition-related costs of $6. Corporate Operating profit (loss) for the three months ended March 31, 2019, included charges of $28 resulting from the Global Growth and Efficiency Program, which ended on December 31, 2019.


18
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



13.
Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2020 and December 31, 2019:
 
Assets
 
Liabilities
 
 
Account
 
Fair Value
 
Account
 
Fair Value
Designated derivative instruments
 
 
March 31, 2020
 
December 31, 2019
 
 
 
March 31, 2020
 
December 31, 2019
Interest rate swap contracts
Other current assets
 
$
—

 
$
—

 
Other accruals
 
$
—

 
$
—

Interest rate swap contracts
Other assets
 
16

 
4

 
Other liabilities
 
—

 
—

Foreign currency contracts
Other current assets
 
58

 
6

 
Other accruals
 
8

 
15

Foreign currency contracts
Other assets
 
—

 
—

 
Other liabilities
 
9

 
14

Commodity contracts
Other current assets
 
—

 
—

 
Other accruals
 
1

 
—

Total designated
 
$
74

 
$
10

 
 
 
$
18

 
$
29

 
 
 
 
 
 
 
 
 
 
 
 
Other financial instruments
 
 
 

 
 

 
 
 
 

 
 

Marketable securities
Other current assets
 
$
43

 
$
23

 
 
 
 

 
 

Total other financial instruments
 
 
$
43

 
$
23

 
 
 
 

 
 



19
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of March 31, 2020 and December 31, 2019. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2020 and December 31, 2019, was $7,909 and $8,056, respectively, and the related carrying value was $7,591 and $7,587, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
 
March 31, 2020
 
December 31, 2019
Long-term debt:
 
 
 
Carrying amount of hedged item
$
415

 
$
403

Cumulative hedging adjustment included in the carrying amount
16

 
4



The following tables present the notional values as of:
 
March 31, 2020
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
535

 
$
—

 
$
400

 
$
—

 
$
935

Cash Flow Hedges
718

 
—

 
—

 
21

 
739

Net Investment Hedges
473

 
3,752

 
—

 
—

 
4,225


 
December 31, 2019
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
388

 
$
—

 
$
400

 
$
—

 
$
788

Cash Flow Hedges
761

 
—

 
—

 
20

 
781

Net Investment Hedges
478

 
3,856

 
—

 
—

 
4,334




20
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



The following table presents the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
 
Three Months Ended March 31,
 
2020
 
2019
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
Gain (loss) on hedges recognized in income:
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps designated as fair value hedges:
 
 
 
 
 
 
 
 
 
 
 
Derivative instrument
$
—

 
$
—

 
$
(12
)
 
$
—

 
$
—

 
$
(3
)
Hedged items
—

 
—

 
12

 
—

 
—

 
3

Foreign currency contracts designated as fair value hedges:
 
 
 
 
 
 

 

 

Derivative instrument
—

 
24

 
—

 
—

 
(1
)
 
—

Hedged items
—

 
(24
)
 
—

 
—

 
1

 
—

Foreign currency contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
2

 
—

 
—

 
3

 
—

 
—

Commodity contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
1

 
—

 
—

 
1

 
—

 
—

Total gain (loss) on hedges recognized in income
$
3

 
$
—

 
$
—

 
$
4

 
$
—

 
$
—




The following table presents the location and amount of unrealized gains (losses) included in OCI:
 
Three Months Ended
March 31,
2020
 
2019
Foreign currency contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
$
25

 
$
(3
)
Commodity contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
—

 
1

Foreign currency contracts designated as net investment hedges:
 
 
 
Gain (loss) on instruments
25

 
6

Gain (loss) on hedged items
(25
)
 
(6
)
Foreign currency debt designated as net investment hedges:
 
 
 
Gain (loss) on instruments
65

 
29

Gain (loss) on hedged items
(65
)
 
(29
)
Total unrealized gain (loss) on hedges recognized in OCI
$
25

 
$
(2
)





21
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Executive Overview

Business Organization

Colgate-Palmolive Company (together with its subsidiaries, “we,” the “Company” or “Colgate”) seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, we are tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, we follow a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which we compete, we prioritize our efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, we are organized along geographic lines with management teams having responsibility for the business and financial results in each region. We compete in more than 200 countries and territories worldwide with established businesses in all regions contributing to our sales and profitability. Approximately 70% of our Net sales are generated from markets outside the U.S., with approximately 45% of our Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce our exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors. Through Hill’s Pet Nutrition, we also compete on a worldwide basis in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and eCommerce retailers. We are engaged in manufacturing and sourcing of products and materials on a global scale and have major manufacturing, warehousing facilities and distribution centers in every region around the world.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. In addition, we review market share data to assess how our brands are performing within their categories on a global and regional basis. The monitoring of these indicators and our Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures and the Company’s use of market share data and the limitations of such data, see “Non-GAAP Financial Measures” and “Market Share Information” below.

COVID-19

The novel coronavirus (“COVID-19”) has had a profound impact on the way people live, work, interact and shop and has severely restricted economic activity around the world. We have a well-established Crisis Management Team (“CMT”) process, and the CMT, together with our senior management team and Colgate people around the world, are working to respond to the challenges presented by COVID-19.

During the quarter ended March 31, 2020, many of the communities in which we manufacture, market and sell our products have experienced unprecedented “stay at home” orders, travel or movement restrictions and other government actions. Because the vast majority of our products (such as oral care products, soaps and other personal hygiene products, home cleaners and pet food) have been deemed essential for the health and well-being of people and their pets, we have, in most instances, been able to continue operating our business. In so doing, the health and safety of Colgate employees has been our first priority and, wherever possible, we have asked our employees globally to work from home, including most employees in our New York City headquarters, Piscataway, New Jersey technology campus, hubs and subsidiaries worldwide and shared business service centers. In those instances where our employees cannot work from home, such as in our factories and in certain of our laboratories, we have implemented additional safety measures and social distancing protocols, consistent with government recommendations and/or requirements, to help to ensure their safety. Even with such measures in place, we have experienced

22
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


some limited factory closures, particularly in India, and in some instances we have seen increased instances of absenteeism. In addition, some of our suppliers, customers, distributors and service providers have experienced disruptions to their businesses.

We saw a significant increase in demand across most of our categories in the quarter ended March 31, 2020. While some of this increase has been caused by consumers’ pantry-loading activity, we believe that some of the increased demand for our health and hygiene products (for example, liquid hand soap) is the result of increased consumption and may be sustainable. At the same time, we experienced declines in Greater China, India and in certain channels, including professional sales and travel retail, due to the economic slowdown and restricted consumer movement. We have also seen changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online. During the quarter ended March 31, 2020, in some instances, we were not able to keep up with the increased consumer demand for our products and our products were at times out of stock on retailers’ shelves. We expect that this may continue for a period of time as we continue to ramp up production of in-demand products.

Government actions in response to COVID-19 could, in the future, impact our consumers’ ability to purchase and our ability to manufacture and distribute our products. Nonetheless, we believe that, in the long-term, consumer demand for products in our categories will be strong. However, uncertainty continues surrounding the timing and extent of recovery, when travel and movement restrictions will abate, the timing and impact of consumer pantry-loading activity in certain markets, product demand trends and the impact of COVID-19 on the global economy. Our retail customers are also being impacted by the global pandemic; their success in addressing COVID-19 and maintaining their operations could impact consumer access to and sales of our products.

While we currently expect to be able to continue operating our business as described above and we intend to continue to work with government authorities and to follow the necessary protocols to maintain the health and safety of our employees and contract providers, uncertainty resulting from COVID-19 could result in an unforeseen additional disruption to our business, including our global supply chain and retailer network.

For more information about the anticipated COVID-19 impact, see “Outlook” below.

Business Strategy

To achieve our business and financial objectives, we are focused on innovating our core businesses; improving our brand building activities with an elevated brand purpose model and the use of equity advertising; innovating to gain market share in high growth segments and adjacencies; expanding into new channels and markets; maximizing growth online; and investing to drive consumption in growing populations. We continue to develop initiatives to build strong relationships with consumers, dental, veterinary and skin health professionals and traditional and eCommerce retailers. In addition, we continue to invest behind our brands, not just in terms of advertising, but also to build key growth capabilities in areas such as innovation and data and analytics. We also continue to broaden our eCommerce offerings, including direct-to-consumer and subscription services. We continue to believe that growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products. We are also working to integrate our sustainability strategy across our organization.

We are also changing the way we work to drive growth and how we approach innovation to respond to the dynamic retail landscape and the evolving preferences of our customers and consumers. The retail landscape, the ease of new entrants into the market in many of our categories and the evolving preferences of our customers and consumers demand that we work differently and faster in an agile, authentic and culturally relevant manner to drive innovation.

The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as our funding-the-growth initiatives, we seek to become even more effective and efficient throughout our businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. We also continue to prioritize our investments in high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses, including by expanding our portfolio in premium skin health.


23
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Significant Items Impacting Comparability
On January 31, 2020, the Company acquired Hello Products LLC, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company's strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses. See Note 4, Acquisitions to the Condensed Consolidated Financial Statements for additional information.

The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described in “Results of Operations-Income Taxes,” and in Note 10, Income Taxes to the Condensed Consolidated Financial Statements, both items were previously recorded in connection with the charge recorded in 2017 and revised in 2018 related to the Tax Cuts and Jobs Act (the “TCJA”).
On September 19, 2019, the Company acquired Laboratoires Filorga Cosmétiques S.A. (“Filorga”), a skin health business, for cash consideration of €1,548 (approximately $1,712). Filorga is a premium anti-aging skin health brand focused primarily on facial care. The acquisition was financed with a combination of debt and cash. This acquisition is part of our strategy to focus on high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses, including by expanding our portfolio in premium skin health. See Note 4, Acquisitions to the Condensed Consolidated Financial Statements for additional information.
Our restructuring program, known as the "Global Growth and Efficiency Program," concluded on December 31, 2019. The program's initiatives were designed to help us ensure sustained solid worldwide growth in unit volume, organic sales, operating profit and earnings per share and to enhance our global leadership positions in our core businesses. See Note 5, Restructuring and Related Implementation Charges to the Condensed Consolidated Financial Statements for additional information.










24
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Outlook

Looking forward, we expect global macroeconomic, political and market conditions to remain challenging, especially due to the COVID-19 crisis. Although we have seen short-term improvement in category growth rates due to consumer pantry-loading activity, we have seen increased volatility in consumption rates in our categories and expect category growth rates to slow going forward as pantry inventory diminishes and to remain below historical levels. While the global marketplace in which we operate has always been highly competitive, we continue to experience heightened competitive activity in certain markets from strong local competitors, from other large multinational companies, some of which have greater resources than we do, and from new entrants into the market in many of our categories. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. We expect promotional activities to increase as retailers try aggressively to get consumers back into the stores after prolonged “stay at home” and other government restrictions ease over the coming months. We have been negatively affected by changes in the policies or practices of our retail trade customers in key markets, such as inventory de-stocking, limitations on access to shelf space or delisting of our products. In addition, the retail landscape in many of our markets continues to be impacted by the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the emergence of alternative retail channels, such as subscription services and direct-to-consumer businesses. These trends have been magnified due to the COVID-19 crisis in many of our geographies and we plan to continue to invest behind our eCommerce capabilities. This rapid growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers. In addition, given that approximately 70% of our Net sales originate in markets outside the U.S., we have experienced and will likely continue to experience increasingly volatile foreign currency fluctuations and higher raw and packaging material costs. While we have taken, and will continue to take, measures to mitigate the effect of these conditions, in the current environment, it may become increasingly difficult to implement certain of these mitigation strategies. Should these conditions persist, they could adversely affect our future results.

As discussed above, we continue to closely monitor the impact of COVID-19 on our business. While we have taken, and will continue to take, measures to mitigate the effects of COVID-19, we cannot estimate with certainty the full extent of COVID-19’s impact on our business, results of operations, cash flows and/or financial condition. For more information about factors that could impact our business, including due to COVID-19, see “Risk Factors” in Part II, Item IA of this Quarterly Report and Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019.

In summary, we believe we are well prepared to meet the challenges ahead due to our strong financial condition, experience operating in challenging environments, resilient global supply chain and continued focus on our key priorities: growing sales through engaging with consumers, developing world-class innovation and working with retail partners; driving efficiency on every line of the income statement to increase margins; generating strong cash flow performance and utilizing that cash effectively to enhance total shareholder return; and leading to win by staying true to the Company’s culture and focusing on its stakeholders. Our key focus is to sustain the underlying momentum of our business, to adapt our financial plans to deliver on 2020, while leaving us well positioned for a return to stronger growth in 2021. Our commitment to these priorities, together with the strength of our global brands, our broad international presence in both developed and emerging markets and cost-saving initiatives, such as our funding-the-growth initiatives, should position us well to manage through the COVID-19 crisis and to increase shareholder value over the long term.
















25
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Results of Operations

Three Months

Worldwide Net sales were $4,097 in the first quarter of 2020, up 5.5% from the first quarter of 2019, as volume growth of 7.0% and net selling price increases of 2.0% were partially offset by negative foreign exchange of 3.5%. Acquisitions contributed 1.5% to volume. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, increased 7.5% in the first quarter of 2020. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.

Net sales in the Oral, Personal and Home Care product segment were $3,378 in the first quarter of 2020, up 3.0% from the first quarter of 2019, as volume growth of 5.5% and net selling price increases of 1.5% were partially offset by negative foreign exchange of 4.0%. Acquisitions contributed 2.0% to volume. Organic sales in the Oral, Personal and Home Care product segment increased 5.0% in the first quarter of 2020.

The Company’s share of the global toothpaste market was 40.5% on a year-to-date basis, down 0.9 share points from the year ago period, and its share of the global manual toothbrush market was 32.1% on a year-to-date basis, up 0.5 share points from the year ago period. Year-to-date market shares in toothpaste were up in Latin America and Europe and down in North America, Asia Pacific and Africa/Eurasia versus the comparable 2019 period. In the manual toothbrush category, year-to-date market shares were up in Latin America, Europe and Asia Pacific, flat in Africa/Eurasia and down in North America versus the comparable 2019 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales in the Hill’s Pet Nutrition segment were $719 in the first quarter of 2020, up 20.0% from the first quarter of 2019, as volume growth of 17.0% and net selling price increases of 4.0% were partially offset by negative foreign exchange of 1.0%. Organic sales in the Hill’s Pet Nutrition segment increased 21.0% in the first quarter of 2020.


26
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Gross Profit/Margin

Worldwide Gross profit increased to $2,465 in the first quarter of 2020 from $2,287 in the first quarter of 2019. Gross profit in the first quarter of 2020 included acquisition-related costs. Gross profit in the first quarter of 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding acquisition-related costs in the first quarter of 2020 and charges resulting from the Global Growth and Efficiency Program in the first quarter of 2019, Gross profit increased to $2,469 in the first quarter of 2020 from $2,298 in the first quarter of 2019, reflecting an increase of $126 resulting from higher Net sales and an increase of $45 resulting from higher Gross profit margin.

Worldwide Gross profit margin increased to 60.2% in the first quarter of 2020 from 58.9% in the first quarter of 2019. Excluding the items described above in both periods as applicable, Gross profit margin increased by 110 basis points (bps) to 60.3% in the first quarter of 2020 from 59.2% in the first quarter of 2019. This increase in Gross profit margin was due to cost savings from the Company’s funding-the-growth initiatives (150 bps), higher pricing (70 bps) and favorable mix (20 bps), partially offset by higher raw and packaging material costs (130 bps), which included foreign exchange transaction costs.
 
 
Three Months Ended March 31,
 
 
2020
 
2019
Gross profit, GAAP
 
$
2,465

 
$
2,287

Acquisition-related costs
 
4

 
—

Global Growth and Efficiency Program
 
—

 
11

Gross profit, non-GAAP
 
$
2,469

 
$
2,298


 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
Basis Point Change
Gross profit margin, GAAP
 
60.2
%
 
58.9
%
 
130

Acquisition-related costs
 
0.1

 
—

 
 
Global Growth and Efficiency Program
 
—

 
0.3

 
 
Gross profit margin, non-GAAP
 
60.3
%
 
59.2
%
 
110


27
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 8% to $1,473 in the first quarter of 2020 from $1,365 in the first quarter of 2019. Selling, general and administrative expenses in the first quarter of 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding charges resulting from the Global Growth and Efficiency Program in the first quarter of 2019, Selling, general and administrative expenses increased to $1,473 in the first quarter of 2020 from $1,361 in the first quarter of 2019, reflecting higher overhead expenses of $57 and increased advertising investment of $55.

Selling, general and administrative expenses as a percentage of Net sales increased to 36.0% in the first quarter of 2020 from 35.1% in the first quarter of 2019. Excluding charges resulting from the Global Growth and Efficiency Program in the first quarter of 2019, Selling, general and administrative expenses as a percentage of Net sales increased by 100 bps to 36.0% in the first quarter of 2020 as compared to 35.0% in the first quarter of 2019. This increase was due to increased advertising investment (80 bps) and higher overhead expenses (20 bps) primarily due to higher logistics costs, both as a percentage of Net sales. In the first quarter of 2020, advertising investment increased as a percentage of Net sales to 11.8% from 11.0% in the first quarter of 2019 or 13% in absolute terms to $484, as compared with $429 in the first quarter of 2019.

 
 
Three Months Ended March 31,
 
 
2020
 
2019
Selling, general and administrative expenses, GAAP
 
$
1,473

 
$
1,365

Global Growth and Efficiency Program
 
—

 
(4
)
Selling, general and administrative expenses, non-GAAP
 
$
1,473

 
$
1,361


 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP
 
36.0
%
 
35.1
 %
 
90
Global Growth and Efficiency Program
 
—

 
(0.1
)
 
 
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP
 
36.0
%
 
35.0
 %
 
100


28
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Operating Profit

Operating profit increased 8% to $952 in the first quarter of 2020 from $879 in the first quarter of 2019. Operating profit in the first quarter of 2020 included acquisition-related costs. Operating profit in the first quarter of 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding acquisition-related costs in the first quarter of 2020 and charges resulting from the Global Growth and Efficiency Program in the first quarter of 2019, Operating profit increased to $958 in the first quarter of 2020 from $907 in the first quarter of 2019, as an increase in Gross profit was partially offset by an increase in Selling, general and administrative expenses.

Operating profit margin was 23.2% in the first quarter of 2020, an increase of 60 bps compared to 22.6% in the first quarter of 2019. Excluding the items described above in both periods as applicable, Operating profit margin was 23.4% in the first quarter of 2020, even with the first quarter of 2019, as higher Gross profit (110 bps) was largely offset by increases in Selling, general and administrative expenses (100 bps), both as a percentage of Net sales.

 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
% Change
Operating profit, GAAP
 
$
952

 
$
879

 
8
%
Global Growth and Efficiency Program
 
—

 
28

 
 
Acquisition-related costs
 
6

 
—

 
 
Operating profit, non-GAAP
 
$
958

 
$
907

 
6
%

 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
Basis Point Change
Operating profit margin, GAAP
 
23.2
%
 
22.6
%
 
60
Global Growth and Efficiency Program
 
—

 
0.8

 
 
Acquisition-related costs
 
0.2

 
—

 
 
Operating profit margin, non-GAAP
 
23.4
%
 
23.4
%
 
—

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $21 in the first quarter of 2020, as compared to $25 in the first quarter of 2019. Non-service related postretirement costs in the first quarter of 2019 included charges resulting from the Global Growth and Efficiency Program. Excluding charges resulting from the Global Growth and Efficiency Program in the first quarter of 2019, Non-service related postretirement costs were $21 in the first quarter of 2020, as compared to $24 in the first quarter of 2019.

 
 
Three Months Ended March 31,
 
 
2020
 
2019
Non-service related postretirement costs, GAAP
 
$
21

 
$
25

Global Growth and Efficiency Program
 
—

 
(1
)
Non-service related postretirement costs, non-GAAP
 
$
21

 
$
24


Interest (Income) Expense, Net

Interest (income) expense, net was $36 in the first quarter of 2020 as compared to $40 in the first quarter of 2019, primarily due to lower average interest rates on debt.


29
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Income Taxes

The effective income tax rate was 16.4% for the first quarter of 2020 as compared to 26.3% for the first quarter of 2019. As reflected in the table below, the non-GAAP effective income tax rate was 24.4% for the quarter ended March 31, 2020, as compared to 26.2% in the comparable period of 2019.

The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 24.7%, compared to 26.1% in the first quarter of 2019. See Note 10, Income Taxes to the Condensed Consolidated Financial Statements for additional details.

 
 
Three Months Ended March 31,
 
 
2020
 
2019
 
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Effective Income Tax Rate(2)
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Effective Income Tax Rate(2)
As Reported GAAP
 
$
895

 
$
147

 
16.4
%
 
$
814

 
$
214

 
26.3
 %
Global Growth and Efficiency Program
 
—

 
—

 
—

 
29

 
7

 
(0.1
)
Subsidiary and operating structure initiatives
 
—

 
71

 
7.9
%
 
—

 
—

 
—

Acquisition-related costs
 
6

 
2

 
0.1
%
 
—

 
—

 
—

Non-GAAP
 
$
901

 
$
220

 
24.4
%
 
$
843

 
$
221

 
26.2
 %
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the TCJA.

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company has now determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes.

Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company now believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26.


30
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company for the first quarter of 2020 increased to $715 from $560 in the first quarter of 2019, and Earnings per common share on a diluted basis increased to $0.83 per share in the first quarter of 2020 from $0.65 in the first quarter of 2019. Net income attributable to Colgate-Palmolive Company in the first quarter of 2020 included acquisition-related costs and a benefit related to subsidiary and operating structure initiatives and Net income attributable to Colgate-Palmolive Company in the first quarter of 2019 included charges resulting from the Global Growth and Efficiency Program. See Note 10, Income Taxes for additional information.

Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the first quarter of 2020 increased 11% to $648 from $582 in the first quarter of 2019, and Earnings per common share on a diluted basis increased 12% to $0.75 in the first quarter of 2020 from $0.67 in the first quarter of 2019.
 
Three Months Ended March 31, 2020
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Net Income Including Noncontrolling Interests
 
Net Income Attributable To Colgate-Palmolive Company
 
Diluted Earnings Per Share(2)
As Reported GAAP
$
895

 
$
147

 
$
748

 
$
715

 
$
0.83

Subsidiary and operating structure initiatives
—

 
71

 
(71
)
 
(71
)
 
(0.08
)
Acquisition-related costs
6

 
2

 
4

 
4

 
—

Non-GAAP
$
901

 
$
220

 
$
681

 
$
648

 
$
0.75


 
Three Months Ended March 31, 2019
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Net Income Including Noncontrolling Interests
 
Net Income Attributable To Colgate-Palmolive Company
 
Diluted Earnings Per Share(2)
As Reported GAAP
$
814

 
$
214

 
$
600

 
$
560

 
$
0.65

Global Growth and Efficiency Program
29

 
7

 
22

 
22

 
0.02

Non-GAAP
$
843

 
$
221

 
$
622

 
$
582

 
$
0.67

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

31
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America
 
Three Months Ended March 31,
 
2020
 
2019
 
Change
Net sales
$
929

 
$
853

 
9.0

%
Operating profit
$
258

 
$
249

 
4

%
% of Net sales
27.8
%
 
29.2
%
 
(140
)
bps

Net sales in North America increased 9.0% in the first quarter of 2020 to $929, as volume growth of 9.5% was partially offset by negative foreign exchange of 0.5%, while net selling prices were flat. The Company's acquisition of Hello Products LLC contributed 1.5% to volume in North America. Organic sales in North America increased 8.0% in the first quarter of 2020. Organic sales growth was led by the United States.

The increase in organic sales in North America in the first quarter of 2020 versus the first quarter of 2019 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste, manual toothbrush and prescription dental categories, partially offset by a decline in organic sales in the mouthwash category. The increase in Personal Care was primarily due to organic sales growth in the skin health, liquid hand soap and bar soap categories. The increase in Home Care was primarily due to organic sales growth in the hand dish, liquid cleaner and fabric softener categories.
 
Operating profit in North America increased 4% in the first quarter of 2020 to $258, while as a percentage of Net sales it decreased 140 bps to 27.8%. This decrease in Operating profit as a percentage of Net sales was due to increases in Selling, general and administrative expenses (100 bps) and Other (income) expense, net (50 bps), partially offset by an increase in Gross profit (10 bps), all as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (120 bps), partially offset by higher raw and packaging material costs (60 bps) and unfavorable mix (30 bps). This increase in Selling, general and administrative expenses was primarily due to increased advertising investment (80 bps) and higher overhead expenses (20 bps), primarily driven by higher logistics costs.

Latin America
 
Three Months Ended March 31,
 
2020
 
2019
 
Change
Net sales
$
889

 
$
889

 
—

%
Operating profit
$
248

 
$
232

 
7

%
% of Net sales
27.9
%
 
26.1
%
 
180

bps

Net sales in Latin America in the first quarter of 2020 were $889, even with the first quarter of 2019, as volume growth of 4.0% and net selling price increases of 6.5% were offset by negative foreign exchange of 10.5%. Organic sales in Latin America increased 10.5% in the first quarter of 2020. Organic sales growth was led by Argentina, Brazil and Mexico.

The increase in organic sales in Latin America in the first quarter of 2020 versus the first quarter of 2019 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste, manual toothbrush and mouthwash categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and underarm protection categories. The increase in Home Care was primarily due to organic sales growth in the liquid cleaner and hand dish categories.


32
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Operating profit in Latin America increased 7% in the first quarter of 2020 to $248, or 180 bps to 27.9% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (140 bps) as a percentage of Net sales. This increase in Gross profit was primarily due to higher pricing and cost savings from the Company’s funding-the-growth initiatives (200 bps), partially offset by higher raw and packaging material costs (240 bps), which included foreign exchange transaction costs.
 
Europe
 
Three Months Ended March 31,
 
2020
 
2019
 
Change
Net sales
$
675

 
$
602

 
12

%
Operating profit
$
154

 
$
151

 
2

%
% of Net sales
22.8
%
 
25.1
%
 
(230
)
bps

Net sales in Europe increased 12.0% in the first quarter of 2020 to $675, as volume growth of 16.5% was partially offset by net selling price decreases of 1.5% and negative foreign exchange of 3.0%. The Company's acquisition of the Filorga skin health business contributed 8.5% to volume in Europe. Organic sales in Europe increased 6.5% in the first quarter of 2020. Organic sales growth was led by the United Kingdom and Germany.

The increase in organic sales in Europe in the first quarter of 2020 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category, partially offset by declines in organic sales in the prescription dental and battery-powered toothbrush categories. The increase in Personal Care was primarily due to an increase in organic sales in the liquid hand soap, body wash and bar soap categories. The increase in Home Care was primarily due to organic sales growth in the spray and liquid cleaners, household bleach and hand dish categories.

Operating profit in Europe increased 2% in the first quarter of 2020 to $154, while as a percentage of Net sales it decreased 230 bps to 22.8%. This decrease in Operating profit as a percentage of Net Sales was due to increases in Selling, general and administrative expenses (230 bps) and Other (income) expense, net (130 bps), partially offset by an increase in Gross profit (130 bps), all as a percentage of Net sales. This increase in Gross profit was primarily due to favorable mix (140 bps) and cost savings from the Company’s funding-the-growth initiatives (110 bps), partially offset by higher raw and packaging material costs (60 bps), which included foreign exchange transaction costs, and lower pricing. This increase in Selling, general and administrative expenses was due to higher overhead expenses (170 bps) and increased advertising investment (60 bps). This increase in Other (income) expense, net was due to the incremental amortization expense related to the Filorga acquisition (130 bps).

Asia Pacific
 
Three Months Ended March 31,
 
2020
 
2019
 
Change
Net sales
$
633

 
$
700

 
(9.5
)
%
Operating profit
$
161

 
$
189

 
(15
)
%
% of Net sales
25.4
%
 
27.0
%
 
(160
)
bps

Net sales in Asia Pacific decreased 9.5% in the first quarter of 2020 to $633, as volume declines of 8.5% and negative foreign exchange of 2.0% were partially offset by net selling price increases of 1.0%. Organic sales in Asia Pacific decreased 7.5% in the first quarter of 2020. Organic sales declines in the Greater China region and India were partially offset by organic sales growth in Australia.

The decrease in organic sales in Asia Pacific in the first quarter of 2020 was primarily due to a decrease in Oral Care organic sales. The decrease in Oral Care was primarily due to declines in organic sales in the toothpaste and manual toothbrush categories.


33
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Operating profit in Asia Pacific decreased 15% in the first quarter of 2020 to $161, or 160 bps to 25.4% of Net Sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (180 bps), partially offset by an increase in Gross profit (10 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (180 bps), partially offset by higher raw and packaging material costs (150 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was due to higher overhead expenses (140 bps), primarily driven by higher logistics costs, and increased advertising investment (40 bps).

Africa/Eurasia
 
Three Months Ended March 31,
 
2020
 
2019
 
Change
Net sales
$
252

 
$
240

 
5.0

%
Operating profit
$
56

 
$
46

 
22

%
% of Net sales
22.2
%
 
19.2
%
 
300

bps

Net sales in Africa/Eurasia increased 5.0% in the first quarter of 2020 to $252, as volume growth of 10.0% was partially offset by net selling price decreases of 0.5% and negative foreign exchange of 4.5%. The Company’s acquisition of a 51% controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited (the “Nigeria Joint Venture”), contributed 1.5% to volume in Africa/Eurasia. Organic sales in Africa/Eurasia increased 8.0% in the first quarter of 2020. Organic sales growth was led by Turkey and Russia.

The increase in organic sales in Africa/Eurasia in the first quarter of 2020 versus the first quarter of 2019 was primarily due to increases in Oral Care and Personal Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and body wash categories.

Operating profit in Africa/Eurasia increased 22% in the first quarter of 2020 to $56, or 300 bps to 22.2% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (270 bps) and a decrease in Selling, general and administrative expenses (40 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (230 bps) and lower raw and packaging material costs (40 bps). This decrease in Selling, general and administrative expenses was due to lower overhead expenses (230 bps), partially offset by increased advertising investment (190 bps).

Hill’s Pet Nutrition
 
Three Months Ended March 31,
 
2020
 
2019
 
Change
Net sales
$
719

 
$
600

 
20.0

%
Operating profit
$
203

 
$
164

 
24

%
% of Net sales
28.2
%
 
27.3
%
 
90

bps

Net sales for Hill’s Pet Nutrition increased 20.0% in the first quarter of 2020 to $719, as volume growth of 17.0% and net selling price increases of 4.0% were partially offset by negative foreign exchange of 1.0%. Organic sales in Hill’s Pet Nutrition increased 21.0% in the first quarter of 2020. Organic sales growth was led by the United States and Europe.

The increase in organic sales in the first quarter of 2020 versus the first quarter of 2019 was primarily due to increases in organic sales in the Prescription Diet and Science Diet categories.


34
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Operating profit in Hill’s Pet Nutrition increased 24% in the first quarter of 2020 to $203, or 90 bps to 28.2% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (120 bps), partially offset by an increase in Selling, general and administrative expenses (50 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (130 bps) and higher pricing, partially offset by higher raw and packaging material costs (170 bps). This increase in Selling, general and administrative expenses was due to increased advertising investment (210 bps), partially offset by lower overhead expenses (160 bps).

During the quarter ended March 31, 2019, Hill’s announced a voluntary recall, which was subsequently expanded, of select canned dog food products due to potentially elevated levels of Vitamin D resulting from a supplier error. In the United States, the voluntary recall was conducted in cooperation with the U.S. Food and Drug Administration. Following the announcement of the voluntary recall, and as of March 31, 2020, Hill’s and/or the Company have been named as defendants in 37 putative class action lawsuits, one putative class action filed on behalf of a European Union class and one individual action, all related to the voluntary recall and filed in various jurisdictions in the United States. In addition, two putative class actions related to the voluntary recall have been filed in Canada. Eight of the putative class actions lawsuits in the United States and one of the putative class action lawsuits in Canada have been voluntarily dismissed. Hill’s is entitled to indemnification from the supplier related to the voluntary recall. Sales of products voluntarily recalled represent less than 2% of Hill’s annual Net sales. The sales loss and other costs associated with the voluntary recall and subsequent expansion did not have a material impact on the Company’s Net sales or Operating profit are not expected to have a material impact in future periods.

Corporate
 
Three Months Ended March 31,
 
2020
 
2019
 
Change

 
Operating profit (loss)
$
(128
)
 
$
(152
)
 
(16
)
%

Operating profit (loss) related to Corporate was ($128) in the first quarter of 2020 as compared to ($152) in the first quarter of 2019. In the first quarter of 2020, Corporate Operating profit (loss) included acquisition-related costs of $6. In the first quarter of 2019, Corporate Operating profit (loss) included charges of $28 resulting from the Global Growth and Efficiency Program, which concluded on December 31, 2019.


35
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Quarterly Report on Form 10-Q. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the three months ended March 31, 2020 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and excluding, as applicable, the charges resulting from the Global Growth and Efficiency Program, acquisition-related costs and a benefit related to a recent reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure being implemented within one of the Company's divisions. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain acquisition, divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three months ended March 31, 2020 and 2019 is presented within the applicable section of Results of Operations.

The following table provides a quantitative reconciliation of Net sales growth to organic sales growth for the three months ended March 31, 2020:

Three Months Ended March 31, 2020
Net Sales Growth
(GAAP)
Foreign
Exchange
Impact
Acquisitions and Divestments
Impact
Organic
Sales Growth
(Non-GAAP)
Oral, Personal and Home Care
 
 
 
 
North America
9.0%
(0.5)%
1.5%
8.0%
Latin America
—%
(10.5)%
—%
10.5%
Europe
12.0%
(3.0)%
8.5%
6.5%
Asia Pacific
(9.5)%
(2.0)%
—%
(7.5)%
Africa/Eurasia
5.0%
(4.5)%
1.5%
8.0%
Total Oral, Personal and Home Care
3.0%
(4.0)%
2.0%
5.0%
Pet Nutrition
20.0%
(1.0)%
—%
21.0%
Total Company
5.5%
(3.5)%
1.5%
7.5%



36
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures and stock repurchases). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations increased 27% to $768 in the first three months of 2020, compared with $605 in the comparable period of 2019, primarily due to higher net income, lower voluntary contributions to the Company’s pension plans and lower income tax payments. The Company continues to be tightly focused on working capital. The Company’s working capital was (3.6%) as a percentage of Net sales in the first three months of 2020 as compared to (3.9%) in the first three months of 2019. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt).

Investing activities used $459 of cash in the first three months of 2020, compared with $98 in the comparable period of 2019. As more fully described below, investing activities in the first three months of 2020 include the Company’s acquisition of Hello Products LLC.

On September 19, 2019, the Company acquired Filorga for cash consideration of €1,516 (approximately $1,674) plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. On August 15, 2019, the Company acquired a 51% controlling interest in the Nigeria Joint Venture for $31. On January 31, 2020, the Company acquired Hello Products LLC for cash consideration of $351.

These acquisitions were financed with a combination of debt and cash. As a result of the incremental debt related to these acquisitions, the Company moderated its share repurchases in the first quarter of 2020 and will continue to do so into 2021 in order to reduce debt levels.

Capital spending was $82 in the first three months of 2020 compared to $71 in the comparable period of 2019. Capital expenditures for 2020 are expected to be approximately 2.5% to 3.0% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. 

Financing activities used $308 of cash during the first three months of 2020, compared with $392 used in the comparable period of 2019, primarily reflecting higher proceeds from the exercise of stock options in the first three months of 2020 compared with the comparable period of 2019.

Long-term debt, including the current portion, increased to $7,591 as of March 31, 2020 as compared to $7,587 as of December 31, 2019 and total debt was $7,846 as of March 31, 2020 as compared to $7,847 as of December 31, 2019. During the first quarter of 2019, the Company issued €500 of seven-year notes at a fixed coupon rate of 0.500% and €500 of fifteen-year notes at a fixed coupon rate of 1.375%. The debt issuances were under the Company’s shelf registration statement. The debt issuances support the Company’s capital structure objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. Proceeds from the debt issuances were used for general corporate purposes, which included the retirement of commercial paper and the repayment of the Company’s $500 1.75% fixed rate notes, which became due in March 2019, and €500 floating rate notes, which became due May 2019.


37
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Domestic and foreign commercial paper outstanding was $858 and $216 as of March 31, 2020 and 2019, respectively. The average daily balances outstanding for commercial paper in the first three months of 2020 and 2019 were $1,694 and $1,548, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its unused lines of credit of approximately $4,500 (including under the facilities discussed below) or by issuing medium-term notes pursuant to an effective shelf registration statement. In November 2018, the Company entered into an amended and restated $2,650 revolving credit facility with a syndicate of banks that was scheduled to expire in November 2023. In August 2019, the term of the facility was extended by one year and it now expires in November 2024. In August 2019, the Company entered into a $1,500 364-day credit facility with a syndicate of banks that is scheduled to expire in August 2020. Commitment fees related to the credit facilities are not material.

Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long term Debt and Credit Facilities, on the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 for further information about the Company’s long-term debt and credit facilities.

In the first quarter of 2020, the Company increased the quarterly common stock dividend to $0.44 per share from $0.43 per share previously, effective in the second quarter of 2020.

Cash and cash equivalents decreased $29 during the first three months of 2020 to $854 at March 31, 2020, compared to $883 at December 31, 2019, most of which ($794 and $798, respectively) were held by the Company’s foreign subsidiaries.

During the quarter ended March 31, 2020, COVID-19 did not have a significant impact on the Company’s access to global credit and capital markets needed to maintain sufficient liquidity for its continued operating and cash needs. For more information regarding the anticipated impact of COVID-19, see “Executive Overview” and “Risk Factors” in Part II, Item 1A of this Quarterly Report and in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

38
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Goodwill and Indefinite-Lived Intangible Assets

As a result of the COVID-19 pandemic, the Company assessed whether a “triggering event” had occurred indicating a possible impairment of its goodwill and indefinite life intangible assets. As a result of this assessment, the Company determined that a “triggering event” had occurred relative to its recently acquired Filorga skin health business and, as required, performed a quantitative analysis, with the assistance of a third-party valuation firm, of the value of the Filorga reporting unit and its indefinite-life intangible assets. Based on the analysis, the Company determined that the fair value of the Filorga reporting unit and the related indefinite life intangible assets continue to exceed their carrying values and were not impaired as of March 31, 2020.

Determining the fair value of the Filorga reporting unit and indefinite-lived intangible assets requires significant judgment and estimates by management regarding several key inputs, including future cash flows consistent with management’s strategic plans, sales growth rates and the selection of royalty rates and a discount rate, amongst others. Estimating sales growth rates requires significant judgment by management in areas such as future economic conditions, category and industry growth rates, product pricing, consumer tastes and preferences and future expansion expectations. Given the inherent uncertainties in estimating the future impacts of the COVID-19 pandemic on global macroeconomic conditions and interest rates in general and on the Filorga business in particular, actual results may differ from management’s current estimates and could have an adverse impact on one or more of the assumptions used in our quantitative models related to the Filorga reporting unit, resulting in potential impairment charges in subsequent periods. As of March 31, 2020, the fair value of the Filorga reporting unit exceeded its carrying value by 10%. A reduction in the long-term growth rate of 50 basis points or an increase in the discount rate of 25 basis points would result in a reduction of the fair value of the Filorga reporting unit of approximating 5%. Given the recent acquisition of Filorga, where there is inherently a lower surplus of fair value over carrying value, management will continue to assess triggering events that may necessitate additional qualitative or quantitative analyses of our reporting units and indefinite-lived intangible assets in future periods.











39
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin growth, earnings per share growth, financial goals, the impact of foreign exchange, the impact of COVID-19, cost-reduction plans, tax rates, new product introductions, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not nor does any other person assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic and political environment in different countries and its effect on consumer spending habits, foreign currency rate fluctuations, exchange controls, tariffs, price or profit controls, labor relations, changes in foreign or domestic laws, or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, increased competition and evolving competitive practices (including from the growth of eCommerce and the entry of new competitors and business models), the ability to operate and respond effectively during a pandemic, epidemic or widespread public health concern, including COVID-19, disruptions in global supply chain, the availability and cost of raw and packaging materials, the ability to maintain or increase selling prices as needed, changes in the policies of retail trade customers, the emergence of new sales channels, the growth of eCommerce and the changing retail landscape (as consumers increasingly shop online), the ability to develop innovative new products, the ability to continue lowering costs and operate in an agile manner, the ability to maintain the security of our information technology systems from a cyber-security incident or data breach, the ability to achieve our sustainability goals, the ability to complete acquisitions and divestitures as planned, the ability to successfully integrate acquired businesses, the ability to attract and retain key employees, and the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and subsequent Quarterly Reports on Form 10-Q).


40
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2019.


41



COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2020 (the “Evaluation”). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control Over Financial Reporting

The Company is in the process of upgrading its enterprise IT system to SAP S/4 HANA. This change is not expected to have a material impact on the Company’s internal controls over financial reporting.

Except as noted above, there were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.



42



COLGATE-PALMOLIVE COMPANY

PART II.    OTHER INFORMATION

Item 1.    Legal Proceedings

For information regarding legal matters, please refer to Note 11, Contingencies to the Condensed Consolidated Financial Statements contained in Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Item 1A.    Risk Factors

With the exception of the change in risk factors discussed below, there have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

We face various risks related to pandemics, epidemics or similar widespread public health concerns, which may have a material adverse effect on our business, results of operations, cash flows and financial condition.

We face various risks related to pandemics, epidemics or similar widespread public health concerns, including the novel coronavirus pandemic (“COVID-19”). A pandemic, epidemic or similar widespread health concern could have, and COVID-19 has had and may continue to have, a variety of impacts on our business, results of operations, cash flows and financial condition, including:

•
Our ability to continue to maintain and support the health and safety of our employees, including key employees;
•
Volatility in the demand for and availability of our products, which may be caused by the temporary inability of our consumers to purchase our products due to illness, financial hardship, quarantine, government actions mandating the closure of our distributors or retailers or imposing travel or movement restrictions, shifts in demand away from more discretionary or higher priced products to lower priced products, or pantry-loading activity;
•
Changes in purchasing patterns of our consumers, including the frequency of visits by consumers to retail locations and a shift to purchasing our products online from eCommerce retailers;
•
Inability to meet our customers' needs and achieve our cost targets due to temporary or long-term disruptions in the manufacture, sourcing and distribution of our products or materials despite our business continuity and contingency plans in place for key manufacturing sites and the supply of raw and packaging materials;
•
Failure of third parties on which we rely, including our suppliers, contract manufacturers, customers, commercial banks, joint venture partners and external business partners, to meet their obligations to us, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties;
•
Significant changes in the economic and political conditions of the markets in which we operate, which could restrict and have restricted our employees’ ability to work and travel, could mandate and have mandated or caused the closure of certain distributors or retailers, our offices, shared business service centers and/or operating and manufacturing facilities or otherwise could prevent and have prevented us as well as our third-party partners, suppliers or customers from sufficiently staffing operations, including operations necessary for the manufacture, distribution, sale and support of our products; and/or
•
Disruptions and volatility in the global capital markets, which may increase the cost of capital and adversely impact our access to capital, and currency and commodity prices.

Despite our efforts to manage these impacts, their ultimate impact also depends on factors beyond our knowledge or control, including the duration, severity and geographic scope of an outbreak, including COVID-19, and the actions taken to contain its spread and mitigate its public health and economic effects.


43



COLGATE-PALMOLIVE COMPANY

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds    

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended March 31, 2020:
Month
 
Total Number of Shares Purchased(1)
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)
 
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3)
(in millions)
January 1 through 31, 2020
 
797,787

 
$
69.81

 
762,303

 
$
3,229

February 1 through 29, 2020
 
1,294,084

 
$
74.52

 
1,183,595

 
$
3,141

March 1 through 31, 2020
 
1,031,036

 
$
67.36

 
993,383

 
$
3,074

Total
 
3,122,907

 
$
70.95

 
2,939,281

 
 


(1) Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.
(2) The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 183,626 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.
(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of March 31, 2020.


Item 3.    Defaults Upon Senior Securities

None.


Item 4.    Mine Safety Disclosures

Not Applicable.


Item 5.    Other Information

None.


44



COLGATE-PALMOLIVE COMPANY


Item 6.    Exhibits

Exhibit No.
 
Description
10-A
 
 
 
 
31-A
 
 
 
 
31-B
 
 
 
 
32
 
 
 
 
101
 
The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020, formatted in Inline eXtensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; (v) Condensed Consolidated Statements of Changes in Shareholders’ Equity and (vi) Notes to Condensed Consolidated Financial Statements.
 
 
 
104
 
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).**


__________
*
Indicates a management contract or compensatory plan or arrangement.

**
Filed herewith.

*** Furnished herewith.


45



COLGATE-PALMOLIVE COMPANY
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
COLGATE-PALMOLIVE COMPANY
 
(Registrant)
 
 
 
Principal Executive Officer:
 
 
May 1, 2020
/s/ Noel R. Wallace
 
Noel R. Wallace
 
Chairman of the Board, President and
Chief Executive Officer
 
 
 
Principal Financial Officer:
 
 
May 1, 2020
/s/ Henning I. Jakobsen
 
Henning I. Jakobsen
 
Chief Financial Officer
 
 
 
Principal Accounting Officer:
 
 
May 1, 2020
/s/ Philip G. Shotts
 
Philip G. Shotts
 
Vice President and Controller


46
 EX-10.A 2 exhibit10a033120q12020.htm EXHIBIT 10.A Exhibit



EXHIBIT 10-A

COLGATE-PALMOLIVE COMPANY

2020 PERFORMANCE STOCK UNIT AWARD
NOTICE OF GRANT


<<Title>> <<First Name>> <<Last Name>>
Colgate-Palmolive
<<Location>>

You have been granted the following performance-based Restricted Stock Units (“PBRSUs”) in accordance with the attached 2020 Performance Stock Unit Award Agreement (the “Agreement”):

Date of Grant:

/$GrantDate$/
Target Number of PBRSUs:

/$AwardsGranted$/
Fair Market Value of Common Stock on Grant Date:


/$FMV$/


Performance Period:

January 1, 2020 through December 31, 2022
Vesting Date:
The date the Committee certifies performance of the performance criteria set forth in Exhibit A to the Agreement (the “Certification Date”)

Settlement Date:
As soon as administratively practicable following the Certification Date, but no later than the earlier of (i) 60 days after the Certification Date and (ii) March 15, 2023.

This award is made under the Colgate-Palmolive Company 2019 Incentive Compensation Plan (the “Plan”), and is subject to the terms, conditions, limitations and restrictions contained in or established pursuant to the Plan, the Agreement and, if applicable, the Company’s Clawback Policy and all requirements of applicable law, including the provisions relating to the forfeiture of PBRSUs upon termination of your employment. Capitalized terms used in this Notice of Grant that are not defined in this Notice of Grant have the meanings as used or defined in the Agreement.


ATTACHMENT: 2020 Performance Stock Unit Award Agreement


1




COLGATE-PALMOLIVE COMPANY
2020 PERFORMANCE STOCK UNIT AWARD AGREEMENT

THIS AWARD AGREEMENT (this “Agreement”), effective as of the date indicated on the Notice of Grant delivered herewith (the “Notice of Grant”), is made and entered into by and between Colgate- Palmolive Company, a Delaware corporation (the “Company”), and the individual named on the Notice of Grant (“you”).
WITNESSETH:
WHEREAS, the Colgate-Palmolive Company 2019 Incentive Compensation Plan (the “Plan”) provides for the grant of performance-based Restricted Stock Units, which are referred to in this Agreement as “PBRSUs;” and
WHEREAS, the Committee has awarded to you the PBRSUs described in the Notice of Grant, subject to the terms and conditions of this Agreement and the Plan.
NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements herein contained, and as an inducement to you to continue as an employee of the Company (or its Affiliates), you and the Company hereby agree as follows:
Capitalized terms used and not otherwise defined in this Agreement shall have the meanings set forth in the Plan.
A.    Terms and Conditions Applicable to PBRSUs
1.Grant of Award. The Award consists of that number of PBRSUs that has been approved for the Award to you by the Committee as the target number of PBRSUs, as set forth in the Notice of Grant (“Target PBRSUs”). Each PBRSU is equivalent to one Share. Your rights to the PBRSUs are subject to this Agreement and the Plan (which is incorporated herein by reference with the same effect as if set forth herein in full) in addition to such other terms and conditions, if any, as may be imposed by law.
2.Vesting of Award.
(a)Vesting Upon Performance and Continued Service. The number of PBRSUs earned and vested with respect to the Performance Period (as defined in Exhibit A) shall be determined based on the extent to which the performance criteria set forth in Exhibit A hereto (the “Performance Criteria”) are attained. Except as otherwise provided in Section A.2(b) and Section A.2(c) below, if (i) the Committee certifies in writing the extent to which the applicable Performance Criteria in the Performance Period are attained and (ii) you remain continuously employed by the Company or an Affiliate through the date on which the Committee certifies such performance (the “Certification Date”), you will become vested in the number of PBRSUs earned pursuant to Exhibit A as of the Certification Date.

1


(b)Termination of Employment due to Death, Disability or Retirement. Unless otherwise determined by the Committee, if (i) you are employed with the Company or an Affiliate for at least six months of the Performance Period and (ii) (A) you begin to receive benefits under the Company’s long-term disability plan, (B) you terminate your employment with the Company or an Affiliate due to Retirement or (C) your employment with the Company or an Affiliate terminates due to your death, in each case on or before the Certification Date, the remaining portion of the Performance Period shall continue through its last day, and you shall become vested as of the Certification Date in a pro-rata portion of the PBRSUs equal to the product obtained by multiplying (x) the total number of PBRSUs earned with respect to the Performance Period based on actual performance during the Performance Period as determined in accordance with Exhibit A by (y) a fraction, the numerator of which is the total number of days in the Performance Period during which you are employed by the Company or an Affiliate (or, in the case of (A) above, the number of days during the Performance Period before you began receiving benefits under the Company’s long-term disability plan) and the denominator of which is the total number of days during the Performance Period.
(c)Vesting Upon a Change in Control. The treatment of your PBRSUs in the event of a Change in Control shall be governed by Section 11 of the Plan.
(d)Forfeiture of Unvested PBRSUs. Except as provided in Section A.2(b) or Section A.2(c) above, or as otherwise determined by the Committee, if your employment with the Company or an Affiliate terminates for any reason during the Performance Period or the period after the Performance Period and before the Certification Date, any PBRSUs will be forfeited and canceled as of the date of such termination of employment.
3.Distribution of Shares.
(a)Distribution Upon Vesting. The Company will distribute to you (or to your estate in the event of your death) the Shares represented by the PBRSUs that are earned and vested in accordance with Section A.2 above and Exhibit A as soon as administratively practicable, but no later than the earlier of (i) 60 days after the Certification Date, and (ii) March 15, 2022.
(b)Forfeiture of Shares; Termination for Cause. Notwithstanding any provision of this Agreement or the Plan to the contrary, if (i) your employment with the Company or an Affiliate is terminated for Cause, or (ii) your employment with the Company or an Affiliate is terminated for any reason, voluntarily or involuntarily, and before the Certification Date it is discovered that you engaged in conduct that would have justified termination for Cause, your rights in your unvested PBRSUs will be immediately forfeited and canceled as of such termination date.
B.    Prohibited Conduct. In consideration of the grant by the Company of the PBRSUs and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, you and the Company, intending to be legally bound, agree to the provisions regarding “Prohibited Conduct” set forth on Annex A to this Agreement. Annex A to this Agreement is part of this Agreement.
C.    Additional Terms and Conditions
1.Compliance With Law. The Plan, the granting and vesting of the PBRSUs, and any obligations of the Company under the Plan, shall be subject to all applicable federal, state and foreign country laws, rules and regulations, and to such approvals by any regulatory or governmental agency as may be required, and to any rules or regulations of any exchange on which the Shares are listed. The International

2


Appendix hereto describes additional terms and conditions applicable to the PBRSUs in certain foreign countries. The Company, in its discretion, may postpone the vesting of the PBRSUs, the issuance or delivery of Shares under this Award or any other action permitted under the Plan to permit the Company, with reasonable diligence, to complete such stock exchange listing or registration or qualification of such Shares or other required action under any federal, state or foreign country law, rule or regulation and may require you to make such representations and furnish such information as it may consider appropriate in connection with the issuance or delivery of Shares in compliance with applicable laws, rules and regulations. The Company shall not be obligated by virtue of any provision of the Plan to recognize the vesting of the PBRSUs or to otherwise sell or issue Shares in violation of any such laws, rules or regulations. Neither the Company nor its directors or officers shall have any obligation or liability to you caused by any postponement of the vesting or settlement of the PBRSUs (or Shares issuable thereunder).
2.No Stockholder Rights. Except as set forth in the Plan, neither you nor any person claiming under or through you shall be, or have any of the rights or privileges of, a stockholder of the Company (e.g., you have no right to vote or receive dividends) in respect of the Shares issuable pursuant to this Award unless and until your Shares shall have been issued.
3.Tax Withholding. No later than the date as of which an amount first becomes includible in your gross income for federal, state, local or foreign tax purposes with respect to this Award, you shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local or foreign taxes of any kind required by law to be withheld with respect to such amount. Unless otherwise determined by the Company, withholding obligations may be settled with Common Stock, including Common Stock that is part of this Award that gives rise to the withholding requirement, having a Fair Market Value on the date of withholding equal to the amount required to be withheld for tax purposes, all in accordance with any such procedures as the Committee may establish. The obligations of the Company under this Agreement shall be conditional on such payment or arrangements, and the Company and its Affiliates shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to you. The Committee may establish such procedures as it deems appropriate, including making irrevocable elections, for the settlement of withholding obligations with Common Stock.
4.PBRSUs Not Transferable. The PBRSUs granted herein are not transferable except in accordance with the provisions of the Plan.
5.Plan Incorporated. You accept the PBRSUs hereby granted subject to all the provisions of the Plan, which are incorporated into this Agreement, including the provisions that authorize the Committee to administer and interpret the Plan and which provide that the Committee’s decisions, determinations and interpretations with respect to the Plan are final and conclusive on all persons affected thereby. In the event of a conflict between this Agreement and the Plan, the Plan shall prevail.
6.No Guaranteed Employment. Nothing contained in this Agreement shall affect the right of the Company or an Affiliate to terminate your employment at any time, with or without Cause, or shall be deemed to create any rights to employment on your part. The rights and obligations arising under this

3


Agreement are not intended to and do not affect the employment relationship that otherwise exists between the Company or an Affiliate and you, whether such employment relationship is at will or defined by an employment contract. Moreover, this Agreement is not intended to and does not amend any existing employment contract between the Company and you. To the extent there is a conflict between this Agreement and such an employment contract as it relates to the PBRSUs awarded hereunder, the terms of this Agreement shall govern and take priority.
7.Notices. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Secretary at the Company’s principal executive offices, and any notice to be given to you shall be addressed to you at the address on file with the Company and/or the Company’s plan administrator, Merrill, Lynch, Pierce, Fenner & Smith Incorporated (“Merrill”). Either the Company or you may designate a different address by written notice to the other. Written notice to said addresses shall be effective to bind the Company, you and your representatives and beneficiaries.
8.Binding Agreement. Subject to the limitations in this Agreement on the transferability by you of the Award granted herein, this Agreement shall be binding upon and inure to the benefit of the representatives, executors, successors or beneficiaries of the parties hereto.
9.Governing Law; Jurisdiction. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Delaware and the United States, as applicable, without reference to the conflict of laws provisions thereof. Any disputes involving this Agreement or the related Restricted Stock Unit Award will be heard and determined before the Delaware Court of Chancery or if not maintainable therein, then before an appropriate federal or state court located in Delaware, and you and the Company each agree to submit yourself and your respective property to the non-exclusive jurisdiction of the foregoing courts with respect to such disputes, in each case, as permitted.
10.Severability. If any provision of this Agreement is declared or found to be illegal, unenforceable or void, in whole or in part, then the parties shall be relieved of all obligations arising under such provision, but only to the extent that it is illegal, unenforceable or void, it being the intent and agreement of the parties that this Agreement shall be deemed amended by modifying such provision to the extent necessary to make it legal and enforceable while preserving its intent or, if that is not possible, by substituting therefor another provision that is legal and enforceable and achieves the same objectives.
11.Interpretation. All section titles and captions in this Agreement are for convenience only, shall not be deemed part of this Agreement, and in no way shall define, limit, extend or describe the scope or intent of any provisions of this Agreement.
12.Entire Agreement. This Agreement constitutes the entire agreement among the parties hereto pertaining to the subject matter hereof and supersedes all prior agreements and understandings pertaining thereto.

4


13.No Waiver. No failure by any party to insist upon the strict performance of any covenant, duty, agreement or condition of this Agreement or to exercise any right or remedy consequent upon a breach thereof shall constitute waiver of any such breach or any other covenant, duty, agreement or condition.
14.Section 409A of the Code. This Agreement is intended to comply with the requirements of Section 409A of the Code or an exemption or exclusion therefrom and, with respect to amounts that are subject to Section 409A of the Code, it is intended that this Agreement be administered in all respects in accordance with Section 409A of the Code. In no event may you, directly or indirectly, designate the calendar year of any payment to be made under this Agreement that constitutes non-qualified deferred compensation subject to Section 409A of the Code.
15.Data Privacy. You understand that the Company and the Company subsidiary for which you work may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, any Shares or directorships held in the Company, details of all PBRSUs. By accepting the PBRSUs, you explicitly and unambiguously consent to the collection, use, transfer, holding, storage and disclosure in electronic or other form, of your personal data as described in this Agreement and any other Award grant materials (“Data”) by and among, as applicable, the Company, its subsidiaries and Affiliates (collectively referred to in this Data Privacy section as the “Company”) and certain third party service providers including, but not limited to, Plan brokers, financial advisers and legal counsel, engaged by the Company (collectively, the “Providers”) for the purpose of implementing, administering and managing the Plan and complying with applicable laws, regulations and legislation. You understand that the Data which may be collected, used, transferred, held, stored or disclosed by the Company and the Providers consists of certain Data about you, including, but not limited to, your name, home address, telephone number, date of birth, social insurance number or other government identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all PBRSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor. The Data may also include information relating to your health (for example, where your employment terminates due to death or Disability). You further understand that such collection, use, transfer, holding, storage or disclosure of the Data may be necessary for the purpose of implementing, administering and managing the Plan and complying with applicable laws, regulations and legislation. You understand that the Company or the Providers may be located in the United States or elsewhere, and that the laws of the country in which the Company and the Providers collect, use, transfer, hold, store or disclose the Data may have different legal protections for the Data than your country. However, regardless of the location of the Data, the Company protects the Data through reasonable physical, technical and administrative safeguards and requires that the Providers also have such safeguards in place. You understand that you may, at any time, request a copy of your Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting your local human resources representative in writing. You understand that refusing or withdrawing your consent may affect your ability to participate in the Plan as more fully described below. You understand that you are providing the consent herein on a purely voluntary basis. If you do not consent, or if you later seek to revoke your consent, your employment status or service

5


and career with your employer will not be adversely affected; the only adverse consequence of refusing or withdrawing your consent is that the Company would not be able to grant PBRSUs or other equity awards or administer or maintain such awards. Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.

16.Counterparts. This Agreement may be executed in counterparts, all of which together shall constitute one agreement binding on all the parties hereto, notwithstanding that all such parties are not signatories to the original or the same counterpart.

COLGATE-PALMOLIVE COMPANY


_______________________________________
Authorized Signature

Using the Merrill BenefitsOnline system or other available means, you must accept the above PBRSUs in accordance with and subject to the terms and conditions of this Agreement and the Plan, acknowledge that you have read this Agreement and the Plan, and agree to be bound by this Agreement, the Plan and the actions of the Committee. If you do not do so prior to the Certification Date, then the Company may declare the Award null and void at any time.



6




Exhibit A
Performance Criteria for 2020-2022 PBRSU Award under
Colgate Palmolive Company 2019 Incentive Compensation Plan
1.The number of PBRSUs earned will be determined based on (a) Relative Net Income Growth; (b) Relative Organic Sales Growth and (c) Free Cash Flow Productivity, subject to adjustment by the TSR modifier, all as set forth below.
2.For purposes of the basic calculation (pre-TSR modifier), (a) the Relative Net Income Growth measure is weighted 30%, (b) the Relative Organic Sales Growth measure is weighted 50%, and (c) the Free Cash Flow Productivity measure is weighted 20%.
3.The Relative Net Income Growth component is calculated as follows:
Company Relative Net Income Growth
Payout as a % of Target Award
High
200%
75th percentile
150%
50th percentile
100%
25th percentile
50%
Below 25th percentile
0%
To the extent the Company’s Relative Net Income Growth percentile falls between two applicable values, the applicable payout percentage shall be interpolated on a linear basis.
4.The Relative Organic Sales Growth component is calculated as follows:
Company Relative Organic Sales Growth
Payout as a % of Target Award
High
200%
75th percentile
150%
50th percentile
100%
25th percentile
50%
Below 25th percentile
0%
To the extent the Company’s Relative Organic Sales Growth percentile falls between two applicable values, the applicable payout percentage shall be interpolated on a linear basis.
5.The Free Cash Flow Productivity component is calculated as follows:
Company’s Free Cash Flow Productivity
Payout as a % of Target Award
105% or above
200%
97.5%
150%
90%
100%
75%
50%
Below 75%
0%
To the extent the Company’s Free Cash Flow Productivity percentage falls between two applicable values, the applicable payout percentage shall be interpolated on a linear basis.

Exhibit A-1


6.The number of PBRSUs determined based on the immediately preceding paragraphs 3 through 5 will increase or decrease by up to 25% based on the Company’s TSR relative to the Compensation Peer Group, as follows:
Company’s TSR Relative to Compensation Peer Group
Award Modifier
≥75th percentile
+25%
60th percentile
+15%
50th percentile
0
40th percentile
-15%
≤25th percentile
-25%
To the extent the Company’s TSR relative to the Compensation Peer Group is between the values set forth in the table above, the TSR award modifier shall be interpolated on a linear basis.
7.The maximum number of Shares that may be earned shall equal 250% of the Target PBRSUs.
8.Notwithstanding anything to the contrary contained herein, in the event the Company’s TSR is negative, the maximum number of Shares that may be earned shall equal the number of Target PBRSUs.
9.Sample Calculation (for illustrative purposes only)
If the Company achieves Relative Net Income performance at the 50th percentile, Relative Organic Sales Growth performance at the 75th percentile, Free Cash Flow Productivity at 75% and TSR at the 60th percentile:

 
Performance Achieved
Award Payout
Weight
% of Target Award Earned
Pre-TSR Modifier Payout
Total Payout
(with TSR Modifier)
Relative
Net Income Growth
50th Percentile
100% of Target Award
30%
100% * 30% = 30%
(30% + 75% +10%) =
115% of Target Award
115%*115%=
132.25% of Target Award
Relative Organic Sales Growth
75th Percentile
150% of Target Award
50%
150% * 50% = 75%
Free Cash Flow Productivity
75%
50% of Target Award
20%
50% * 20% = 10%
10.
For purposes of this Agreement, the following terms are defined as set forth below:
(a)
“Compensation Peer Group” means Campbell Soup Company, The Clorox Company, The Coca-Cola Company, Conagra Brands, Inc., The Estee Lauder Companies Inc., General Mills, Inc., Johnson & Johnson, Kellogg Company, Kimberly-Clark Corporation, The Kraft Heinz Company, Mondelez International, Inc., PepsiCo, Inc., The Procter and Gamble Company, Reckitt Benckiser Group plc and Unilever N.V. If any company contained in the Compensation Peer Group ceases to be a company whose shares are publicly traded during the Performance Period or in the event of any other extraordinary circumstance as determined by the Committee, that Company will be excluded from the Compensation Peer Group for purposes of all determinations regarding this Award.


Exhibit A-2


(b)
“Free Cash Flow Productivity” means, with respect to the Performance Period, the sum of the actual reported Free cash flow before dividends as a percentage of actual reported GAAP Net income including non-controlling interests for each year of the Performance Period divided by three.
(c)
“Net Income Growth” means, with respect to the Performance Period, the sum of the actual, reported non-GAAP net income growth of the applicable company for each year of the Performance Period divided by three.
(d)
“Organic Sales Growth” means, with respect to the Performance Period, the sum of the actual reported organic sales growth of the applicable company for each year of the Performance Period divided by three.
(e)
“Performance Period” means the period from January 1, 2020 through December 31, 2021.
(f)
“Relative Net Income Growth” means, with respect to the Performance Period, a percentage indicating the Company’s Net Income Growth relative to the Net Income Growth of all of the other companies in the Compensation Peer Group.
(g)
“Relative Organic Sales Growth” means, with respect to the Performance Period, a percentage indicating the Company’s Organic Sales Growth relative to the Organic Sales Growth of all of the other companies in the Compensation Peer Group.
(h)
“TSR” means, with respect to the Performance Period, the increase in stock price (taking into account any stock split, recapitalization or similar event) from the beginning of the Performance Period to the end of the Performance Period, plus dividends paid during the Performance Period and assuming such dividends have been reinvested. For purposes of measuring TSR, the stock price at the beginning of the Performance Period shall equal the closing price of a share on December 31, 2019 and the stock price at the conclusion of the Performance Period shall equal the closing price of a share on the last trading day of calendar year 2022.
Note: For purposes of determining the Organic Sales Growth and Net Income Growth for each of the companies in the Compensation Peer Group for the last year of the Performance Period, unless otherwise determined by the Committee, the Organic Sales Growth and Net Income Growth publicly reported for the four most recent quarters that have been disclosed as of the day before the date of the Committee’s regularly scheduled meeting in February 2023 shall be used.
11.
Notwithstanding anything to the contrary contained herein, the Committee shall have the discretion to adjust the number of PBRSUs earned (and the number of Shares delivered) upward (but not in excess of 250% of the Target PBRSUs) or downward, including to reflect the occurrence of extraordinary events (as determined by the Committee).


Exhibit A-3


Annex A

Prohibited Conduct

1.Defined Terms.
a.“Covered Products” means any product, composition, formulation, process, machine or service of any person or organization (other than the Company or an Affiliate) in existence, being researched or under development that competes with, or is intended to compete with, a product, composition, formulation, process, machine or service being researched or under development, produced, distributed, marketed, sold or licensed by the Company or an Affiliate (i) related to any aspect of any one of the Company’s or an Affiliate’s lines of business on which you have worked during the Relevant Period, or (ii) for which you have confidential information of the Company or an Affiliate.
b.“Prohibited Geography” means any country, geography, territory, region or division with respect to which you have worked, provided services or advised the Company or an Affiliate in any capacity.
c.“Relevant Period” means the 12-month period immediately prior to the termination of your employment with the Company or an Affiliate.
d.“Restricted Time” means the period during which you are employed by the Company or an Affiliate plus the 12-month period immediately following the termination of your employment with the Company or an Affiliate for any reason.
2.Restrictive Covenants. Each of the covenants contained in Paragraphs 2(a)-(c) of this Annex A are collectively referred to as the “Restrictive Covenants.”
a.Non-Compete. During the Restricted Time, you will not, without the prior written consent of the Company’s Chief Human Resources Officer or Chief Legal Officer, either directly or indirectly, for yourself or on behalf of or in conjunction with any other person, partnership, corporation or other entity, serve as a director, officer, employee, consultant, contractor or advisor, provide services or advice in any capacity, or acquire any ownership interest in an entity that manufactures, markets, sells, develops, distributes or produces Covered Products in the Prohibited Geography. Notwithstanding the foregoing, you will not be considered to be in violation of this covenant solely by reason of owning, directly or indirectly, up to 5% in the aggregate of any class of securities of any publicly traded corporation engaged in the prohibited activities described above.
b.Non-Interference. With respect to Covered Products, during the Restricted Time, you will not solicit or sell to (or attempt to solicit or sell to) any customer or prospective customer, or any supplier, licensee or other business relation of the Company or an Affiliate (each, a “Restricted Third Party”) (i) for which you had, directly or indirectly, responsibility on behalf of the Company or an Affiliate during the Relevant Period, or (ii) for which you have confidential information of the Restricted Third Party, , nor will you induce (or attempt to induce) any Restricted Third Party to cease or diminish doing business with the Company or an Affiliate or in any way interfere with the relationship between any Restricted Third Party and the Company or an Affiliate. A “prospective customer” of the Company or an Affiliate is a person or entity with whom the Company or an Affiliate was engaged in communications or negotiations to provide services or sell Covered Products during the Relevant Period.
c.Employee Non-Solicitation. During the Restricted Time, you will not in any way, including through someone else acting on your recommendation, suggestion, identification or advice, (i) solicit, employ or retain any person who is employed by the Company or an Affiliate, or (ii) otherwise induce or attempt to induce (A) any such person to terminate his or her employment with the Company or an Affiliate or to accept any position with any other entity, or (B) any prospective employee not to establish an employment


Annex-1


Annex A

relationship with the Company or an Affiliate. A “prospective employee” is a person who was in communications or negotiations to become an employee of the Company or an Affiliate during the Relevant Period.
3.Reasonableness of Provisions. You agree that: (a) the terms and provisions of this Agreement (including Annex A) are reasonable; (b) the consideration provided by the Company under this Agreement is not illusory; (c) the Restrictive Covenants are necessary and reasonable for the protection of the legitimate business interests and goodwill of the Company; and (d) the consideration given by the Company under this Agreement gives rise to the Company’s interest in the Restrictive Covenants set forth in this Annex A.

4.Repayment and Forfeiture. You specifically recognize and affirm that each of the Restrictive Covenants is a material and important term of this Agreement which has induced the Company to provide for the award of the PBRSUs granted hereunder. You further agree that in the event that the Company determines that you have breached any of the Restrictive Covenants, in addition to any other remedies at law or in equity the Company may have available to it, the Company may in its sole discretion: (a) cancel any unvested PBRSUs granted hereunder; and (b) require you to pay to the Company the Net Proceeds (as defined below) of any PBRSUs that vested during the Look-Back Period (as defined below). You will pay to the Company the Net Proceeds in cash upon demand, and the Company will be entitled to set off against any amount due to you from the Company or an Affiliate the amount of any such Net Proceeds, to the extent that such set-off is not inconsistent with Code Section 409A or other applicable law. For purposes of this Paragraph 4, the term “Net Proceeds” means the aggregate value of the Shares covered by the PBRSUs that have vested, net of applicable tax withholdings, determined based on the Fair Market Value of such Shares on the applicable vesting date. The “Look-Back Period” means the longer of the following two periods: (i) the 12-month period immediately preceding the date on which the Company becomes aware of a breach of any of the Restrictive Covenants; or (ii) the six-month period immediately prior to the date of the termination of your employment with the Company or an Affiliate.

5.Equitable Relief. In the event the Company determines that you have breached or attempted or threatened to breach any of the Restrictive Covenants, in addition to any other remedies at law or in equity the Company may have available to it, it is agreed that the Company will be entitled, upon application to any court, tribunal or arbitrator of competent jurisdiction, to a temporary restraining order or preliminary injunction (without the necessity of (a) proving irreparable harm, (b) establishing that monetary damages are inadequate or (c) posting any bond with respect thereto) against you prohibiting such breach or attempted or threatened breach by proving only the existence of such breach or attempted or threatened breach.
6.Extension of Restrictive Period. You agree that the Restricted Time will be extended by any time during which you are in violation of any of the Restrictive Covenants.

7.Acknowledgments. You and the Company agree that it is our mutual intent to enter into a valid and enforceable agreement. You and the Company acknowledge the reasonableness of the Restrictive Covenants, including the reasonableness of the geographic area, duration as to time and scope of activity restrained. You further acknowledge that your skills are such that you can be gainfully employed in noncompetitive employment and that the agreement not to compete will not prevent you from earning a living. You acknowledge that the remedies set forth in this Agreement are not the exclusive remedies and the Company may avail itself of other remedies at law or in equity in the event you breach any of the Restrictive Covenants.

8.Provisions Independent. The Restrictive Covenants will be construed as an agreement independent of any other agreement, including any employee benefit agreement, and independent of any other provision of this Agreement, and the existence of any claim or cause of action you bring against the Company or an


Annex-2


Annex A

Affiliate, whether predicated upon this Agreement or otherwise, will not constitute a defense to the enforcement by the Company of such covenants.

9.Notification of Subsequent Employer. You agree that the Company may notify any person or entity employing you or evidencing an intention of employing you of the existence and provisions of this Agreement.

10.Transfers to a Related Entity. In the event you transfer to an Affiliate as a result of actions by the Company, any reference to “Company” in this Annex A will be deemed to refer to such Affiliate in addition to the Company.




Annex-3

 EX-31.A 3 exhibit31a033120q12020.htm EXHIBIT 31.A Exhibit


EXHIBIT 31-A

I, Noel R. Wallace, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 1, 2020

/s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer



 EX-31.B 4 exhibit31b033120q12020.htm EXHIBIT 31.B Exhibit


EXHIBIT 31-B

I, Henning I. Jakobsen, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 1, 2020

/s/ Henning I. Jakobsen
Henning I. Jakobsen
Chief Financial Officer



 EX-32 5 exhibit32033120q12020.htm EXHIBIT 32 Exhibit


EXHIBIT 32
The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1)
the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
(2)
information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: May 1, 2020
/s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer
 
/s/ Henning I. Jakobsen
Henning I. Jakobsen
Chief Financial Officer




 EX-101.SCH 6 cl-20200331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2104100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1005001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Fair Value Measurements and Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2417406 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) link:presentationLink link:calculationLink link:definitionLink 2417405 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) link:presentationLink link:calculationLink link:definitionLink 2417404 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2411401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Restructuring and Related Implementation Charges link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Restructuring and Related Implementation Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Retirement Plans and Other Retiree Benefits link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Retirement Plans and Other Retiree Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Segment Information - Schedule of Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Use of Estimates link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Use of Estimates (Policies) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cl-20200331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 cl-20200331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 cl-20200331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounting Policies [Abstract] Use of Estimates Significant Accounting Policies [Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Unearned Compensation Unearned Compensation [Member] Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded. Treasury Stock Treasury Stock [Member] Retained Earnings Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Noncontrolling Interests Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Changes in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Dividends Dividends, Common Stock Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Shares issued for stock options Stock Issued During Period, Value, Stock Options Exercised Shares issued for restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Treasury stock acquired Treasury Stock, Value, Acquired, Cost Method Other Stockholders' Equity, Other Ending balance Accumulated other comprehensive loss, cumulative translation losses Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Hello Product LLC Hello Product LLC [Member] Hello Product LLC [Member] Laboratoires Filorga Cosmétiques Laboratoires Filorga Cosmétiques [Member] Laboratoires Filorga Cosmétiques [Member] Nigeria Joint Venture Nigeria Joint Venture [Member] Nigeria Joint Venture [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Trademarks Trademarks [Member] Customer Relationships Customer Relationships [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] North America North America [Member] Europe Europe [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Payments to acquire business, cash Payments to Acquire Businesses, Gross Purchase price consideration Business Combination, Consideration Transferred Other intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Goodwill Goodwill Additional purchase price consideration Business Combination, Consideration Transferred, Other Useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Controlling interest acquired (in percent) Business Acquisition, Percentage of Voting Interests Acquired Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Global Growth and Efficiency Program Global Growth and Efficiency Program [Member] Global Growth and Efficiency Program [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Restructuring and Implementation-Related Charges Restructuring And Implementation-Related Charges [Member] Restructuring And Implementation-Related Charges [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Charges Restructuring and Related Cost, Incurred Cost Inventory, Net, Items Net of Reserve Alternative [Abstract] Inventories by Major Class Schedule of Inventory, Current [Table Text Block] Inventories Inventory Disclosure [Text Block] Acquisitions Business Combination Disclosure [Text Block] Segment Reporting [Abstract] Net Sales and Operating Profit by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Statement of Financial Position [Abstract] Assets Assets [Abstract] Current Assets Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Receivables (net of allowances of $84 and $76, respectively) Accounts Receivable, after Allowance for Credit Loss, Current Inventories Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment: Property, Plant and Equipment, Net [Abstract] Cost Property, Plant and Equipment, Gross Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Deferred income taxes Deferred Income Tax Assets, Net Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Current Liabilities Liabilities, Current [Abstract] Notes and loans payable Short-term Bank Loans and Notes Payable Current portion of long-term debt Long-term Debt, Current Maturities Accounts payable Accounts Payable, Current Accrued income taxes Accrued Income Taxes, Current Other accruals Other Accrued Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Deferred income taxes Deferred Income Tax Liabilities, Net Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Shareholders’ Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Common stock Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Unearned compensation Unearned Compensation Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded. Treasury stock, at cost Treasury Stock, Value Total Colgate-Palmolive Company shareholders’ equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total equity Total liabilities and equity Liabilities and Equity Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total Inventories, net Inventory, Net, Including Noncurrent Inventory, Net, Including Noncurrent Non-current inventory, net Inventory, Noncurrent Current Inventories, net Loss Contingency [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Minimum number of countries and territories serving consumers (more than) (in countries and territories) Minimum Number Of Countries And Territories Serving Consumers Minimum Number Of Countries And Territories Serving Consumers Loss contingency, possible loss Loss Contingency, Estimate of Possible Loss Brazilian internal revenue authority, matter 1 Tax Assessments With Interest The amount of tax assessment with estimated interest accrued as of the balance sheet date arising from income tax examinations related to an acquisition. Loss contingency, number of cases on appeal Loss Contingency, Number Of Cases On Appeal Loss Contingency, Number of Cases On Appeal Loss contingency, number of appeals lost (in appeals) Loss Contingency, Number Of Appeals Lost Loss Contingency, Number Of Appeals Lost Brazilian internal revenue authority, matter 2 Tax Assessments With Interest And Penalties The amount of tax assessment with estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations related to investments held by a foreign subsidiary. Fine imposed by Greek competition authority Fine Imposed By Greek Competition Authority Fine Imposed by Greek Competition Authority Loss contingency, pending claims, number (in cases) Loss Contingency, Pending Claims, Number Loss contingency, new claims filed, number (in cases) Loss Contingency, New Claims Filed, Number Loss contingency, claims dismissed or settled, number (in cases) Loss Contingency, Claims Settled and Dismissed, Number Loss contingency, number of cases resulting in adverse jury verdict Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number Statement of Cash Flows [Abstract] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Net income including noncontrolling interests Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Restructuring and termination benefits, net of cash Restructuring, net of cash The amount of noncash restructuring costs net of cash payments. Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Deferred income taxes Deferred Income Taxes and Tax Credits Voluntary benefit plan contributions Payment for Pension and Other Postretirement Benefits Cash effects of changes in: Increase (Decrease) in Operating Capital [Abstract] Receivables Increase (Decrease) in Receivables Inventories Increase (Decrease) in Inventories Accounts payable and other accruals Increase (Decrease) in Accounts Payable and Accrued Liabilities Other non-current assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operations Net Cash Provided by (Used in) Operating Activities Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Productive Assets Purchases of marketable securities and investments Payments to Acquire Marketable Securities Proceeds from sale of marketable securities and investments Proceeds from Sale and Maturity of Marketable Securities Payment for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Principal payments on debt Repayments of Debt Proceeds from issuance of debt Proceeds from Issuance of Debt Dividends paid Payments of Ordinary Dividends Purchases of treasury shares Payments for Repurchase of Common Stock Proceeds from exercise of stock options Proceeds from Stock Options Exercised Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on Cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Net increase (decrease) in Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents at beginning of the period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of the period Supplemental Cash Flow Information Supplemental Cash Flow Information [Abstract] Income taxes paid Income Taxes Paid Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of sales Gross Profit [Member] Gross Profit [Member] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Other (income) expense, net Other (Income) Expense, Net [Member] Other (Income) Expense, Net [Member] Non-service related postretirement costs Non-Service Related Postretirement Costs [Member] Non-Service Related Postretirement Costs [Member] Total Global Growth and Efficiency Program charges, pretax Total Global Growth and Efficiency Program charges, aftertax Restructuring And Related Cost, Incurred Cost, After Tax Restructuring And Related Cost, Incurred Cost, After Tax New Accounting Pronouncements and Changes in Accounting Principles [Abstract] Recent Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Dividends declared per common share (in dollars per share) Common Stock, Dividends, Per Share, Declared Number of dividends declared per quarter Number Of Dividends Declared Per Quarter Number of Dividends Declared Per Quarter Statement of Comprehensive Income [Abstract] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Cumulative translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Retirement plans and other retiree benefit adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Gains (losses) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Total Other comprehensive income (loss), net of tax Total Comprehensive income including noncontrolling interests Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Less: Cumulative translation adjustments attributable to noncontrolling interests Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest Total Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Total Comprehensive income attributable to Colgate-Palmolive Company Comprehensive Income (Loss), Net of Tax, Attributable to Parent Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Other assets and liabilities, net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Deferred income taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncontrolling interests Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Fair value of net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Fair value of net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Restructuring and Related Implementation Charges Restructuring and Related Activities Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements and Financial Instruments Financial Instruments Disclosure [Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales Revenue, Net Revenue Benchmark [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Corporate Corporate, Non-Segment [Member] Included in Operating profit (loss) Operating Income (Loss) [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Number of product segments (in segments) Number Of Product Segments Number of Product Segments Number of reportable segments (in segments) Number of Reportable Segments Number of operating segments (in segments) Number of Operating Segments Percentage of consolidated Net sales represented by sales outside US Percentage Of Consolidated Net Sales Represented By Sales Outside US Percentage of Consolidated Net Sales represented by Sales outside US Percentage of consolidated Net sales coming from emerging markets Percentage Of Consolidated Net Sales Coming From Emerging Markets Percentage of Consolidated Net Sales coming from Emerging Markets Acquisition related costs Business Combination, Acquisition Related Costs Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Cost of sales Cost of Sales [Member] Interest (income) expense, net Interest (Income) Expense, Net [Member] Interest (Income) Expense, Net [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash Flow Hedges Cash Flow Hedging [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swaps Interest Rate Contract [Member] Foreign Currency Contracts Foreign Exchange Contract [Member] Commodity contracts Commodity Contract [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Gain (loss) on derivative instrument Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Gain (loss) on hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Amount reclassified from OCI Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Total gain (loss) on hedges recognized in income Derivative, Gain (Loss) on Derivative, Net Retirement Benefits [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Domestic Plan Domestic Plan [Member] United States UNITED STATES International Foreign Plan [Member] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension Benefits Pension Plan [Member] Other Retiree Benefits Other Postretirement Benefits Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Components of net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of actuarial loss (gain) Defined Benefit Plan, Amortization of Gain (Loss) Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Voluntary benefit plan contribution Defined Benefit Plan, Plan Assets, Contributions by Employer Schedule of derivative instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of hedged item and cumulative adjustment to carrying amount Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Schedule of notional values Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Schedule of gains (losses) recognized in Statements of Income Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of gains (losses) included in Other Comprehensive Income Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Commodity Contracts Foreign Currency Debt Debt [Member] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Cash flow hedges [Abstract] Effect of Cash Flow Hedges on Results of Operations [Abstract] Gain (loss) recognized in OCI Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Net investment hedges [Abstract] Summary of Net Investment Hedge Activity [Abstract] Gain (loss) on instruments Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Gain (loss) on hedged items Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification And Tax Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification and Tax Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Value Reported Value Measurement [Member] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Long-term Debt Long-term Debt [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Estimated fair value of long-term debt Debt Instrument, Fair Value Disclosure Carrying value of long-term debt Long-term Debt Carrying amount of hedged item Hedged Liability, Fair Value Hedge Cumulative hedging adjustment included in the carrying amount Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) Retirement Plans and Other Retiree Benefits Pension and Other Postretirement Benefits Disclosure [Text Block] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Contingencies Commitments and Contingencies Disclosure [Text Block] Cover [Abstract] Entities [Table] Entities [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] 0.000% Notes due 2021 0.000% Notes due 2021 [Member] 0.000% Notes due 2021 [Member] 0.500% Notes Due 2026 0.500% Notes Due 2026 [Member] 0.500% Notes Due 2026 [Member] 1.375% Notes Due 2034 1.375% Notes Due 2034 [Member] 1.375% Notes Due 2034 [Member] 0.875% Notes due 2039 0.875% Notes due 2039 [Member] 0.875% Notes due 2039 [Member] Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Segment Information Segment Reporting Disclosure [Text Block] Income Statement [Abstract] Net sales Revenue from Contract with Customer, Excluding Assessed Tax Cost of sales Cost of Revenue Gross profit Gross Profit Selling, general and administrative expenses Selling, General and Administrative Expense Other (income) expense, net Other Operating Income (Expense), Net Operating profit Operating Income (Loss) Non-service related postretirement costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Interest (income) expense, net Interest expense, net The aggregate interest and debt related expenses associated with nonoperating financing activities of the entity, less the amount of income derived from investments in debt securities and on cash and cash equivalents, the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision for income taxes Income Tax Expense (Benefit) Net income including noncontrolling interests Net income attributable to Colgate-Palmolive Company Net Income (Loss) Attributable to Parent Earnings per common share, basic (in dollars per share) Earnings Per Share, Basic Earnings per common share, diluted (in dollars per share) Earnings Per Share, Diluted Equity [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Cumulative translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Retirement plans and other retiree benefits adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Gains (losses) on cash flow hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Total Other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Other comprehensive income (loss), before reclassifications, pretax Other Comprehensive Income (Loss), before Reclassifications, before Tax Reclassification from AOCI, pretax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Other comprehensive income (loss), pretax Other Comprehensive Income (Loss), before Tax Other comprehensive income (loss), before reclassifications, net of tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Reclassification from AOCI, net of tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Earnings Per Share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Components Of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Fair Value Hedges Fair Value Hedging [Member] Net Investment Hedges Net Investment Hedging [Member] Notional values Derivative, Notional Amount Fair Value Derivatives Balance Sheet Location [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other current assets Other Current Assets [Member] Other assets Other Assets [Member] Other accruals Other Current Liabilities [Member] Other liabilities Other Liabilities [Member] Interest rate swap contracts Foreign currency contracts Derivative and Financial Instruments, Fair Value [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Designated derivative instruments Designated derivative instruments [Abstract] Designated derivative instruments [Abstract] Derivative assets, designated Derivative Asset Derivative liabilities, designated Derivative Liability Other financial instruments Financial Instruments, Owned, at Fair Value [Abstract] Marketable securities Marketable Securities Total other financial instruments Investments, Fair Value Disclosure Latin America Latin America [Member] Asia Pacific Asia Pacific [Member] Africa/Eurasia Africa Eurasia [Member] A specified group of foreign regions about which segment information is provided by the entity. Business Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Oral, Personal and Home Care Oral, Personal and Home Care [Member] Oral, Personal and Home Care Pet Nutrition Pet Nutrition [Member] Pet Nutrition Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Product Concentration Risk Product Concentration Risk [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Oral Care Oral Care [Member] Oral Care products include toothpaste, toothbrushes, mouth rinses and other similar items. Personal Care Personal Care [Member] Personal Care products include bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants and other similar items. Home Care Home Care [Member] Home Care products include laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items. Operating Segments Operating Segments [Member] Total Net sales Percent of net sales Concentration Risk, Percentage Total Operating profit Employee-Related Costs One-time Termination Benefits [Member] Incremental Depreciation Incremental Depreciation [Member] Incremental Depreciation [Member] Asset Impairments Asset Impairment [Member] Asset Impairment [Member] Other Other Restructuring [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Beginning Balance Restructuring Reserve Cash payments Payments for Restructuring Charges against assets Restructuring Reserve, Charges Against Assets Restructuring Reserve, Charges Against Assets Foreign exchange Restructuring Reserve, Foreign Currency Translation Gain (Loss) Other Restructuring Reserve, Translation and Other Adjustment Ending Balance Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Net income attributable to Colgate-Palmolive Company Earnings Per Share Reconciliation [Abstract] Basic EPS Net Income (Loss) Available to Common Stockholders, Basic Diluted EPS Net Income (Loss) Available to Common Stockholders, Diluted Shares Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Stock options and restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Per Share Earnings Per Share, Basic and Diluted [Abstract] Basic EPS (in dollars per share) Diluted EPS (in dollars per share) Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Provisional income tax benefit Discrete Income Tax Provision (Benefit) Discrete Income Tax Provision (Benefit) Foreign withholding income tax Foreign Withholding Income Tax Foreign Withholding Income Tax Valuation allowance against deferred tax asset Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Withholding tax due Withholding Tax Due Withholding Tax Due Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] EX-101.PRE 10 cl-20200331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R43.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Segment Reporting Information [Line Items]    
Total Net sales $ 4,097 $ 3,884
Total Operating profit 952 879
Corporate    
Segment Reporting Information [Line Items]    
Total Operating profit $ (128) $ (152)
Product Concentration Risk | Sales Revenue, Net    
Segment Reporting Information [Line Items]    
Percent of net sales 100.00% 100.00%
Product Concentration Risk | Oral Care | Sales Revenue, Net    
Segment Reporting Information [Line Items]    
Percent of net sales 44.00% 48.00%
Product Concentration Risk | Personal Care | Sales Revenue, Net    
Segment Reporting Information [Line Items]    
Percent of net sales 20.00% 19.00%
Product Concentration Risk | Home Care | Sales Revenue, Net    
Segment Reporting Information [Line Items]    
Percent of net sales 18.00% 18.00%
Product Concentration Risk | Pet Nutrition | Sales Revenue, Net    
Segment Reporting Information [Line Items]    
Percent of net sales 18.00% 15.00%
Oral, Personal and Home Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales $ 3,378 $ 3,284
Total Operating profit 877 867
Pet Nutrition | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales 719 600
Total Operating profit 203 164
North America | Oral, Personal and Home Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales 929 853
Total Operating profit 258 249
Latin America | Oral, Personal and Home Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales 889 889
Total Operating profit 248 232
Europe | Oral, Personal and Home Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales 675 602
Total Operating profit 154 151
Asia Pacific | Oral, Personal and Home Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales 633 700
Total Operating profit 161 189
Africa/Eurasia | Oral, Personal and Home Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total Net sales 252 240
Total Operating profit $ 56 $ 46
XML 12 R47.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cost of sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income $ 3 $ 4
Cost of sales | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Cost of sales | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Amount reclassified from OCI 2  
Cost of sales | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 1  
Cost of sales | Cash Flow Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI   3
Cost of sales | Cash Flow Hedges | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI   1
Selling, general and administrative expenses    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income 0 0
Selling, general and administrative expenses | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Selling, general and administrative expenses | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 24 (1)
Gain (loss) on hedged items (24) 1
Amount reclassified from OCI 0  
Selling, general and administrative expenses | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 0  
Selling, general and administrative expenses | Cash Flow Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI   0
Selling, general and administrative expenses | Cash Flow Hedges | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI   0
Interest (income) expense, net    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income 0 0
Interest (income) expense, net | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument (12) (3)
Gain (loss) on hedged items 12 3
Interest (income) expense, net | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Amount reclassified from OCI 0  
Interest (income) expense, net | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI $ 0  
Interest (income) expense, net | Cash Flow Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI   0
Interest (income) expense, net | Cash Flow Hedges | Commodity contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI   $ 0
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 14 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted

For the three months ended March 31, 2020 and 2019, earnings per share were as follows:

 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
Basic EPS
$
715

 
856.9

 
$
0.83

 
$
560

 
862.0

 
$
0.65

Stock options and
restricted stock units
 
 
1.5

 
 

 
 

 
1.2

 
 

Diluted EPS
$
715

 
858.4

 
$
0.83

 
$
560

 
863.2

 
$
0.65

XML 15 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Use of Estimates (Policies)
 3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
Recent Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This new guidance is effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, FASB issued ASU No. 2020-03, "Codification to Financial Instruments." This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323) and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This new guidance was effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326)” Codification Improvements to Financial Instruments-Credit Losses (Topic 326). Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This ASU introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.
XML 17 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Restructuring and Related Implementation Charges - Narrative (Details) - Global Growth and Efficiency Program - USD ($)
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]    
Charges $ 0 $ 29,000,000
Restructuring and Implementation-Related Charges    
Restructuring Cost and Reserve [Line Items]    
Charges $ 0  
XML 19 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Net income attributable to Colgate-Palmolive Company    
Basic EPS $ 715 $ 560
Diluted EPS $ 715 $ 560
Shares    
Basic EPS (in shares) 856,900,000 862,000,000.0
Stock options and restricted stock units (in shares) 1,500,000 1,200,000
Diluted EPS (in shares) 858,400,000 863,200,000
Per Share    
Basic EPS (in dollars per share) $ 0.83 $ 0.65
Diluted EPS (in dollars per share) $ 0.83 $ 0.65
Antidilutive securities excluded from computation of earnings per share (in shares) 20,965,110 21,980,033
XML 20 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Inventories
 3 Months Ended
Mar. 31, 2020
Inventory, Net, Items Net of Reserve Alternative [Abstract]  
Inventories Inventories

Inventories by major class are as follows:
 
March 31,
2020
 
December 31,
2019
Raw materials and supplies
$
329

 
$
305

Work-in-process
46

 
49

Finished goods
976

 
1,056

       Total Inventories, net
$
1,351

 
$
1,410

            Non-current inventory, net
$
(50
)
 
$
(10
)
              Current Inventories, net
$
1,301

 
$
1,400
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Use of Estimates
 3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
XML 22 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes
 3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Acts (the "TCJA").

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company has now determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes.

Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company now believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26.
XML 23 R2.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Net sales $ 4,097 $ 3,884
Cost of sales 1,632 1,597
Gross profit 2,465 2,287
Selling, general and administrative expenses 1,473 1,365
Other (income) expense, net 40 43
Operating profit 952 879
Non-service related postretirement costs 21 25
Interest (income) expense, net 36 40
Income before income taxes 895 814
Provision for income taxes 147 214
Net income including noncontrolling interests 748 600
Less: Net income attributable to noncontrolling interests 33 40
Net income attributable to Colgate-Palmolive Company $ 715 $ 560
Earnings per common share, basic (in dollars per share) $ 0.83 $ 0.65
Earnings per common share, diluted (in dollars per share) $ 0.83 $ 0.65
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Activities    
Net income including noncontrolling interests $ 748 $ 600
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:    
Depreciation and amortization 133 128
Restructuring and termination benefits, net of cash (30) 5
Stock-based compensation expense 16 17
Deferred income taxes (99) 53
Voluntary benefit plan contributions 0 (102)
Cash effects of changes in:    
Receivables (211) (145)
Inventories 29 (32)
Accounts payable and other accruals 220 44
Other non-current assets and liabilities (38) 37
Net cash provided by operations 768 605
Investing Activities    
Capital expenditures (82) (71)
Purchases of marketable securities and investments (42) (27)
Proceeds from sale of marketable securities and investments 16 0
Payment for acquisitions, net of cash acquired (351) 0
Net cash used in investing activities (459) (98)
Financing Activities    
Principal payments on debt (1,200) (1,774)
Proceeds from issuance of debt 1,188 2,076
Dividends paid (373) (366)
Purchases of treasury shares (220) (399)
Proceeds from exercise of stock options 297 71
Net cash provided by (used in) financing activities (308) (392)
Effect of exchange rate changes on Cash and cash equivalents (30) 2
Net increase (decrease) in Cash and cash equivalents (29) 117
Cash and cash equivalents at beginning of the period 883 726
Cash and cash equivalents at end of the period 854 843
Supplemental Cash Flow Information    
Income taxes paid $ 128 $ 149
XML 25 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Jan. 31, 2020
Dec. 31, 2019
Sep. 19, 2019
Business Acquisition [Line Items]        
Goodwill $ 3,559   $ 3,508  
Hello Product LLC        
Business Acquisition [Line Items]        
Receivables   $ 11    
Inventories   13    
Other assets and liabilities, net   (4)    
Other intangible assets   200    
Goodwill   131    
Fair value of net assets acquired   $ 351    
Laboratoires Filorga Cosmétiques        
Business Acquisition [Line Items]        
Cash       $ 30
Receivables       53
Inventories       70
Other current assets       18
Other intangible assets       1,051
Goodwill       923
Other current liabilities       (67)
Deferred income taxes       (276)
Noncontrolling interests       (90)
Fair value of net assets acquired       $ 1,712
XML 26 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Inventory, Net, Items Net of Reserve Alternative [Abstract]    
Raw materials and supplies $ 329 $ 305
Work-in-process 46 49
Finished goods 976 1,056
Total Inventories, net 1,351 1,410
Non-current inventory, net (50) (10)
Current Inventories, net $ 1,301 $ 1,400
XML 27 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies
 3 Months Ended
Mar. 31, 2020
Loss Contingency [Abstract]  
Contingencies
Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $175 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $118. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. There is one case currently on appeal at the administrative level. In the event the Company is ultimately unsuccessful in this administrative appeal, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. In April 2019, the Company lost another administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $49, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matter

Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of March 31, 2020 of such competition law matters pending against the Company during the three months ended March 31, 2020 is set forth below.

▪
In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of March 31, 2020 and December 31, 2019, there were 121 individual cases pending against the Company in state and federal courts throughout the United States. During the three months ended March 31, 2020, five new cases were filed and five cases were resolved by voluntary dismissal or settlement. The value of the settlements in the quarter presented was not material, either individually or in the aggregate, to the period’s results of operations.

The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share

For the three months ended March 31, 2020 and 2019, earnings per share were as follows:

 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
Basic EPS
$
715

 
856.9

 
$
0.83

 
$
560

 
862.0

 
$
0.65

Stock options and
restricted stock units
 
 
1.5

 
 

 
 

 
1.2

 
 

Diluted EPS
$
715

 
858.4

 
$
0.83

 
$
560

 
863.2

 
$
0.65



For the three months ended March 31, 2020 and 2019, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 20,965,110 and 21,980,033, respectively.
XML 29 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Recent Accounting Pronouncements
 3 Months Ended
Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
Recent Accounting Pronouncements
Recent Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This new guidance is effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, FASB issued ASU No. 2020-03, "Codification to Financial Instruments." This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323) and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This new guidance was effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326)” Codification Improvements to Financial Instruments-Credit Losses (Topic 326). Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This ASU introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements.
XML 30 R3.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Comprehensive Income [Abstract]    
Net income including noncontrolling interests $ 748 $ 600
Other comprehensive income (loss), net of tax:    
Cumulative translation adjustments (355) 26
Retirement plans and other retiree benefit adjustments 16 12
Gains (losses) on cash flow hedges 18 (5)
Total Other comprehensive income (loss), net of tax (321) 33
Total Comprehensive income including noncontrolling interests 427 633
Less: Net income attributable to noncontrolling interests 33 40
Less: Cumulative translation adjustments attributable to noncontrolling interests (16) 5
Total Comprehensive income attributable to noncontrolling interests 17 45
Total Comprehensive income attributable to Colgate-Palmolive Company $ 410 $ 588
XML 31 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Unearned Compensation
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
 [1]
Noncontrolling Interests
Changes in Shareholders' Equity [Roll Forward]                
Accumulated other comprehensive loss, cumulative translation losses $ 3,155              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs 1,038              
Beginning balance at Dec. 31, 2018   $ 1,466 $ 2,204 $ (3) $ (21,196) $ 21,615 $ (4,188) $ 299
Changes in Shareholders' Equity [Roll Forward]                
Net income 600         560   40
Other comprehensive income (loss), net of tax 33           28 5
Dividends [2]           (734)   (2)
Stock-based compensation expense     17          
Shares issued for stock options     33   49      
Shares issued for restricted stock units     (13)   13      
Treasury stock acquired         (399)      
Other         1 (5)    
Ending balance at Mar. 31, 2019   1,466 2,241 (3) (21,532) 21,436 (4,160) 342
Changes in Shareholders' Equity [Roll Forward]                
Accumulated other comprehensive loss, cumulative translation losses 3,134              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs 1,026              
Accumulated other comprehensive loss, cumulative translation losses 3,128              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs 1,138              
Beginning balance at Dec. 31, 2019 558 1,466 2,488 (2) (22,063) 22,501 (4,273) 441
Changes in Shareholders' Equity [Roll Forward]                
Net income 748         715   33
Other comprehensive income (loss), net of tax (321)           (305) (16)
Dividends [2]           (738)   (4)
Stock-based compensation expense     16          
Shares issued for stock options     133   164      
Shares issued for restricted stock units     (15)   15      
Treasury stock acquired         (220)      
Other     1 1   3    
Ending balance at Mar. 31, 2020 341 $ 1,466 $ 2,623 $ (1) $ (22,104) $ 22,481 $ (4,578) $ 454
Changes in Shareholders' Equity [Roll Forward]                
Accumulated other comprehensive loss, cumulative translation losses 3,467              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs $ 1,122              
[1] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,467 at March 31, 2020 ($3,134 at March 31, 2019) and $3,128 at December 31, 2019 ($3,155 at December 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,122 at March 31, 2020 ($1,026 at March 31, 2019) and $1,138 at December 31, 2019 ($1,038 at December 31, 2018), respectively.
[2] Two dividends were declared in each of the first quarters of 2020 and 2019
XML 32 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2020
USD ($)
segment
Mar. 31, 2019
USD ($)
Segment Reporting Information [Line Items]    
Number of product segments (in segments) | segment 2  
Number of reportable segments (in segments) | segment 5  
Number of operating segments (in segments) | segment 5  
Corporate | Included in Operating profit (loss)    
Segment Reporting Information [Line Items]    
Acquisition related costs | $ $ 6  
Sales Revenue, Net    
Segment Reporting Information [Line Items]    
Percentage of consolidated Net sales represented by sales outside US 70.00%  
Percentage of consolidated Net sales coming from emerging markets 45.00%  
Global Growth and Efficiency Program    
Segment Reporting Information [Line Items]    
Charges | $ $ 0 $ 29
Global Growth and Efficiency Program | Corporate | Included in Operating profit (loss)    
Segment Reporting Information [Line Items]    
Charges | $   $ 28
XML 33 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 34 R46.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values $ 935 $ 788
Fair Value Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 535 388
Fair Value Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Fair Value Hedges | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 400 400
Fair Value Hedges | Commodity Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 739 781
Cash Flow Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 718 761
Cash Flow Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Cash Flow Hedges | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Cash Flow Hedges | Commodity Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 21 20
Net Investment Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 4,225 4,334
Net Investment Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 473 478
Net Investment Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 3,752 3,856
Net Investment Hedges | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Net Investment Hedges | Commodity Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values $ 0 $ 0
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Income (Loss) (Tables)
 3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2020 and 2019 were as follows:
 
 
2020
 
2019
 
 
Pretax
 
Net of Tax
 
Pretax
 
Net of Tax
Cumulative translation adjustments
 
$
(320
)
 
$
(339
)
 
$
27

 
$
21

Retirement plans and other retiree benefits:
 
 
 
 
 
 
 
 
Net actuarial gain (loss) and prior service costs arising during the period
 
2

 
1

 
(1
)
 
(1
)
Amortization of net actuarial loss, transition and prior service costs (1)
 
17

 
15

 
17

 
13

Retirement plans and other retiree benefits adjustments
 
19

 
16

 
16

 
12

Cash flow hedges:
 
 
 
 
 
 
 
 
Unrealized gains (losses) on cash flow hedges
 
25

 
20

 
(2
)
 
(2
)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
 
(3
)
 
(2
)
 
(4
)
 
(3
)
Gains (losses) on cash flow hedges
 
22

 
18

 
(6
)
 
(5
)
Total Other comprehensive income (loss)
 
$
(279
)
 
$
(305
)
 
$
37

 
$
28


(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisitions (Tables)
 3 Months Ended
Mar. 31, 2020
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:
Cash
$
30

Receivables
53

Inventories
70

Other current assets
18

Other intangible assets
1,051

Goodwill
923

Other current liabilities
(67
)
Deferred income taxes
(276
)
Noncontrolling interests
(90
)
Fair value of net assets acquired
$
1,712


The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:

Receivables
$
11

Inventories
13

Other assets and liabilities, net
(4
)
Other intangible assets
200

Goodwill
131

Fair value of net assets acquired
$
351
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Retirement Plans and Other Retiree Benefits
 3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
Retirement Plans and Other Retiree Benefits
Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three months ended March 31, 2020 and 2019 were as follows:

 
Three Months Ended March 31,
 
Pension Benefits
 
Other Retiree Benefits
 
United States
 
International
 
 
 
 
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
Service cost
$
—

 
$
—

 
$
4

 
$
4

 
$
6

 
$
4

Interest cost
19

 
23

 
5

 
5

 
11

 
11

Expected return on plan assets
(27
)
 
(26
)
 
(4
)
 
(5
)
 
—

 
(1
)
Amortization of actuarial loss (gain)
11

 
13

 
1

 
2

 
5

 
2

Net periodic benefit cost
$
3

 
$
10

 
$
6

 
$
6

 
$
22

 
$
16


For the three months ended March 31, 2020 and 2019, the Company made voluntary contributions to its U.S. postretirement plans of $0 and $102, respectively.
XML 38 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Restructuring and Related Implementation Charges
 3 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]  
Restructuring and Related Implementation Charges
Restructuring and Related Implementation Charges
    
The Company’s restructuring program (the "Global Growth and Efficiency Program"), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program's three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions, and optimizing the global supply chain and facilities. There were no restructuring and implementation-related charges incurred for the three months ended March 31, 2020.

For the three months ended March 31, 2019 restructuring and implementation-related charges are reflected in the income statement as follows:
 
Three Months Ended
 
March 31, 2019
Cost of sales
 
$
11

Selling, general and administrative expenses
 
4

Other (income) expense, net
 
13

Non-service related postretirement costs
 
1

Total Global Growth and Efficiency Program charges, pretax
 
$
29

 
 
 
Total Global Growth and Efficiency Program charges, aftertax
 
$
22



Restructuring and implementation-related charges in the preceding table were recorded in the Corporate segment as these decisions were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance.

The following table summarizes the activity for restructuring accrual:

 
 
Three Months Ended March 31, 2020
 
 
Employee-Related
Costs 
 
Incremental
Depreciation 
 
Asset
Impairments
 
Other
 
Total
Balance at December 31, 2019
 
$
26

 
$
—

 
$
—

 
$
74

 
$
100

Charges
 
—

 
—

 
—

 
—

 
—

Cash payments
 
(15
)
 
—

 
—

 
(15
)
 
(30
)
Charges against assets
 
—

 
—

 
—

 
—

 
—

Foreign exchange
 
(1
)
 
—

 
—

 
—

 
(1
)
Other
 
—

 
—

 
—

 
—

 
—

Balance at March 31, 2020
 
$
10

 
$
—

 
$
—

 
$
59

 
$
69
XML 39 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Total Other comprehensive income (loss), net of tax $ (321) $ 33
Cumulative translation adjustments    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), pretax (320) 27
Total Other comprehensive income (loss), net of tax (339) 21
Retirement plans and other retiree benefits adjustments    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before reclassifications, pretax 2 (1)
Reclassification from AOCI, pretax 17 17
Other comprehensive income (loss), pretax 19 16
Other comprehensive income (loss), before reclassifications, net of tax 1 (1)
Reclassification from AOCI, net of tax 15 13
Total Other comprehensive income (loss), net of tax 16 12
Gains (losses) on cash flow hedges    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before reclassifications, pretax 25 (2)
Reclassification from AOCI, pretax (3) (4)
Other comprehensive income (loss), pretax 22 (6)
Other comprehensive income (loss), before reclassifications, net of tax 20 (2)
Reclassification from AOCI, net of tax (2) (3)
Total Other comprehensive income (loss), net of tax 18 (5)
Total Other comprehensive income (loss)    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), pretax (279) 37
Total Other comprehensive income (loss), net of tax [1] $ (305) $ 28
[1] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,467 at March 31, 2020 ($3,134 at March 31, 2019) and $3,128 at December 31, 2019 ($3,155 at December 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,122 at March 31, 2020 ($1,026 at March 31, 2019) and $1,138 at December 31, 2019 ($1,038 at December 31, 2018), respectively.
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of derivative instruments
The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2020 and December 31, 2019:
 
Assets
 
Liabilities
 
 
Account
 
Fair Value
 
Account
 
Fair Value
Designated derivative instruments
 
 
March 31, 2020
 
December 31, 2019
 
 
 
March 31, 2020
 
December 31, 2019
Interest rate swap contracts
Other current assets
 
$
—

 
$
—

 
Other accruals
 
$
—

 
$
—

Interest rate swap contracts
Other assets
 
16

 
4

 
Other liabilities
 
—

 
—

Foreign currency contracts
Other current assets
 
58

 
6

 
Other accruals
 
8

 
15

Foreign currency contracts
Other assets
 
—

 
—

 
Other liabilities
 
9

 
14

Commodity contracts
Other current assets
 
—

 
—

 
Other accruals
 
1

 
—

Total designated
 
$
74

 
$
10

 
 
 
$
18

 
$
29

 
 
 
 
 
 
 
 
 
 
 
 
Other financial instruments
 
 
 

 
 

 
 
 
 

 
 

Marketable securities
Other current assets
 
$
43

 
$
23

 
 
 
 

 
 

Total other financial instruments
 
 
$
43

 
$
23

 
 
 
 

 
 
Schedule of hedged item and cumulative adjustment to carrying amount
The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
 
March 31, 2020
 
December 31, 2019
Long-term debt:
 
 
 
Carrying amount of hedged item
$
415

 
$
403

Cumulative hedging adjustment included in the carrying amount
16

 
4
Schedule of notional values
The following tables present the notional values as of:
 
March 31, 2020
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
535

 
$
—

 
$
400

 
$
—

 
$
935

Cash Flow Hedges
718

 
—

 
—

 
21

 
739

Net Investment Hedges
473

 
3,752

 
—

 
—

 
4,225


 
December 31, 2019
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
388

 
$
—

 
$
400

 
$
—

 
$
788

Cash Flow Hedges
761

 
—

 
—

 
20

 
781

Net Investment Hedges
478

 
3,856

 
—

 
—

 
4,334
Schedule of gains (losses) recognized in Statements of Income
The following table presents the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
 
Three Months Ended March 31,
 
2020
 
2019
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
Gain (loss) on hedges recognized in income:
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps designated as fair value hedges:
 
 
 
 
 
 
 
 
 
 
 
Derivative instrument
$
—

 
$
—

 
$
(12
)
 
$
—

 
$
—

 
$
(3
)
Hedged items
—

 
—

 
12

 
—

 
—

 
3

Foreign currency contracts designated as fair value hedges:
 
 
 
 
 
 

 

 

Derivative instrument
—

 
24

 
—

 
—

 
(1
)
 
—

Hedged items
—

 
(24
)
 
—

 
—

 
1

 
—

Foreign currency contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
2

 
—

 
—

 
3

 
—

 
—

Commodity contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
1

 
—

 
—

 
1

 
—

 
—

Total gain (loss) on hedges recognized in income
$
3

 
$
—

 
$
—

 
$
4

 
$
—

 
$
—
Schedule of gains (losses) included in Other Comprehensive Income
The following table presents the location and amount of unrealized gains (losses) included in OCI:
 
Three Months Ended
March 31,
2020
 
2019
Foreign currency contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
$
25

 
$
(3
)
Commodity contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
—

 
1

Foreign currency contracts designated as net investment hedges:
 
 
 
Gain (loss) on instruments
25

 
6

Gain (loss) on hedged items
(25
)
 
(6
)
Foreign currency debt designated as net investment hedges:
 
 
 
Gain (loss) on instruments
65

 
29

Gain (loss) on hedged items
(65
)
 
(29
)
Total unrealized gain (loss) on hedges recognized in OCI
$
25

 
$
(2
)
XML 41 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) - Global Growth and Efficiency Program - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]    
Total Global Growth and Efficiency Program charges, pretax $ 0 $ 29
Total Global Growth and Efficiency Program charges, aftertax   22
Cost of sales    
Restructuring Cost and Reserve [Line Items]    
Total Global Growth and Efficiency Program charges, pretax   11
Selling, general and administrative expenses    
Restructuring Cost and Reserve [Line Items]    
Total Global Growth and Efficiency Program charges, pretax   4
Other (income) expense, net    
Restructuring Cost and Reserve [Line Items]    
Total Global Growth and Efficiency Program charges, pretax   13
Non-service related postretirement costs    
Restructuring Cost and Reserve [Line Items]    
Total Global Growth and Efficiency Program charges, pretax   $ 1
XML 42 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
 3 Months Ended
Mar. 31, 2020
shares
Entity Information [Line Items]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Mar. 31, 2020
Document Transition Report false
Entity File Number 1-644
Entity Registrant Name COLGATE-PALMOLIVE COMPANY
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 13-1815595
Entity Address, Address Line One 300 Park Avenue
Entity Address, City or Town New York,
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10022
City Area Code 212
Local Phone Number 310-2000
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 856,528,455
Entity Central Index Key 0000021665
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2020
Document Fiscal Period Focus Q1
Amendment Flag false
Common Stock  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, $1.00 par value
Trading Symbol CL
Security Exchange Name NYSE
0.000% Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Notes due 2021
Trading Symbol CL21A
Security Exchange Name NYSE
0.500% Notes Due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 0.500% Notes due 2026
Trading Symbol CL26
Security Exchange Name NYSE
1.375% Notes Due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Notes due 2034
Trading Symbol CL34
Security Exchange Name NYSE
0.875% Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 0.875% Notes due 2039
Trading Symbol CL39
Security Exchange Name NYSE
XML 43 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 84 $ 76
XML 44 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Basis of Presentation
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission (the “SEC”).
XML 45 R48.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI $ 25 $ (2)
Foreign Currency Contracts    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 25 (3)
Net investment hedges [Abstract]    
Gain (loss) on instruments 25 6
Gain (loss) on hedged items (25) (6)
Commodity Contracts    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 0 1
Foreign Currency Debt    
Net investment hedges [Abstract]    
Gain (loss) on instruments 65 29
Gain (loss) on hedged items $ (65) $ (29)
XML 46 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes (Details)
 3 Months Ended
Mar. 31, 2020
USD ($)
Income Tax Disclosure [Abstract]  
Provisional income tax benefit $ 71,000,000
Foreign withholding income tax 45,000,000
Valuation allowance against deferred tax asset 26,000,000
Withholding tax due $ 0
XML 47 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Designated derivative instruments    
Derivative assets, designated $ 74 $ 10
Derivative liabilities, designated 18 29
Other financial instruments    
Total other financial instruments 43 23
Other current assets    
Other financial instruments    
Marketable securities 43 23
Other current assets | Interest rate swap contracts    
Designated derivative instruments    
Derivative assets, designated 0 0
Other current assets | Foreign currency contracts    
Designated derivative instruments    
Derivative assets, designated 58 6
Other current assets | Commodity contracts    
Designated derivative instruments    
Derivative assets, designated 0 0
Other assets | Interest rate swap contracts    
Designated derivative instruments    
Derivative assets, designated 16 4
Other assets | Foreign currency contracts    
Designated derivative instruments    
Derivative assets, designated 0 0
Other accruals | Interest rate swap contracts    
Designated derivative instruments    
Derivative liabilities, designated 0 0
Other accruals | Foreign currency contracts    
Designated derivative instruments    
Derivative liabilities, designated 8 15
Other accruals | Commodity contracts    
Designated derivative instruments    
Derivative liabilities, designated 1 0
Other liabilities | Interest rate swap contracts    
Designated derivative instruments    
Derivative liabilities, designated 0 0
Other liabilities | Foreign currency contracts    
Designated derivative instruments    
Derivative liabilities, designated $ 9 $ 14
XML 48 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2020
Inventory, Net, Items Net of Reserve Alternative [Abstract]  
Inventories by Major Class

Inventories by major class are as follows:
 
March 31,
2020
 
December 31,
2019
Raw materials and supplies
$
329

 
$
305

Work-in-process
46

 
49

Finished goods
976

 
1,056

       Total Inventories, net
$
1,351

 
$
1,410

            Non-current inventory, net
$
(50
)
 
$
(10
)
              Current Inventories, net
$
1,301

 
$
1,400
XML 49 R21.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments
 3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Financial Instruments
Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2020 and December 31, 2019:
 
Assets
 
Liabilities
 
 
Account
 
Fair Value
 
Account
 
Fair Value
Designated derivative instruments
 
 
March 31, 2020
 
December 31, 2019
 
 
 
March 31, 2020
 
December 31, 2019
Interest rate swap contracts
Other current assets
 
$
—

 
$
—

 
Other accruals
 
$
—

 
$
—

Interest rate swap contracts
Other assets
 
16

 
4

 
Other liabilities
 
—

 
—

Foreign currency contracts
Other current assets
 
58

 
6

 
Other accruals
 
8

 
15

Foreign currency contracts
Other assets
 
—

 
—

 
Other liabilities
 
9

 
14

Commodity contracts
Other current assets
 
—

 
—

 
Other accruals
 
1

 
—

Total designated
 
$
74

 
$
10

 
 
 
$
18

 
$
29

 
 
 
 
 
 
 
 
 
 
 
 
Other financial instruments
 
 
 

 
 

 
 
 
 

 
 

Marketable securities
Other current assets
 
$
43

 
$
23

 
 
 
 

 
 

Total other financial instruments
 
 
$
43

 
$
23

 
 
 
 

 
 


The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of March 31, 2020 and December 31, 2019. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2020 and December 31, 2019, was $7,909 and $8,056, respectively, and the related carrying value was $7,591 and $7,587, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
 
March 31, 2020
 
December 31, 2019
Long-term debt:
 
 
 
Carrying amount of hedged item
$
415

 
$
403

Cumulative hedging adjustment included in the carrying amount
16

 
4



The following tables present the notional values as of:
 
March 31, 2020
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
535

 
$
—

 
$
400

 
$
—

 
$
935

Cash Flow Hedges
718

 
—

 
—

 
21

 
739

Net Investment Hedges
473

 
3,752

 
—

 
—

 
4,225


 
December 31, 2019
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
388

 
$
—

 
$
400

 
$
—

 
$
788

Cash Flow Hedges
761

 
—

 
—

 
20

 
781

Net Investment Hedges
478

 
3,856

 
—

 
—

 
4,334



The following table presents the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
 
Three Months Ended March 31,
 
2020
 
2019
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
Gain (loss) on hedges recognized in income:
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps designated as fair value hedges:
 
 
 
 
 
 
 
 
 
 
 
Derivative instrument
$
—

 
$
—

 
$
(12
)
 
$
—

 
$
—

 
$
(3
)
Hedged items
—

 
—

 
12

 
—

 
—

 
3

Foreign currency contracts designated as fair value hedges:
 
 
 
 
 
 

 

 

Derivative instrument
—

 
24

 
—

 
—

 
(1
)
 
—

Hedged items
—

 
(24
)
 
—

 
—

 
1

 
—

Foreign currency contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
2

 
—

 
—

 
3

 
—

 
—

Commodity contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
1

 
—

 
—

 
1

 
—

 
—

Total gain (loss) on hedges recognized in income
$
3

 
$
—

 
$
—

 
$
4

 
$
—

 
$
—




The following table presents the location and amount of unrealized gains (losses) included in OCI:
 
Three Months Ended
March 31,
2020
 
2019
Foreign currency contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
$
25

 
$
(3
)
Commodity contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
—

 
1

Foreign currency contracts designated as net investment hedges:
 
 
 
Gain (loss) on instruments
25

 
6

Gain (loss) on hedged items
(25
)
 
(6
)
Foreign currency debt designated as net investment hedges:
 
 
 
Gain (loss) on instruments
65

 
29

Gain (loss) on hedged items
(65
)
 
(29
)
Total unrealized gain (loss) on hedges recognized in OCI
$
25

 
$
(2
)
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Net Sales and Operating Profit by Segment
Net sales by segment were as follows:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
929

 
$
853

Latin America
889

 
889

Europe
675

 
602

Asia Pacific
633

 
700

Africa/Eurasia
252

 
240

Total Oral, Personal and Home Care
3,378

 
3,284

Pet Nutrition
719

 
600

Total Net sales
$
4,097

 
$
3,884


The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
 
 
 
Oral Care
44
%
 
48
%
Personal Care
20
%
 
19
%
Home Care
18
%
 
18
%
Pet Nutrition
18
%
 
15
%
Total Net sales
100
%
 
100
%

Operating profit by segment was as follows:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Operating profit
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
258

 
$
249

Latin America
248

 
232

Europe
154

 
151

Asia Pacific
161

 
189

Africa/Eurasia
56

 
46

Total Oral, Personal and Home Care
877

 
867

Pet Nutrition
203

 
164

Corporate
(128
)
 
(152
)
Total Operating profit
$
952

 
$
879
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Details)
$ in Millions
 1 Months Ended 3 Months Ended
Sep. 30, 2015
appeal
Mar. 31, 2020
USD ($)
case
country_and_territory
Jun. 30, 2019
case
Dec. 31, 2019
case
Apr. 30, 2019
USD ($)
Jul. 31, 2017
USD ($)
Dec. 31, 2005
USD ($)
Loss Contingencies [Line Items]              
Minimum number of countries and territories serving consumers (more than) (in countries and territories) | country_and_territory   200          
Brazilian internal revenue authority, matter 1 | $   $ 118.0          
Loss contingency, number of cases on appeal | case   1          
Loss contingency, number of appeals lost (in appeals) | appeal 1            
Brazilian internal revenue authority, matter 2 | $             $ 49.0
Fine imposed by Greek competition authority | $         $ 10.5 $ 11.0  
Loss contingency, pending claims, number (in cases) | case   121   121      
Loss contingency, new claims filed, number (in cases) | case   5          
Loss contingency, claims dismissed or settled, number (in cases) | case   5          
Loss contingency, number of cases resulting in adverse jury verdict | case     1        
Minimum              
Loss Contingencies [Line Items]              
Loss contingency, possible loss | $   $ 0.0          
Maximum              
Loss Contingencies [Line Items]              
Loss contingency, possible loss | $   $ 175.0          
XML 52 R45.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Long-term Debt    
Debt Instrument [Line Items]    
Carrying amount of hedged item $ 415 $ 403
Cumulative hedging adjustment included in the carrying amount 16 4
Carrying Value    
Debt Instrument [Line Items]    
Carrying value of long-term debt 7,591 7,587
Fair Value, Inputs, Level 2    
Debt Instrument [Line Items]    
Estimated fair value of long-term debt $ 7,909 $ 8,056
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 223 298 1 true 69 0 false 10 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.colgate.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome CONDENSED CONSOLIDATED STATEMENTS OF INCOME Statements 2 false false R3.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.colgate.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.colgate.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 7 false false R8.htm 1005001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Sheet http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Statements 8 false false R9.htm 2101100 - Disclosure - Basis of Presentation Sheet http://www.colgate.com/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 2101100 - Disclosure - Use of Estimates Sheet http://www.colgate.com/role/UseOfEstimates Use of Estimates Notes 10 false false R11.htm 2102100 - Disclosure - Recent Accounting Pronouncements Sheet http://www.colgate.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 11 false false R12.htm 2104100 - Disclosure - Acquisitions Sheet http://www.colgate.com/role/Acquisitions Acquisitions Notes 12 false false R13.htm 2105100 - Disclosure - Restructuring and Related Implementation Charges Sheet http://www.colgate.com/role/RestructuringAndRelatedImplementationCharges Restructuring and Related Implementation Charges Notes 13 false false R14.htm 2107100 - Disclosure - Inventories Sheet http://www.colgate.com/role/Inventories Inventories Notes 14 false false R15.htm 2108100 - Disclosure - Earnings Per Share Sheet http://www.colgate.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2109100 - Disclosure - Other Comprehensive Income (Loss) Sheet http://www.colgate.com/role/OtherComprehensiveIncomeLoss Other Comprehensive Income (Loss) Notes 16 false false R17.htm 2110100 - Disclosure - Retirement Plans and Other Retiree Benefits Sheet http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefits Retirement Plans and Other Retiree Benefits Notes 17 false false R18.htm 2111100 - Disclosure - Income Taxes Sheet http://www.colgate.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2112100 - Disclosure - Contingencies Sheet http://www.colgate.com/role/Contingencies Contingencies Notes 19 false false R20.htm 2113100 - Disclosure - Segment Information Sheet http://www.colgate.com/role/SegmentInformation Segment Information Notes 20 false false R21.htm 2117100 - Disclosure - Fair Value Measurements and Financial Instruments Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstruments Fair Value Measurements and Financial Instruments Notes 21 false false R22.htm 2201201 - Disclosure - Use of Estimates (Policies) Sheet http://www.colgate.com/role/UseOfEstimatesPolicies Use of Estimates (Policies) Policies http://www.colgate.com/role/RecentAccountingPronouncements 22 false false R23.htm 2304301 - Disclosure - Acquisitions (Tables) Sheet http://www.colgate.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.colgate.com/role/Acquisitions 23 false false R24.htm 2305301 - Disclosure - Restructuring and Related Implementation Charges (Tables) Sheet http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesTables Restructuring and Related Implementation Charges (Tables) Tables http://www.colgate.com/role/RestructuringAndRelatedImplementationCharges 24 false false R25.htm 2307301 - Disclosure - Inventories (Tables) Sheet http://www.colgate.com/role/InventoriesTables Inventories (Tables) Tables http://www.colgate.com/role/Inventories 25 false false R26.htm 2308301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.colgate.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.colgate.com/role/EarningsPerShare 26 false false R27.htm 2309301 - Disclosure - Other Comprehensive Income (Loss) (Tables) Sheet http://www.colgate.com/role/OtherComprehensiveIncomeLossTables Other Comprehensive Income (Loss) (Tables) Tables http://www.colgate.com/role/OtherComprehensiveIncomeLoss 27 false false R28.htm 2310301 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables) Sheet http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsTables Retirement Plans and Other Retiree Benefits (Tables) Tables http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefits 28 false false R29.htm 2313301 - Disclosure - Segment Information (Tables) Sheet http://www.colgate.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.colgate.com/role/SegmentInformation 29 false false R30.htm 2317301 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables Fair Value Measurements and Financial Instruments (Tables) Tables http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstruments 30 false false R31.htm 2404402 - Disclosure - Acquisitions - Narrative (Details) Sheet http://www.colgate.com/role/AcquisitionsNarrativeDetails Acquisitions - Narrative (Details) Details 31 false false R32.htm 2404403 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) Sheet http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) Details 32 false false R33.htm 2405402 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details) Sheet http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails Restructuring and Related Implementation Charges - Narrative (Details) Details http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesTables 33 false false R34.htm 2405403 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) Sheet http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) Details 34 false false R35.htm 2405404 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) Sheet http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) Details 35 false false R36.htm 2407402 - Disclosure - Inventories (Details) Sheet http://www.colgate.com/role/InventoriesDetails Inventories (Details) Details http://www.colgate.com/role/InventoriesTables 36 false false R37.htm 2408402 - Disclosure - Earnings Per Share (Details) Sheet http://www.colgate.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.colgate.com/role/EarningsPerShareTables 37 false false R38.htm 2409402 - Disclosure - Other Comprehensive Income (Loss) (Details) Sheet http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails Other Comprehensive Income (Loss) (Details) Details http://www.colgate.com/role/OtherComprehensiveIncomeLossTables 38 false false R39.htm 2410402 - Disclosure - Retirement Plans and Other Retiree Benefits (Details) Sheet http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails Retirement Plans and Other Retiree Benefits (Details) Details http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsTables 39 false false R40.htm 2411401 - Disclosure - Income Taxes (Details) Sheet http://www.colgate.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.colgate.com/role/IncomeTaxes 40 false false R41.htm 2412401 - Disclosure - Contingencies (Details) Sheet http://www.colgate.com/role/ContingenciesDetails Contingencies (Details) Details http://www.colgate.com/role/Contingencies 41 false false R42.htm 2413402 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.colgate.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 42 false false R43.htm 2413403 - Disclosure - Segment Information - Schedule of Segment Information (Details) Sheet http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails Segment Information - Schedule of Segment Information (Details) Details 43 false false R44.htm 2417402 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) Details 44 false false R45.htm 2417403 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) Details 45 false false R46.htm 2417404 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) Details 46 false false R47.htm 2417405 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) Details 47 false false R48.htm 2417406 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) Details 48 false false All Reports Book All Reports cl-3312020x10q.htm cl-20200331.xsd cl-20200331_cal.xml cl-20200331_def.xml cl-20200331_lab.xml cl-20200331_pre.xml exhibit10a033120q12020.htm exhibit31a033120q12020.htm exhibit31b033120q12020.htm exhibit32033120q12020.htm http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 54 cl-3312020x10q_htm.xml IDEA: XBRL DOCUMENT 0000021665 2020-01-01 2020-03-31 0000021665 cl:A0.000Notesdue2021Member 2020-01-01 2020-03-31 0000021665 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000021665 cl:A0.875Notesdue2039Member 2020-01-01 2020-03-31 0000021665 cl:A0.500NotesDue2026Member 2020-01-01 2020-03-31 0000021665 cl:A1.375NotesDue2034Member 2020-01-01 2020-03-31 0000021665 2020-03-31 0000021665 2019-01-01 2019-03-31 0000021665 2019-12-31 0000021665 2018-12-31 0000021665 2019-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000021665 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000021665 cl:UnearnedCompensationMember 2019-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000021665 cl:UnearnedCompensationMember 2018-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2018-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-03-31 0000021665 us-gaap:TreasuryStockMember 2018-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000021665 us-gaap:RetainedEarningsMember 2018-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-03-31 0000021665 us-gaap:CommonStockMember 2018-12-31 0000021665 us-gaap:TreasuryStockMember 2019-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000021665 us-gaap:CommonStockMember 2019-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommonStockMember 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2020-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2019-12-31 0000021665 cl:UnearnedCompensationMember 2020-01-01 2020-03-31 0000021665 cl:UnearnedCompensationMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000021665 cl:UnearnedCompensationMember 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2019-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000021665 us-gaap:CommonStockMember 2019-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 2019-09-19 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:CustomerRelationshipsMember 2019-09-19 2019-09-19 0000021665 cl:HelloProductLLCMember 2020-01-31 2020-01-31 0000021665 srt:EuropeMember cl:LaboratoiresFilorgaCosmtiquesMember 2019-09-19 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:TrademarksMember 2019-09-19 0000021665 cl:NigeriaJointVentureMember 2019-08-15 2019-08-15 0000021665 srt:NorthAmericaMember cl:HelloProductLLCMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 0000021665 cl:NigeriaJointVentureMember 2019-08-15 0000021665 cl:LaboratoiresFilorgaCosmtiquesMember us-gaap:CustomerRelationshipsMember 2019-09-19 0000021665 cl:HelloProductLLCMember 2020-01-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:GrossProfitMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:OtherIncomeExpenseNetMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:NonServiceRelatedPostretirementCostsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:IncrementalDepreciationMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 us-gaap:OtherRestructuringMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 us-gaap:OneTimeTerminationBenefitsMember cl:GlobalGrowthandEfficiencyProgramMember 2020-03-31 0000021665 cl:AssetImpairmentMember cl:GlobalGrowthandEfficiencyProgramMember 2019-12-31 0000021665 cl:RestructuringAndImplementationRelatedChargesMember cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-03-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000021665 2017-07-31 0000021665 2019-04-01 2019-06-30 0000021665 srt:MinimumMember 2020-03-31 0000021665 2015-09-01 2015-09-30 0000021665 2019-04-30 0000021665 srt:MaximumMember 2020-03-31 0000021665 2005-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2019-01-01 2019-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2020-01-01 2020-03-31 0000021665 us-gaap:SalesRevenueNetMember 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember cl:GlobalGrowthandEfficiencyProgramMember 2019-01-01 2019-03-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentAssetsMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember 2019-12-31 0000021665 us-gaap:LongTermDebtMember 2019-12-31 0000021665 us-gaap:LongTermDebtMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000021665 us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2019-12-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2019-12-31 0000021665 us-gaap:FairValueInputsLevel2Member 2020-03-31 0000021665 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000021665 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommodityContractMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-03-31 0000021665 us-gaap:DebtMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember 2019-01-01 2019-03-31 0000021665 us-gaap:DebtMember 2019-01-01 2019-03-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2019-01-01 2019-03-31 0000021665 us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:NetInvestmentHedgingMember 2020-03-31 0000021665 us-gaap:CashFlowHedgingMember 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2020-03-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2020-03-31 cl:case cl:country_and_territory iso4217:USD iso4217:USD shares cl:Dividend cl:appeal cl:segment iso4217:EUR shares pure 2 false --12-31 Q1 2020 0000021665 76000000 84000000 0.85 0.87 121 5 10-Q true 2020-03-31 false 1-644 COLGATE-PALMOLIVE COMPANY DE 13-1815595 300 Park Avenue New York, NY 10022 212 310-2000 Common Stock, $1.00 par value CL NYSE 0.000% Notes due 2021 CL21A NYSE 0.500% Notes due 2026 CL26 NYSE 1.375% Notes due 2034 CL34 NYSE 0.875% Notes due 2039 CL39 NYSE Yes Yes Large Accelerated Filer false false false 856528455 4097000000 3884000000 1632000000 1597000000 2465000000 2287000000 1473000000 1365000000 -40000000 -43000000 952000000 879000000 21000000 25000000 36000000 40000000 895000000 814000000 147000000 214000000 748000000 600000000 33000000 40000000 715000000 560000000 0.83 0.65 0.83 0.65 748000000 600000000 -355000000 26000000 -16000000 -12000000 18000000 -5000000 -321000000 33000000 427000000 633000000 33000000 40000000 -16000000 5000000 17000000 45000000 410000000 588000000 854000000 883000000 1551000000 1440000000 1301000000 1400000000 542000000 456000000 4248000000 4179000000 8167000000 8580000000 4680000000 4830000000 3487000000 3750000000 3559000000 3508000000 2822000000 2667000000 179000000 177000000 775000000 753000000 15070000000 15034000000 255000000 260000000 255000000 254000000 1216000000 1237000000 485000000 370000000 2232000000 1917000000 4443000000 4038000000 7336000000 7333000000 415000000 507000000 2535000000 2598000000 14729000000 14476000000 1466000000 1466000000 2623000000 2488000000 22481000000 22501000000 -4578000000 -4273000000 1000000 2000000 22104000000 22063000000 -113000000 117000000 454000000 441000000 341000000 558000000 15070000000 15034000000 748000000 600000000 133000000 128000000 -30000000 5000000 16000000 17000000 -99000000 53000000 0 102000000 211000000 145000000 -29000000 32000000 220000000 44000000 38000000 -37000000 768000000 605000000 82000000 71000000 42000000 27000000 16000000 0 351000000 0 -459000000 -98000000 1200000000 1774000000 1188000000 2076000000 373000000 366000000 220000000 399000000 297000000 71000000 -308000000 -392000000 -30000000 2000000 -29000000 117000000 883000000 726000000 854000000 843000000 128000000 149000000 1466000000 2488000000 -2000000 -22063000000 22501000000 -4273000000 441000000 715000000 33000000 -305000000 -16000000 738000000 4000000 16000000 133000000 164000000 -15000000 15000000 220000000 -1000000 -1000000 -3000000 1466000000 2623000000 -1000000 -22104000000 22481000000 -4578000000 454000000 1466000000 2204000000 -3000000 -21196000000 21615000000 -4188000000 299000000 560000000 40000000 28000000 5000000 734000000 2000000 17000000 33000000 49000000 -13000000 13000000 399000000 -1000000 5000000 1466000000 2241000000 -3000000 -21532000000 21436000000 -4160000000 342000000 -3467000000 -3134000000 -3128000000 -3155000000 1122000000 1026000000 1138000000 1038000000 2 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, filed with the Securities and Exchange Commission (the “SEC”).</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.</span></div> <div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.</span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;text-indent:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This new guidance is effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, FASB issued ASU No. 2020-03, "Codification to Financial Instruments." This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323) and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This new guidance was effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326)” Codification Improvements to Financial Instruments-Credit Losses (Topic 326). Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This ASU introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements. <div style="line-height:120%;padding-left:24px;text-indent:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This new guidance is effective upon issuance of this ASU for contract modifications and hedging relationships on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, FASB issued ASU No. 2020-03, "Codification to Financial Instruments." This ASU improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments related to Issue 1, Issue 2, Issue 4, and Issue 5 were effective upon issuance of this update. The amendments related to Issue 3, Issue 6 and Issue 7 were effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323) and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825).” This ASU clarifies three topics related to financial instruments accounting. This new guidance was effective for the Company beginning on January 1, 2020. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance was effective for the Company beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard was effective for the Company on a prospective basis beginning on January 1, 2020 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326)” Codification Improvements to Financial Instruments-Credit Losses (Topic 326). Subsequent updates were released in November 2018 (ASU No. 2018-19), November 2019 (ASU No. 2019-10 and 2019-11) and February 2020 (ASU No. 2020-02) that provided additional guidance on this Topic. This ASU introduces the current expected credit loss (CECL) model, which will require an entity to measure credit losses for certain financial instruments and financial assets, including trade receivables. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. The Company adopted the new standard, which primarily impacts the Company’s trade receivables and related methodology for assessing the collectability of its customer accounts, on January 1, 2020, on a “modified retrospective” basis. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements. </span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisitions</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Hello Products LLC</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 31, 2020, the Company acquired Hello Products LLC, an oral care business, for cash consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>$351</span></span><span style="font-family:inherit;font-size:10pt;">. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total purchase price consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>$351</span></span><span style="font-family:inherit;font-size:10pt;"> has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value of net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>351</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets acquired include trademarks of </span><span style="font-family:inherit;font-size:10pt;"><span>$155</span></span><span style="font-family:inherit;font-size:10pt;">, which are considered to have an indefinite useful life, and customer relationships of </span><span style="font-family:inherit;font-size:10pt;"><span>$45</span></span><span style="font-family:inherit;font-size:10pt;">, which have a finite useful life. Goodwill of </span><span style="font-family:inherit;font-size:10pt;"><span>$131</span></span><span style="font-family:inherit;font-size:10pt;"> was allocated to the North America segment. </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company expects to finalize the purchase price allocation no later than the first quarter of 2021.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Laboratoires Filorga Cosmétiques (“Filorga”)</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On September 19, 2019 (the “Acquisition Date”), the Company acquired the Filorga skin health business for cash consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>€1,516</span></span><span style="font-family:inherit;font-size:10pt;"> (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1,674</span></span><span style="font-family:inherit;font-size:10pt;">), which included interest on the equity purchase price, plus additional consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>€32</span></span><span style="font-family:inherit;font-size:10pt;"> (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$38</span></span><span style="font-family:inherit;font-size:10pt;">), the majority of which related to repayment of loans from former shareholders of Filorga. Filorga is a premium anti-aging skin health brand focused primarily on facial care. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses, including by expanding its portfolio in premium skin health.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total purchase price consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,712</span></span><span style="font-family:inherit;font-size:10pt;"> has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>923</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(67</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(276</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value of net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,712</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets acquired include trademarks of </span><span style="font-family:inherit;font-size:10pt;"><span>$774</span></span><span style="font-family:inherit;font-size:10pt;">, which are considered to have an indefinite useful life, and customer relationships of </span><span style="font-family:inherit;font-size:10pt;"><span>$277</span></span><span style="font-family:inherit;font-size:10pt;">, which have an estimated life of </span><span style="font-family:inherit;font-size:10pt;"><span>14 years</span></span><span style="font-family:inherit;font-size:10pt;">. Goodwill of </span><span style="font-family:inherit;font-size:10pt;"><span>$923</span></span><span style="font-family:inherit;font-size:10pt;"> was allocated to the Europe segment. The Company expects that goodwill will not be deductible for tax purposes.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company continues to evaluate potential contingencies that may have existed as of the acquisition date and expects to finalize the purchase price allocation no later than the third quarter of 2020.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Nigeria Joint Venture</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 15, 2019, the Company acquired a </span><span style="font-family:inherit;font-size:10pt;"><span>51%</span></span><span style="font-family:inherit;font-size:10pt;"> controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited, for </span><span style="font-family:inherit;font-size:10pt;"><span>$31</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.</span></div> 351000000 351000000 11000000 13000000 4000000 200000000 131000000 351000000 155000000 45000000 131000000 1516000000 1674000000 32000000 38000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total purchase price consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,712</span></span><span style="font-family:inherit;font-size:10pt;"> has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.98245614035088%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>923</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(67</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(276</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value of net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,712</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total purchase price consideration of </span><span style="font-family:inherit;font-size:10pt;"><span>$351</span></span><span style="font-family:inherit;font-size:10pt;"> has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>131</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value of net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>351</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1712000000 30000000 53000000 70000000 18000000 1051000000 923000000 67000000 276000000 90000000 1712000000 774000000 277000000 P14Y 923000000 0.51 31000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring and Related Implementation Charges </span></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">    </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s restructuring program (the "Global Growth and Efficiency Program"), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program's three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions, and optimizing the global supply chain and facilities. There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> restructuring and implementation-related charges incurred for the three months ended March 31, 2020. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three months ended March 31, 2019 restructuring and implementation-related charges are reflected in the income statement as follows:</span></div><div style="line-height:120%;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.90643274853801%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-service related postretirement costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Global Growth and Efficiency Program charges, pretax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Global Growth and Efficiency Program charges, aftertax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restructuring and implementation-related charges in the preceding table were recorded in the Corporate segment as these decisions were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance. </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity for restructuring accrual:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee-Related<br/>Costs </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Incremental<br/>Depreciation </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset<br/>Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges against assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 <div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the three months ended March 31, 2019 restructuring and implementation-related charges are reflected in the income statement as follows:</span></div><div style="line-height:120%;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.90643274853801%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-service related postretirement costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Global Growth and Efficiency Program charges, pretax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Global Growth and Efficiency Program charges, aftertax</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 11000000 4000000 13000000 1000000 29000000 22000000 <div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity for restructuring accrual:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee-Related<br/>Costs </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Incremental<br/>Depreciation </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset<br/>Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges against assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 26000000 0 0 74000000 100000000 0 0 0 0 0 15000000 0 0 15000000 30000000 0 0 0 0 0 1000000 0 0 0 1000000 0 0 0 0 0 10000000 0 0 59000000 69000000 <span style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories by major class are as follows:</span></div><div style="line-height:100%;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials and supplies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>329</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>305</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>976</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,056</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">       Total Inventories, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,351</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,410</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">            Non-current inventory, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">              Current Inventories, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories by major class are as follows:</span></div><div style="line-height:100%;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials and supplies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>329</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>305</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>976</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,056</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">       Total Inventories, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,351</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,410</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">            Non-current inventory, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">              Current Inventories, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 329000000 305000000 46000000 49000000 976000000 1056000000 1351000000 1410000000 50000000 10000000 1301000000 1400000000 <span style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings Per Share</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, earnings per share were as follows:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"/></tr><tr><td style="width:19%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="21" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income attributable to Colgate-Palmolive Company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Per</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income attributable to Colgate-Palmolive Company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Per</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic EPS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>715</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>856.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.83</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>560</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>862.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and </span></div><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">restricted stock units</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted EPS</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>715</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>858.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.83</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>560</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>863.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were </span><span style="font-family:inherit;font-size:10pt;"><span>20,965,110</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>21,980,033</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div> <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;">, earnings per share were as follows:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"/></tr><tr><td style="width:19%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="21" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income attributable to Colgate-Palmolive Company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Per</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income attributable to Colgate-Palmolive Company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Per</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic EPS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>715</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>856.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.83</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>560</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>862.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options and </span></div><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">restricted stock units</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted EPS</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>715</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>858.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.83</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>560</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>863.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 715000000 856900000 0.83 560000000 862000000.0 0.65 1500000 1200000 715000000 858400000 0.83 560000000 863200000 0.65 20965110 21980033 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Comprehensive Income (Loss)</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;"> </span></div><div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the </span><span style="font-family:inherit;font-size:10pt;text-align:center;">three months ended</span><span style="font-family:inherit;font-size:10pt;text-align:center;"> </span><span style="font-family:inherit;font-size:10pt;text-align:center;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;text-align:center;"> and </span><span style="font-family:inherit;font-size:10pt;text-align:center;">2019</span><span style="font-family:inherit;font-size:10pt;text-align:center;"> were as follows:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pretax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net of Tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pretax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net of Tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cumulative translation adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(320</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(339</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement plans and other retiree benefits:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net actuarial gain (loss) and prior service costs arising during the period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss, transition and prior service costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retirement plans and other retiree benefits adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains (losses) on cash flow hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassification of (gains) losses into net earnings on cash flow hedges </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gains (losses) on cash flow hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(279</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(305</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></span><span style="font-family:inherit;font-size:8pt;">These components of Other comprehensive income (loss) are included in the computation of total pension cost. See </span><span style="font-family:inherit;font-size:8pt;">Note 9</span><span style="font-family:inherit;font-size:8pt;">, </span><span style="font-family:inherit;font-size:8pt;">Retirement Plans and Other Retiree Benefits</span><span style="font-family:inherit;font-size:8pt;"> for additional details.</span></div><div style="line-height:120%;padding-left:36px;text-indent:-12px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) </sup></span><span style="font-family:inherit;font-size:8pt;">These (gains) losses are reclassified into Cost of sales. See </span><span style="font-family:inherit;font-size:8pt;">Note 13</span><span style="font-family:inherit;font-size:8pt;">, </span><span style="font-family:inherit;font-size:8pt;">Fair Value Measurements and Financial Instruments</span><span style="font-family:inherit;font-size:8pt;"> for additional details.</span></div><div style="line-height:120%;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.</span></div> <div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-align:center;">Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the </span><span style="font-family:inherit;font-size:10pt;text-align:center;">three months ended</span><span style="font-family:inherit;font-size:10pt;text-align:center;"> </span><span style="font-family:inherit;font-size:10pt;text-align:center;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;text-align:center;"> and </span><span style="font-family:inherit;font-size:10pt;text-align:center;">2019</span><span style="font-family:inherit;font-size:10pt;text-align:center;"> were as follows:</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pretax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net of Tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pretax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net of Tax</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cumulative translation adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(320</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(339</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement plans and other retiree benefits:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net actuarial gain (loss) and prior service costs arising during the period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of net actuarial loss, transition and prior service costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Retirement plans and other retiree benefits adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrealized gains (losses) on cash flow hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassification of (gains) losses into net earnings on cash flow hedges </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gains (losses) on cash flow hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(279</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(305</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></span><span style="font-family:inherit;font-size:8pt;">These components of Other comprehensive income (loss) are included in the computation of total pension cost. See </span><span style="font-family:inherit;font-size:8pt;">Note 9</span><span style="font-family:inherit;font-size:8pt;">, </span><span style="font-family:inherit;font-size:8pt;">Retirement Plans and Other Retiree Benefits</span><span style="font-family:inherit;font-size:8pt;"> for additional details.</span></div><div style="line-height:120%;padding-left:36px;text-indent:-12px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) </sup></span><span style="font-family:inherit;font-size:8pt;">These (gains) losses are reclassified into Cost of sales. See </span><span style="font-family:inherit;font-size:8pt;">Note 13</span><span style="font-family:inherit;font-size:8pt;">, </span><span style="font-family:inherit;font-size:8pt;">Fair Value Measurements and Financial Instruments</span><span style="font-family:inherit;font-size:8pt;"> for additional details.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -320000000 -339000000 27000000 21000000 2000000 1000000 -1000000 -1000000 -17000000 -15000000 -17000000 -13000000 19000000 16000000 16000000 12000000 25000000 20000000 -2000000 -2000000 3000000 2000000 4000000 3000000 22000000 18000000 -6000000 -5000000 -279000000 -305000000 37000000 28000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Retirement Plans and Other Retiree Benefits</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Components of Net periodic benefit cost for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pension Benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Retiree Benefits</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">International</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss (gain)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">For the </span><span style="font-family:inherit;font-size:10pt;">three months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, the Company made voluntary contributions to its U.S. postretirement plans of $</span><span style="font-family:inherit;font-size:10pt;"><span>0</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$102</span></span>, respectively. <div style="line-height:120%;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Components of Net periodic benefit cost for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2019</span><span style="font-family:inherit;font-size:10pt;"> were as follows:</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pension Benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Retiree Benefits</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">International</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss (gain)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 0 4000000 4000000 6000000 4000000 19000000 23000000 5000000 5000000 11000000 11000000 27000000 26000000 4000000 5000000 0 1000000 -11000000 -13000000 -1000000 -2000000 -5000000 -2000000 3000000 10000000 6000000 6000000 22000000 16000000 0 102000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The provision for income taxes for the quarter ended March 31, 2020 includes </span><span style="font-family:inherit;font-size:10pt;"><span>$71</span></span><span style="font-family:inherit;font-size:10pt;"> of income tax benefits recorded on a discrete period basis of which </span><span style="font-family:inherit;font-size:10pt;"><span>$45</span></span><span style="font-family:inherit;font-size:10pt;"> relates to previously recorded foreign withholding taxes and </span><span style="font-family:inherit;font-size:10pt;"><span>$26</span></span><span style="font-family:inherit;font-size:10pt;"> relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Acts (the "TCJA"). </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a recent reorganization of the ownership structure of certain foreign subsidiaries, the Company has now determined that </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed </span><span style="font-family:inherit;font-size:10pt;"><span>$45</span></span><span style="font-family:inherit;font-size:10pt;"> of previously recorded foreign withholding taxes.</span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure being implemented within one of the Company's divisions, the Company now believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of </span><span style="font-family:inherit;font-size:10pt;"><span>$26</span></span>. -71000000 -45000000 -26000000 0 -45000000 -26000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a global company serving consumers in more than </span><span style="font-family:inherit;font-size:10pt;"><span>200</span></span><span style="font-family:inherit;font-size:10pt;"> countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;"> to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$175</span></span><span style="font-family:inherit;font-size:10pt;"> (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Brazilian Matters</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:11pt;"><span style="font-family:inherit;font-size:10pt;">There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the </span><span style="font-family:inherit;font-size:11pt;">“</span><span style="font-family:inherit;font-size:10pt;">Seller</span><span style="font-family:inherit;font-size:11pt;">”</span><span style="font-family:inherit;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$118</span></span><span style="font-family:inherit;font-size:10pt;">. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. There is </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> case currently on appeal at the administrative level. In the event the Company is ultimately unsuccessful in this administrative appeal, further appeals are available within the Brazilian federal courts. </span></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In September 2015, the Company lost </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. In April 2019, the Company lost another administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously. </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$49</span></span><span style="font-family:inherit;font-size:10pt;">, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Competition Matter</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> of such competition law matters pending against the Company during the three months ended March 31, 2020 is set forth below.</span></div><div style="line-height:120%;padding-left:72px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined </span><span style="font-family:inherit;font-size:10pt;"><span>$11</span></span><span style="font-family:inherit;font-size:10pt;">. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to </span><span style="font-family:inherit;font-size:10pt;"><span>$10.5</span></span><span style="font-family:inherit;font-size:10pt;"> and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Talcum Powder Matters</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and December 31, 2019, there were </span><span style="font-family:inherit;font-size:10pt;"><span>121</span></span><span style="font-family:inherit;font-size:10pt;"> individual cases pending against the Company in state and federal courts throughout the United States. During the three months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> new cases were filed and </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> cases were resolved by voluntary dismissal or settlement. The value of the settlements in the quarter presented was not material, either individually or in the aggregate, to the period’s results of operations. </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits. </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">ERISA Matter</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.</span></div> 200 0 175000000 118000000 1 1 49000000 11000000 10500000 121 5 5 1 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Information</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company operates in </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> product segments: Oral, Personal and Home Care; and Pet Nutrition. </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The operations of the Oral, Personal and Home Care product segment are managed geographically in </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales by segment were as follows:</span></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.42300194931774%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:50%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net sales</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral, Personal and Home Care</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>929</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Latin America</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>889</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>889</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>675</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>602</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>633</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>700</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Africa/Eurasia</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>252</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Oral, Personal and Home Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pet Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>719</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>600</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,097</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,884</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Approximately </span><span style="font-family:inherit;font-size:10pt;"><span>70%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s Net sales are generated from markets outside the U.S., with approximately </span><span style="font-family:inherit;font-size:10pt;"><span>45%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.21052631578947%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:71%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Personal Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Home Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pet Nutrition</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating profit by segment was as follows:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.7953216374269%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating profit</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral, Personal and Home Care</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>258</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>249</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Latin America</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>232</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Africa/Eurasia</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Oral, Personal and Home Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>877</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>867</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pet Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>203</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(128</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Operating profit</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>952</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>879</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate Operating profit (loss) for the three months ended March 31, 2020 included a charge for acquisition-related costs of $</span><span style="font-family:inherit;font-size:10pt;"><span>6</span></span><span style="font-family:inherit;font-size:10pt;">. Corporate Operating profit (loss) for the three months ended March 31, 2019, included charges of $</span><span style="font-family:inherit;font-size:10pt;"><span>28</span></span><span style="font-family:inherit;font-size:10pt;"> resulting from the Global Growth and Efficiency Program, which ended on December 31, 2019.</span></div> 2 5 <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net sales by segment were as follows:</span></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.42300194931774%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:50%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net sales</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral, Personal and Home Care</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>929</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Latin America</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>889</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>889</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>675</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>602</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>633</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>700</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Africa/Eurasia</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>252</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Oral, Personal and Home Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pet Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>719</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>600</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,097</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,884</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.21052631578947%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:71%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Personal Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Home Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pet Nutrition</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating profit by segment was as follows:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.7953216374269%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating profit</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral, Personal and Home Care</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">North America</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>258</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>249</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Latin America</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>232</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Europe</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>154</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>189</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Africa/Eurasia</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Oral, Personal and Home Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>877</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>867</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pet Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>203</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(128</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(152</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Operating profit</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>952</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>879</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 929000000 853000000 889000000 889000000 675000000 602000000 633000000 700000000 252000000 240000000 3378000000 3284000000 719000000 600000000 4097000000 3884000000 0.70 0.45 0.44 0.48 0.20 0.19 0.18 0.18 0.18 0.15 1 1 258000000 249000000 248000000 232000000 154000000 151000000 161000000 189000000 56000000 46000000 877000000 867000000 203000000 164000000 -128000000 -152000000 952000000 879000000 6000000 28000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements and Financial Instruments</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:21%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Account</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Account</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Designated derivative instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap contracts</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accruals</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap contracts</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accruals</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity contracts</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accruals</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total designated</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other financial instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketable securities</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total other financial instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. The estimated fair value of the Company’s long-term debt, including the current portion, as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, was </span><span style="font-family:inherit;font-size:10pt;"><span>$7,909</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$8,056</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, and the related carrying value was </span><span style="font-family:inherit;font-size:10pt;"><span>$7,591</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$7,587</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:63%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying amount of hedged item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>415</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>403</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cumulative hedging adjustment included in the carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the notional values as of:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair Value Hedges </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>535</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash Flow Hedges </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>739</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net Investment Hedges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>473</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,752</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,225</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair Value Hedges </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>388</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>788</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash Flow Hedges </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>761</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>781</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net Investment Hedges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>478</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,334</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of sales </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Selling, general and administrative expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest (income) expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Selling, general and administrative expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest (income) expense, net</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on hedges recognized in income:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps designated as fair value hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instrument</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Hedged items</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts designated as fair value hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instrument</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Hedged items</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts designated as cash flow hedges: </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amount reclassified from OCI</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity contracts designated as cash flow hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amount reclassified from OCI</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total gain (loss) on hedges recognized in income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the location and amount of unrealized gains (losses) included in OCI:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:63%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign currency contracts designated as cash flow hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity contracts designated as cash flow hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in OCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign currency contracts designated as net investment hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on instruments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on hedged items</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign currency debt designated as net investment hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on instruments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on hedged items</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(65</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total unrealized gain (loss) on hedges recognized in OCI</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:21%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Account</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Account</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Designated derivative instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap contracts</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accruals</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swap contracts</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accruals</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity contracts</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other accruals</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total designated</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other financial instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketable securities</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total other financial instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 0 0 0 16000000 4000000 0 0 58000000 6000000 8000000 15000000 0 0 9000000 14000000 0 0 1000000 0 74000000 10000000 18000000 29000000 43000000 23000000 43000000 23000000 7909000000 8056000000 7591000000 7587000000 <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:63%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying amount of hedged item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>415</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>403</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cumulative hedging adjustment included in the carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 415000000 403000000 16000000 4000000 <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables present the notional values as of:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair Value Hedges </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>535</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash Flow Hedges </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>718</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>739</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net Investment Hedges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>473</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,752</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,225</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.10136452241716%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair Value Hedges </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>388</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>788</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash Flow Hedges </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>761</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>781</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net Investment Hedges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>478</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,334</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 535000000 0 400000000 0 935000000 718000000 0 0 21000000 739000000 473000000 3752000000 0 0 4225000000 388000000 0 400000000 0 788000000 761000000 0 0 20000000 781000000 478000000 3856000000 0 0 4334000000 <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:31%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of sales </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Selling, general and administrative expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest (income) expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Selling, general and administrative expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Interest (income) expense, net</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on hedges recognized in income:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate swaps designated as fair value hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instrument</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Hedged items</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts designated as fair value hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative instrument</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Hedged items</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(24</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts designated as cash flow hedges: </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amount reclassified from OCI</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Commodity contracts designated as cash flow hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amount reclassified from OCI</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total gain (loss) on hedges recognized in income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 0 -12000000 0 0 -3000000 0 0 12000000 0 0 3000000 0 24000000 0 0 -1000000 0 0 -24000000 0 0 1000000 0 2000000 0 0 3000000 0 0 1000000 0 0 1000000 0 0 3000000 0 0 4000000 0 0 <div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the location and amount of unrealized gains (losses) included in OCI:</span></div><div style="line-height:120%;text-align:center;padding-left:24px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:63%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign currency contracts designated as cash flow hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Commodity contracts designated as cash flow hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) recognized in OCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign currency contracts designated as net investment hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on instruments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on hedged items</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign currency debt designated as net investment hedges:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on instruments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (loss) on hedged items</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(65</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total unrealized gain (loss) on hedges recognized in OCI</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 25000000 -3000000 0 1000000 25000000 6000000 -25000000 -6000000 65000000 29000000 -65000000 -29000000 25000000 -2000000 Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,467 at March 31, 2020 ($3,134 at March 31, 2019) and $3,128 at December 31, 2019 ($3,155 at December 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,122 at March 31, 2020 ($1,026 at March 31, 2019) and $1,138 at December 31, 2019 ($1,038 at December 31, 2018), respectively. Two dividends were declared in each of the first quarters of 2020 and 2019 XML 55 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Retirement Plans and Other Retiree Benefits (Tables)
 3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
Components Of Net Periodic Benefit Cost

Components of Net periodic benefit cost for the three months ended March 31, 2020 and 2019 were as follows:

 
Three Months Ended March 31,
 
Pension Benefits
 
Other Retiree Benefits
 
United States
 
International
 
 
 
 
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
Service cost
$
—

 
$
—

 
$
4

 
$
4

 
$
6

 
$
4

Interest cost
19

 
23

 
5

 
5

 
11

 
11

Expected return on plan assets
(27
)
 
(26
)
 
(4
)
 
(5
)
 
—

 
(1
)
Amortization of actuarial loss (gain)
11

 
13

 
1

 
2

 
5

 
2

Net periodic benefit cost
$
3

 
$
10

 
$
6

 
$
6

 
$
22

 
$
16
XML 56 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 57 0000021665-20-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000021665-20-000007-xbrl.zip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�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end XML 58 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Restructuring and Related Implementation Charges (Tables)
 3 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
For the three months ended March 31, 2019 restructuring and implementation-related charges are reflected in the income statement as follows:
 
Three Months Ended
 
March 31, 2019
Cost of sales
 
$
11

Selling, general and administrative expenses
 
4

Other (income) expense, net
 
13

Non-service related postretirement costs
 
1

Total Global Growth and Efficiency Program charges, pretax
 
$
29

 
 
 
Total Global Growth and Efficiency Program charges, aftertax
 
$
22
Schedule of Restructuring Reserve by Type of Cost
The following table summarizes the activity for restructuring accrual:

 
 
Three Months Ended March 31, 2020
 
 
Employee-Related
Costs 
 
Incremental
Depreciation 
 
Asset
Impairments
 
Other
 
Total
Balance at December 31, 2019
 
$
26

 
$
—

 
$
—

 
$
74

 
$
100

Charges
 
—

 
—

 
—

 
—

 
—

Cash payments
 
(15
)
 
—

 
—

 
(15
)
 
(30
)
Charges against assets
 
—

 
—

 
—

 
—

 
—

Foreign exchange
 
(1
)
 
—

 
—

 
—

 
(1
)
Other
 
—

 
—

 
—

 
—

 
—

Balance at March 31, 2020
 
$
10

 
$
—

 
$
—

 
$
59

 
$
69

XML 59 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Segment Information
Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
929

 
$
853

Latin America
889

 
889

Europe
675

 
602

Asia Pacific
633

 
700

Africa/Eurasia
252

 
240

Total Oral, Personal and Home Care
3,378

 
3,284

Pet Nutrition
719

 
600

Total Net sales
$
4,097

 
$
3,884



Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Net sales
 
 
 
Oral Care
44
%
 
48
%
Personal Care
20
%
 
19
%
Home Care
18
%
 
18
%
Pet Nutrition
18
%
 
15
%
Total Net sales
100
%
 
100
%

Operating profit by segment was as follows:
 
Three Months Ended
 
March 31,
 
2020
 
2019
Operating profit
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
258

 
$
249

Latin America
248

 
232

Europe
154

 
151

Asia Pacific
161

 
189

Africa/Eurasia
56

 
46

Total Oral, Personal and Home Care
877

 
867

Pet Nutrition
203

 
164

Corporate
(128
)
 
(152
)
Total Operating profit
$
952

 
$
879



Corporate Operating profit (loss) for the three months ended March 31, 2020 included a charge for acquisition-related costs of $6. Corporate Operating profit (loss) for the three months ended March 31, 2019, included charges of $28 resulting from the Global Growth and Efficiency Program, which ended on December 31, 2019.
XML 60 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Income (Loss)
 3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Other Comprehensive Income (Loss)
Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2020 and 2019 were as follows:
 
 
2020
 
2019
 
 
Pretax
 
Net of Tax
 
Pretax
 
Net of Tax
Cumulative translation adjustments
 
$
(320
)
 
$
(339
)
 
$
27

 
$
21

Retirement plans and other retiree benefits:
 
 
 
 
 
 
 
 
Net actuarial gain (loss) and prior service costs arising during the period
 
2

 
1

 
(1
)
 
(1
)
Amortization of net actuarial loss, transition and prior service costs (1)
 
17

 
15

 
17

 
13

Retirement plans and other retiree benefits adjustments
 
19

 
16

 
16

 
12

Cash flow hedges:
 
 
 
 
 
 
 
 
Unrealized gains (losses) on cash flow hedges
 
25

 
20

 
(2
)
 
(2
)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
 
(3
)
 
(2
)
 
(4
)
 
(3
)
Gains (losses) on cash flow hedges
 
22

 
18

 
(6
)
 
(5
)
Total Other comprehensive income (loss)
 
$
(279
)
 
$
(305
)
 
$
37

 
$
28


(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.
XML 61 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisitions
 3 Months Ended
Mar. 31, 2020
Business Combinations [Abstract]  
Acquisitions
Acquisitions

Hello Products LLC

On January 31, 2020, the Company acquired Hello Products LLC, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.

The total purchase price consideration of $351 has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:

Receivables
$
11

Inventories
13

Other assets and liabilities, net
(4
)
Other intangible assets
200

Goodwill
131

Fair value of net assets acquired
$
351



Other intangible assets acquired include trademarks of $155, which are considered to have an indefinite useful life, and customer relationships of $45, which have a finite useful life. Goodwill of $131 was allocated to the North America segment.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company expects to finalize the purchase price allocation no later than the first quarter of 2021.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.

Laboratoires Filorga Cosmétiques (“Filorga”)

On September 19, 2019 (the “Acquisition Date”), the Company acquired the Filorga skin health business for cash consideration of €1,516 (approximately $1,674), which included interest on the equity purchase price, plus additional consideration of €32 (approximately $38), the majority of which related to repayment of loans from former shareholders of Filorga. Filorga is a premium anti-aging skin health brand focused primarily on facial care. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses, including by expanding its portfolio in premium skin health.

The total purchase price consideration of $1,712 has been allocated to the net assets acquired based on their respective preliminary estimated fair values as follows:
Cash
$
30

Receivables
53

Inventories
70

Other current assets
18

Other intangible assets
1,051

Goodwill
923

Other current liabilities
(67
)
Deferred income taxes
(276
)
Noncontrolling interests
(90
)
Fair value of net assets acquired
$
1,712



Other intangible assets acquired include trademarks of $774, which are considered to have an indefinite useful life, and customer relationships of $277, which have an estimated life of 14 years. Goodwill of $923 was allocated to the Europe segment. The Company expects that goodwill will not be deductible for tax purposes.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company continues to evaluate potential contingencies that may have existed as of the acquisition date and expects to finalize the purchase price allocation no later than the third quarter of 2020.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.

Nigeria Joint Venture

On August 15, 2019, the Company acquired a 51% controlling interest in Colgate Tolaram Pte. Ltd., a joint venture which owns the Nigeria-based Hypo Homecare Products Limited, for $31.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.
XML 62 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisitions - Narrative (Details)
€ in Millions, $ in Millions
Jan. 31, 2020
USD ($)
Sep. 19, 2019
USD ($)
Sep. 19, 2019
EUR (€)
Aug. 15, 2019
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Business Acquisition [Line Items]            
Goodwill         $ 3,559 $ 3,508
Hello Product LLC            
Business Acquisition [Line Items]            
Payments to acquire business, cash $ 351          
Purchase price consideration 351          
Other intangible assets 200          
Goodwill 131          
Hello Product LLC | North America            
Business Acquisition [Line Items]            
Goodwill 131          
Hello Product LLC | Trademarks            
Business Acquisition [Line Items]            
Other intangible assets 155          
Hello Product LLC | Customer Relationships            
Business Acquisition [Line Items]            
Other intangible assets $ 45          
Laboratoires Filorga Cosmétiques            
Business Acquisition [Line Items]            
Payments to acquire business, cash   $ 1,674 € 1,516      
Purchase price consideration   1,712        
Other intangible assets   1,051        
Goodwill   923        
Additional purchase price consideration   38 € 32      
Laboratoires Filorga Cosmétiques | Europe            
Business Acquisition [Line Items]            
Goodwill   923        
Laboratoires Filorga Cosmétiques | Trademarks            
Business Acquisition [Line Items]            
Other intangible assets   774        
Laboratoires Filorga Cosmétiques | Customer Relationships            
Business Acquisition [Line Items]            
Other intangible assets   $ 277        
Useful life   14 years 14 years      
Nigeria Joint Venture            
Business Acquisition [Line Items]            
Purchase price consideration       $ 31    
Controlling interest acquired (in percent)       51.00%    
XML 63 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) - Global Growth and Efficiency Program - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Restructuring Reserve [Roll Forward]    
Beginning Balance $ 100  
Charges 0 $ 29
Cash payments (30)  
Charges against assets 0  
Foreign exchange (1)  
Other 0  
Ending Balance 69  
Employee-Related Costs    
Restructuring Reserve [Roll Forward]    
Beginning Balance 26  
Charges 0  
Cash payments (15)  
Charges against assets 0  
Foreign exchange (1)  
Other 0  
Ending Balance 10  
Incremental Depreciation    
Restructuring Reserve [Roll Forward]    
Beginning Balance 0  
Charges 0  
Cash payments 0  
Charges against assets 0  
Foreign exchange 0  
Other 0  
Ending Balance 0  
Asset Impairments    
Restructuring Reserve [Roll Forward]    
Beginning Balance 0  
Charges 0  
Cash payments 0  
Charges against assets 0  
Foreign exchange 0  
Other 0  
Ending Balance 0  
Other    
Restructuring Reserve [Roll Forward]    
Beginning Balance 74  
Charges 0  
Cash payments (15)  
Charges against assets 0  
Foreign exchange 0  
Other 0  
Ending Balance $ 59  
JSON 64 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cl-3312020x10q.htm": { "axisCustom": 0, "axisStandard": 23, "contextCount": 223, "dts": { "calculationLink": { "local": [ "cl-20200331_cal.xml" ] }, "definitionLink": { "local": [ "cl-20200331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "cl-3312020x10q.htm" ] }, "labelLink": { "local": [ "cl-20200331_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "cl-20200331_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml" ] }, "schema": { "local": [ "cl-20200331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 412, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 6, "http://www.colgate.com/20200331": 1, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 12 }, "keyCustom": 23, "keyStandard": 275, "memberCustom": 22, "memberStandard": 44, "nsprefix": "cl", "nsuri": "http://www.colgate.com/20200331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://www.colgate.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Use of Estimates", "role": "http://www.colgate.com/role/UseOfEstimates", "shortName": "Use of Estimates", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - Recent Accounting Pronouncements", "role": "http://www.colgate.com/role/RecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - Acquisitions", "role": "http://www.colgate.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - Restructuring and Related Implementation Charges", "role": "http://www.colgate.com/role/RestructuringAndRelatedImplementationCharges", "shortName": "Restructuring and Related Implementation Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - Inventories", "role": "http://www.colgate.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Earnings Per Share", "role": "http://www.colgate.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Other Comprehensive Income (Loss)", "role": "http://www.colgate.com/role/OtherComprehensiveIncomeLoss", "shortName": "Other Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - Retirement Plans and Other Retiree Benefits", "role": "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefits", "shortName": "Retirement Plans and Other Retiree Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - Income Taxes", "role": "http://www.colgate.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Contingencies", "role": "http://www.colgate.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME", "role": "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - Segment Information", "role": "http://www.colgate.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - Fair Value Measurements and Financial Instruments", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstruments", "shortName": "Fair Value Measurements and Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - Use of Estimates (Policies)", "role": "http://www.colgate.com/role/UseOfEstimatesPolicies", "shortName": "Use of Estimates (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Acquisitions (Tables)", "role": "http://www.colgate.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Restructuring and Related Implementation Charges (Tables)", "role": "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesTables", "shortName": "Restructuring and Related Implementation Charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - Inventories (Tables)", "role": "http://www.colgate.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.colgate.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Other Comprehensive Income (Loss) (Tables)", "role": "http://www.colgate.com/role/OtherComprehensiveIncomeLossTables", "shortName": "Other Comprehensive Income (Loss) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310301 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables)", "role": "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsTables", "shortName": "Retirement Plans and Other Retiree Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - Segment Information (Tables)", "role": "http://www.colgate.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317301 - Disclosure - Fair Value Measurements and Financial Instruments (Tables)", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables", "shortName": "Fair Value Measurements and Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - Acquisitions - Narrative (Details)", "role": "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "D2020Q1Jan31_us-gaap_BusinessAcquisitionAxis_cl_HelloProductLLCMember", "decimals": "-6", "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "I2020Q1Jan31_us-gaap_BusinessAcquisitionAxis_cl_HelloProductLLCMember", "decimals": "-6", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cl_GlobalGrowthandEfficiencyProgramMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details)", "role": "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "shortName": "Restructuring and Related Implementation Charges - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_RestructuringCostAndReserveAxis_cl_RestructuringAndImplementationRelatedChargesMember_us-gaap_RestructuringPlanAxis_cl_GlobalGrowthandEfficiencyProgramMember", "decimals": "INF", "lang": null, "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cl_GlobalGrowthandEfficiencyProgramMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details)", "role": "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "shortName": "Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2019Q1QTD_us-gaap_RestructuringPlanAxis_cl_GlobalGrowthandEfficiencyProgramMember", "decimals": "-6", "lang": null, "name": "cl:RestructuringAndRelatedCostIncurredCostAfterTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2019Q4_us-gaap_RestructuringPlanAxis_cl_GlobalGrowthandEfficiencyProgramMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details)", "role": "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "shortName": "Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2019Q4_us-gaap_RestructuringPlanAxis_cl_GlobalGrowthandEfficiencyProgramMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - Inventories (Details)", "role": "http://www.colgate.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Earnings Per Share (Details)", "role": "http://www.colgate.com/role/EarningsPerShareDetails", "shortName": "Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Other Comprehensive Income (Loss) (Details)", "role": "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails", "shortName": "Other Comprehensive Income (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410402 - Disclosure - Retirement Plans and Other Retiree Benefits (Details)", "role": "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails", "shortName": "Retirement Plans and Other Retiree Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "cl:DiscreteIncomeTaxProvisionBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411401 - Disclosure - Income Taxes (Details)", "role": "http://www.colgate.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "cl:DiscreteIncomeTaxProvisionBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-2", "first": true, "lang": null, "name": "cl:MinimumNumberOfCountriesAndTerritoriesServingConsumers", "reportCount": 1, "unique": true, "unitRef": "country_and_territory", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412401 - Disclosure - Contingencies (Details)", "role": "http://www.colgate.com/role/ContingenciesDetails", "shortName": "Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-2", "first": true, "lang": null, "name": "cl:MinimumNumberOfCountriesAndTerritoriesServingConsumers", "reportCount": 1, "unique": true, "unitRef": "country_and_territory", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "cl:NumberOfProductSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - Segment Information - Narrative (Details)", "role": "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": null, "name": "cl:NumberOfProductSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413403 - Disclosure - Segment Information - Schedule of Segment Information (Details)", "role": "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails", "shortName": "Segment Information - Schedule of Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember", "decimals": "-6", "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417402 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails", "shortName": "Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1_us-gaap_FairValueByLiabilityClassAxis_us-gaap_LongTermDebtMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:HedgedLiabilityFairValueHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417403 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails", "shortName": "Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1_us-gaap_FairValueByLiabilityClassAxis_us-gaap_LongTermDebtMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:HedgedLiabilityFairValueHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417404 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417405 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "cl:ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417406 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "cl:ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1003001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.colgate.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "link:footnote", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "role": "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "link:footnote", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "span", "link:footnote", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfDividendsDeclaredPerQuarter", "reportCount": 1, "unique": true, "unitRef": "Dividend", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)", "role": "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "link:footnote", "div", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfDividendsDeclaredPerQuarter", "reportCount": 1, "unique": true, "unitRef": "Dividend", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Basis of Presentation", "role": "http://www.colgate.com/role/BasisOfPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-3312020x10q.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 69, "tag": { "cl_A0.000Notesdue2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.000% Notes due 2021 [Member]", "label": "0.000% Notes due 2021 [Member]", "terseLabel": "0.000% Notes due 2021" } } }, "localname": "A0.000Notesdue2021Member", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_A0.500NotesDue2026Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.500% Notes Due 2026 [Member]", "label": "0.500% Notes Due 2026 [Member]", "terseLabel": "0.500% Notes Due 2026" } } }, "localname": "A0.500NotesDue2026Member", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_A0.875Notesdue2039Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.875% Notes due 2039 [Member]", "label": "0.875% Notes due 2039 [Member]", "terseLabel": "0.875% Notes due 2039" } } }, "localname": "A0.875Notesdue2039Member", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_A1.375NotesDue2034Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.375% Notes Due 2034 [Member]", "label": "1.375% Notes Due 2034 [Member]", "terseLabel": "1.375% Notes Due 2034" } } }, "localname": "A1.375NotesDue2034Member", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_AfricaEurasiaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A specified group of foreign regions about which segment information is provided by the entity.", "label": "Africa Eurasia [Member]", "terseLabel": "Africa/Eurasia" } } }, "localname": "AfricaEurasiaMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_AssetImpairmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset Impairment [Member]", "label": "Asset Impairment [Member]", "terseLabel": "Asset Impairments" } } }, "localname": "AssetImpairmentMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "domainItemType" }, "cl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAndLiabilitiesOtherNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 10.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net", "negatedTerseLabel": "Other assets and liabilities, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAndLiabilitiesOtherNet", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cl_DesignatedDerivativeInstrumentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated derivative instruments [Abstract]", "label": "Designated derivative instruments [Abstract]", "terseLabel": "Designated derivative instruments" } } }, "localname": "DesignatedDerivativeInstrumentsAbstract", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "cl_DiscreteIncomeTaxProvisionBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Discrete Income Tax Provision (Benefit)", "label": "Discrete Income Tax Provision (Benefit)", "negatedLabel": "Provisional income tax benefit" } } }, "localname": "DiscreteIncomeTaxProvisionBenefit", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "cl_FineImposedByGreekCompetitionAuthority": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fine Imposed by Greek Competition Authority", "label": "Fine Imposed By Greek Competition Authority", "terseLabel": "Fine imposed by Greek competition authority" } } }, "localname": "FineImposedByGreekCompetitionAuthority", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_ForeignWithholdingIncomeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Foreign Withholding Income Tax", "label": "Foreign Withholding Income Tax", "negatedTerseLabel": "Foreign withholding income tax" } } }, "localname": "ForeignWithholdingIncomeTax", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "cl_GlobalGrowthandEfficiencyProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Global Growth and Efficiency Program [Member]", "label": "Global Growth and Efficiency Program [Member]", "terseLabel": "Global Growth and Efficiency Program" } } }, "localname": "GlobalGrowthandEfficiencyProgramMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_GrossProfitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross Profit [Member]", "label": "Gross Profit [Member]", "terseLabel": "Cost of sales" } } }, "localname": "GrossProfitMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "cl_HelloProductLLCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Hello Product LLC [Member]", "label": "Hello Product LLC [Member]", "terseLabel": "Hello Product LLC" } } }, "localname": "HelloProductLLCMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "cl_HomeCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Home Care products include laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items.", "label": "Home Care [Member]", "terseLabel": "Home Care" } } }, "localname": "HomeCareMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_IncrementalDepreciationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Incremental Depreciation [Member]", "label": "Incremental Depreciation [Member]", "terseLabel": "Incremental Depreciation" } } }, "localname": "IncrementalDepreciationMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "domainItemType" }, "cl_InterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate interest and debt related expenses associated with nonoperating financing activities of the entity, less the amount of income derived from investments in debt securities and on cash and cash equivalents, the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.", "label": "Interest expense, net", "terseLabel": "Interest (income) expense, net" } } }, "localname": "InterestExpenseNet", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "cl_InterestIncomeExpenseNetMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest (Income) Expense, Net [Member]", "label": "Interest (Income) Expense, Net [Member]", "terseLabel": "Interest (income) expense, net" } } }, "localname": "InterestIncomeExpenseNetMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails" ], "xbrltype": "domainItemType" }, "cl_InventoryNetIncludingNoncurrent": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colgate.com/role/InventoriesDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Inventory, Net, Including Noncurrent", "label": "Inventory, Net, Including Noncurrent", "totalLabel": "Total Inventories, net" } } }, "localname": "InventoryNetIncludingNoncurrent", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "cl_LaboratoiresFilorgaCosmtiquesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Laboratoires Filorga Cosm\u00e9tiques [Member]", "label": "Laboratoires Filorga Cosm\u00e9tiques [Member]", "terseLabel": "Laboratoires Filorga Cosm\u00e9tiques" } } }, "localname": "LaboratoiresFilorgaCosmtiquesMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "cl_LossContingencyCasesResultingInAdverseJuryVerdictNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number", "label": "Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number", "terseLabel": "Loss contingency, number of cases resulting in adverse jury verdict" } } }, "localname": "LossContingencyCasesResultingInAdverseJuryVerdictNumber", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_LossContingencyNumberOfAppealsLost": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Appeals Lost", "label": "Loss Contingency, Number Of Appeals Lost", "terseLabel": "Loss contingency, number of appeals lost (in appeals)" } } }, "localname": "LossContingencyNumberOfAppealsLost", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_LossContingencyNumberOfCasesOnAppeal": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of Cases On Appeal", "label": "Loss Contingency, Number Of Cases On Appeal", "terseLabel": "Loss contingency, number of cases on appeal" } } }, "localname": "LossContingencyNumberOfCasesOnAppeal", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_MinimumNumberOfCountriesAndTerritoriesServingConsumers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum Number Of Countries And Territories Serving Consumers", "label": "Minimum Number Of Countries And Territories Serving Consumers", "terseLabel": "Minimum number of countries and territories serving consumers (more than) (in countries and territories)" } } }, "localname": "MinimumNumberOfCountriesAndTerritoriesServingConsumers", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_NigeriaJointVentureMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Nigeria Joint Venture [Member]", "label": "Nigeria Joint Venture [Member]", "terseLabel": "Nigeria Joint Venture" } } }, "localname": "NigeriaJointVentureMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_NonServiceRelatedPostretirementCostsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-Service Related Postretirement Costs [Member]", "label": "Non-Service Related Postretirement Costs [Member]", "terseLabel": "Non-service related postretirement costs" } } }, "localname": "NonServiceRelatedPostretirementCostsMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "cl_NumberOfDividendsDeclaredPerQuarter": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Dividends Declared Per Quarter", "label": "Number Of Dividends Declared Per Quarter", "terseLabel": "Number of dividends declared per quarter" } } }, "localname": "NumberOfDividendsDeclaredPerQuarter", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityParenthetical" ], "xbrltype": "integerItemType" }, "cl_NumberOfProductSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Product Segments", "label": "Number Of Product Segments", "terseLabel": "Number of product segments (in segments)" } } }, "localname": "NumberOfProductSegments", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "cl_OralCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Oral Care products include toothpaste, toothbrushes, mouth rinses and other similar items.", "label": "Oral Care [Member]", "terseLabel": "Oral Care" } } }, "localname": "OralCareMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_OralPersonalAndHomeCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Oral, Personal and Home Care", "label": "Oral, Personal and Home Care [Member]", "terseLabel": "Oral, Personal and Home Care" } } }, "localname": "OralPersonalAndHomeCareMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_OtherComprehensiveIncomeLossHedgedItemInNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification and Tax", "label": "Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification And Tax", "terseLabel": "Gain (loss) on hedged items" } } }, "localname": "OtherComprehensiveIncomeLossHedgedItemInNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "monetaryItemType" }, "cl_OtherIncomeExpenseNetMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other (Income) Expense, Net [Member]", "label": "Other (Income) Expense, Net [Member]", "terseLabel": "Other (income) expense, net" } } }, "localname": "OtherIncomeExpenseNetMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "cl_PercentageOfConsolidatedNetSalesComingFromEmergingMarkets": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of Consolidated Net Sales coming from Emerging Markets", "label": "Percentage Of Consolidated Net Sales Coming From Emerging Markets", "terseLabel": "Percentage of consolidated Net sales coming from emerging markets" } } }, "localname": "PercentageOfConsolidatedNetSalesComingFromEmergingMarkets", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfConsolidatedNetSalesRepresentedBySalesOutsideUS": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of Consolidated Net Sales represented by Sales outside US", "label": "Percentage Of Consolidated Net Sales Represented By Sales Outside US", "terseLabel": "Percentage of consolidated Net sales represented by sales outside US" } } }, "localname": "PercentageOfConsolidatedNetSalesRepresentedBySalesOutsideUS", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_PersonalCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Personal Care products include bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants and other similar items.", "label": "Personal Care [Member]", "terseLabel": "Personal Care" } } }, "localname": "PersonalCareMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_PetNutritionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pet Nutrition", "label": "Pet Nutrition [Member]", "terseLabel": "Pet Nutrition" } } }, "localname": "PetNutritionMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_RestructuringAndImplementationRelatedChargesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restructuring And Implementation-Related Charges [Member]", "label": "Restructuring And Implementation-Related Charges [Member]", "terseLabel": "Restructuring and Implementation-Related Charges" } } }, "localname": "RestructuringAndImplementationRelatedChargesMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_RestructuringAndRelatedCostIncurredCostAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Restructuring And Related Cost, Incurred Cost, After Tax", "label": "Restructuring And Related Cost, Incurred Cost, After Tax", "terseLabel": "Total Global Growth and Efficiency Program charges, aftertax" } } }, "localname": "RestructuringAndRelatedCostIncurredCostAfterTax", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringNetOfCash": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of noncash restructuring costs net of cash payments.", "label": "Restructuring, net of cash", "terseLabel": "Restructuring and termination benefits, net of cash" } } }, "localname": "RestructuringNetOfCash", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cl_RestructuringReserveChargesAgainstAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Restructuring Reserve, Charges Against Assets", "label": "Restructuring Reserve, Charges Against Assets", "negatedLabel": "Charges against assets" } } }, "localname": "RestructuringReserveChargesAgainstAssets", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "cl_ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "label": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of gains (losses) included in Other Comprehensive Income" } } }, "localname": "ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "cl_TaxAssessmentsWithInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of tax assessment with estimated interest accrued as of the balance sheet date arising from income tax examinations related to an acquisition.", "label": "Tax Assessments With Interest", "verboseLabel": "Brazilian internal revenue authority, matter 1" } } }, "localname": "TaxAssessmentsWithInterest", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_TaxAssessmentsWithInterestAndPenalties": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of tax assessment with estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations related to investments held by a foreign subsidiary.", "label": "Tax Assessments With Interest And Penalties", "verboseLabel": "Brazilian internal revenue authority, matter 2" } } }, "localname": "TaxAssessmentsWithInterestAndPenalties", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_UnearnedCompensation": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded.", "label": "Unearned Compensation", "negatedLabel": "Unearned compensation" } } }, "localname": "UnearnedCompensation", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "cl_UnearnedCompensationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded.", "label": "Unearned Compensation [Member]", "terseLabel": "Unearned Compensation" } } }, "localname": "UnearnedCompensationMember", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "cl_WithholdingTaxDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Withholding Tax Due", "label": "Withholding Tax Due", "terseLabel": "Withholding tax due" } } }, "localname": "WithholdingTaxDue", "nsuri": "http://www.colgate.com/20200331", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r360" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r361" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r363" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r362" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r358" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r359" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r126", "r132" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r135", "r204", "r206", "r352", "r353" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r136", "r204", "r207", "r354", "r356", "r357" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r18", "r138", "r139", "r205" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Receivables (net of allowances of $84 and $76, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r13", "r331", "r342" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "verboseLabel": "Accrued income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r57", "r62", "r64", "r221", "r272" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Retirement plans and other retiree benefits adjustments" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r34", "r163" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r62", "r71", "r271" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Gains (losses) on cash flow hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r58", "r62" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "terseLabel": "Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r54", "r60", "r61", "r62", "r313", "r320", "r322" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "negatedLabel": "Accumulated other comprehensive loss, cumulative translation losses" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r60", "r61", "r62" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r59", "r62", "r64", "r272" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "verboseLabel": "Total Other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r55", "r62", "r64", "r272" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Cumulative translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r154" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r19" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r235", "r236", "r238", "r239" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r24", "r140", "r144" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r111" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r129", "r330", "r341" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r50" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r283", "r288" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r249", "r250" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Controlling interest acquired (in percent)" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r253" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedTerseLabel": "Noncontrolling interests" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r257", "r258", "r259" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "verboseLabel": "Purchase price consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "auth_ref": [ "r261" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.", "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Additional purchase price consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredOther1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedTerseLabel": "Other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r242", "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Deferred income taxes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r251", "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Fair value of net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r252" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Fair value of net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r315", "r316" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r32", "r95" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r88", "r95", "r97" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of the period", "periodStartLabel": "Cash and cash equivalents at beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r88", "r319" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r280" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "auth_ref": [ "r304" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "terseLabel": "Gain (loss) on derivative instrument" } } }, "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r304" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Gain (loss) on hedged items" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r180", "r191" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r214", "r297" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity contracts", "verboseLabel": "Commodity Contracts" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared per common share (in dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r17" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r67", "r69", "r70" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total Comprehensive income attributable to Colgate-Palmolive Company" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r67", "r69", "r266", "r267", "r275" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive income attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r67", "r69", "r265", "r275" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive income including noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r120", "r121", "r317", "r318" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r120", "r121", "r317", "r318", "r355" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r120", "r121", "r317", "r318", "r355" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r120", "r121", "r317", "r318" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percent of net sales" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r120", "r121", "r317", "r318" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r76" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r256" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r314" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Estimated fair value of long-term debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r42", "r99", "r196", "r197", "r198", "r199", "r323", "r324", "r325", "r340" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtMember": { "auth_ref": [ "r240" ], "lang": { "en-US": { "role": { "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.", "label": "Debt [Member]", "terseLabel": "Foreign Currency Debt" } } }, "localname": "DebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r244" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r243", "r244" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r94" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r220", "r230", "r232" ], "calculation": { "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedLabel": "Amortization of actuarial loss (gain)" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r213", "r214", "r215", "r231", "r232" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Voluntary benefit plan contribution" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r219", "r229", "r232" ], "calculation": { "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r212", "r218", "r228", "r232" ], "calculation": { "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r216", "r226", "r232" ], "calculation": { "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "verboseLabel": "Components of net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r211", "r217", "r227", "r232" ], "calculation": { "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r93", "r127" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r51", "r52", "r314" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative assets, designated" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r285" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Total gain (loss) on hedges recognized in income" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r284", "r287", "r293", "r298" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r282", "r284", "r293" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r282", "r284", "r293", "r298", "r299", "r302", "r305" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r51", "r52", "r314" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities, designated" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r277", "r278" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional values" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r200", "r339" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Dividends" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r223" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r74", "r101", "r106", "r108", "r109", "r110", "r113", "r338", "r350" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic EPS (in dollars per share)", "verboseLabel": "Earnings per common share, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Per Share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r74", "r101", "r106", "r108", "r109", "r110", "r113", "r338", "r350" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted EPS (in dollars per share)", "verboseLabel": "Earnings per common share, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Net income attributable to Colgate-Palmolive Company" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]", "terseLabel": "Cash flow hedges [Abstract]" } } }, "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r319" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on Cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r195" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Derivative and Financial Instruments, Fair Value [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r214", "r215", "r232", "r307", "r326" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r309", "r310" ], "lang": { "en-US": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r306", "r311" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair Value Hedges" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r214", "r215", "r232", "r307", "r327" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r283", "r289", "r302" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Value Derivatives Balance Sheet Location [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "Fair Value Measurements and Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Financial Instruments, Owned, at Fair Value [Abstract]", "terseLabel": "Other financial instruments" } } }, "localname": "FinancialInstrumentsOwnedAtFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r153", "r156", "r159", "r161", "r328" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r153", "r158" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r214", "r296" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts", "verboseLabel": "Foreign Currency Contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r223" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "International" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r149", "r150" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r75" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgedLiabilityFairValueHedge": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability hedged in fair value hedging relationship.", "label": "Hedged Liability, Fair Value Hedge", "terseLabel": "Carrying amount of hedged item" } } }, "localname": "HedgedLiabilityFairValueHedge", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": { "auth_ref": [ "r301" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.", "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)", "terseLabel": "Cumulative hedging adjustment included in the carrying amount" } } }, "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r72", "r101", "r329", "r336", "r351" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r165" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r98", "r128", "r245" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r89", "r96" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and other accruals" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Cash effects of changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedTerseLabel": "Other non-current assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Changes in Shareholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r107", "r112" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "verboseLabel": "Stock options and restricted stock units (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r155", "r160" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r155", "r160" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r152", "r157" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r214", "r295" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest rate swap contracts", "verboseLabel": "Interest Rate Swaps" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r148" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r25", "r147" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r47", "r146" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.colgate.com/role/InventoriesDetailsCalc2": { "order": 2.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Current Inventories, net", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets", "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory, Net, Items Net of Reserve Alternative [Abstract]" } } }, "localname": "InventoryNetItemsNetOfReserveAlternativeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.colgate.com/role/InventoriesDetailsCalc2": { "order": 1.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "negatedTerseLabel": "Non-current inventory, net" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r27", "r28", "r147" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r26", "r147" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r306" ], "calculation": { "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "totalLabel": "Total other financial instruments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r39" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r23", "r334", "r346" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r14", "r194", "r332", "r343" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Carrying value of long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r181", "r182", "r183", "r186", "r187", "r188", "r190", "r192", "r193" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Loss Contingency [Abstract]" } } }, "localname": "LossContingencyAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsSettledAndDismissedNumber": { "auth_ref": [ "r184" ], "lang": { "en-US": { "role": { "documentation": "The number of claims settled and dismissed during the period.", "label": "Loss Contingency, Claims Settled and Dismissed, Number", "terseLabel": "Loss contingency, claims dismissed or settled, number (in cases)" } } }, "localname": "LossContingencyClaimsSettledAndDismissedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r185", "r189", "r192" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss", "terseLabel": "Loss contingency, possible loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r184" ], "lang": { "en-US": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Loss contingency, new claims filed, number (in cases)" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r184" ], "lang": { "en-US": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Loss contingency, pending claims, number (in cases)" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r335" ], "calculation": { "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r46", "r333", "r345" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r88" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r88" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r88", "r91", "r94" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r65", "r68", "r73", "r94", "r112", "r337", "r349" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income attributable to Colgate-Palmolive Company" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r65", "r68", "r269", "r274" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Net income attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r101", "r104" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Basic EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r104", "r105" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Diluted EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r281" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r210" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "terseLabel": "Non-service related postretirement costs" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r102" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/UseOfEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments (in segments)" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments (in segments)" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OneTimeTerminationBenefitsMember": { "auth_ref": [ "r167" ], "lang": { "en-US": { "role": { "documentation": "A lump sum payment to an involuntarily terminated employee in conjunction with exit or disposal activities.", "label": "One-time Termination Benefits [Member]", "terseLabel": "Employee-Related Costs" } } }, "localname": "OneTimeTerminationBenefitsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Total Operating profit", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing operating income (loss).", "label": "Operating Income (Loss) [Member]", "terseLabel": "Included in Operating profit (loss)" } } }, "localname": "OperatingIncomeLossMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r126", "r132" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r276" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r9", "r40" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r283", "r302" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r265", "r266", "r271" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest", "terseLabel": "Less: Cumulative translation adjustments attributable to noncontrolling interests" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r62" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive income (loss), before reclassifications, pretax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r62", "r71" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other comprehensive income (loss), before reclassifications, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r143" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Other comprehensive income (loss), pretax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r56", "r60" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Gains (losses) on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r56", "r60", "r286", "r291", "r303" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) recognized in OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r60", "r63", "r292" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Amount reclassified from OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r54", "r321" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Cumulative translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r294" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) on instruments" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r66", "r69", "r71", "r195" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total Other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r58", "r60" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Retirement plans and other retiree benefit adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r283", "r302" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other accruals" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r283", "r302" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsFairValueOfDerivativeInstrumentsAndOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedTerseLabel": "Other (income) expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r209", "r222", "r223", "r233" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Retiree Benefits" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restructuring and related activities classified as other.", "label": "Other Restructuring [Member]", "terseLabel": "Other" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r84" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r86", "r169" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedLabel": "Cash payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfOrdinaryDividends": { "auth_ref": [ "r84" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.", "label": "Payments of Ordinary Dividends", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfOrdinaryDividends", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r80", "r260" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire business, cash" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r80" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Payment for acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r142" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities and investments" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r81" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r90" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Payment for Pension and Other Postretirement Benefits", "negatedTerseLabel": "Voluntary benefit plan contributions" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "verboseLabel": "Retirement Plans and Other Retiree Benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r208", "r222", "r223", "r233" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Benefits" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r312" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsCarryingValueAndEstimatedFairValueOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r83" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from sale of marketable securities and investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r82", "r237" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r119" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product Concentration Risk" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r65", "r68", "r87", "r129", "r133", "r265", "r268", "r270", "r274", "r275" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income including noncontrolling interests", "totalLabel": "Net income including noncontrolling interests", "verboseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.colgate.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r33", "r162" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r164", "r347" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]", "terseLabel": "Property, plant and equipment:" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r62", "r64" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedTerseLabel": "Reclassification from AOCI, pretax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r62", "r64", "r71" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Reclassification from AOCI, net of tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r85" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Principal payments on debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r179" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Related Implementation Charges" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "auth_ref": [ "r168", "r170", "r176", "r178" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.", "label": "Restructuring and Related Cost, Incurred Cost", "terseLabel": "Total Global Growth and Efficiency Program charges, pretax", "verboseLabel": "Charges" } } }, "localname": "RestructuringAndRelatedCostIncurredCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r169", "r174" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r169", "r177" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Foreign exchange" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": { "auth_ref": [ "r169", "r173" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).", "label": "Restructuring Reserve, Translation and Other Adjustment", "terseLabel": "Other" } } }, "localname": "RestructuringReserveTranslationAndOtherAdjustment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r200", "r344" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r223", "r225" ], "lang": { "en-US": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r223", "r225" ], "lang": { "en-US": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r208", "r209", "r222", "r223", "r233" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r208", "r209", "r222", "r223", "r233" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r203", "r204" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total Net sales", "verboseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r120" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue, Net" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r249", "r250" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleOfRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r222", "r223", "r224", "r225", "r232" ], "lang": { "en-US": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r284", "r293", "r299" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of gains (losses) recognized in Statements of Income" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of derivative instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r112" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of hedged item and cumulative adjustment to carrying amount" } } }, "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r10", "r29", "r30", "r31" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventories by Major Class" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r216" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Components Of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansAndOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r277" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of notional values" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r171", "r172", "r175" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r171", "r172", "r175" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r169", "r177" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r125", "r129", "r130", "r131", "r151" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r125", "r129", "r130", "r131", "r151" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Net Sales and Operating Profit by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r77", "r145" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r78" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossOnHedgesRecognizedInIncomeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesSummaryOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r36", "r348" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short-term Bank Loans and Notes Payable", "terseLabel": "Notes and loans payable" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/UseOfEstimates" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r129", "r151", "r166", "r170", "r178", "r352" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "verboseLabel": "Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r15", "r16", "r17", "r195" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r45", "r195" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r195", "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Shares issued for restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r45", "r195", "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued for stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r17", "r21", "r22", "r141" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Colgate-Palmolive Company shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r263", "r264", "r273" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets", "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Summary of Net Investment Hedge Activity [Abstract]", "verboseLabel": "Net investment hedges [Abstract]" } } }, "localname": "SummaryOfNetInvestmentHedgeActivityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsAndFinancialInstrumentsScheduleOfGainLossIncludedInOciDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r44", "r201" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r44", "r201", "r202" ], "calculation": { "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r195", "r200", "r201" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Treasury stock acquired" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/RestructuringAndRelatedImplementationChargesRestructuringActivityAndRelatedAccrualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r115", "r116", "r117", "r118", "r122", "r123", "r124" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/UseOfEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r241" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedTerseLabel": "Valuation allowance against deferred tax asset" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r105", "r110" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Shares" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r103", "r110" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r137": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r191": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r246": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r276": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4EE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109999712-113959" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4EE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109999712-113959" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r358": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r359": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r361": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r362": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r363": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e526-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" } }, "version": "2.1" } XML 65 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Retirement Plans and Other Retiree Benefits (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Other Retiree Benefits    
Components of net periodic benefit cost    
Service cost $ 6 $ 4
Interest cost 11 11
Expected return on plan assets 0 (1)
Amortization of actuarial loss (gain) 5 2
Net periodic benefit cost 22 16
United States | Pension Benefits    
Components of net periodic benefit cost    
Service cost 0 0
Interest cost 19 23
Expected return on plan assets (27) (26)
Amortization of actuarial loss (gain) 11 13
Net periodic benefit cost 3 10
Voluntary benefit plan contribution 0 102
International | Pension Benefits    
Components of net periodic benefit cost    
Service cost 4 4
Interest cost 5 5
Expected return on plan assets (4) (5)
Amortization of actuarial loss (gain) 1 2
Net periodic benefit cost $ 6 $ 6
XML 66 R8.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)
 3 Months Ended
Mar. 31, 2020
Dividend
$ / shares
Mar. 31, 2019
Dividend
$ / shares
Statement of Stockholders' Equity [Abstract]    
Dividends declared per common share (in dollars per share) | $ / shares $ 0.87 $ 0.85
Number of dividends declared per quarter | Dividend 2 2
XML 67 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 854 $ 883
Receivables (net of allowances of $84 and $76, respectively) 1,551 1,440
Inventories 1,301 1,400
Other current assets 542 456
Total current assets 4,248 4,179
Property, plant and equipment:    
Cost 8,167 8,580
Less: Accumulated depreciation (4,680) (4,830)
Property, plant and equipment, net 3,487 3,750
Goodwill 3,559 3,508
Other intangible assets, net 2,822 2,667
Deferred income taxes 179 177
Other assets 775 753
Total assets 15,070 15,034
Current Liabilities    
Notes and loans payable 255 260
Current portion of long-term debt 255 254
Accounts payable 1,216 1,237
Accrued income taxes 485 370
Other accruals 2,232 1,917
Total current liabilities 4,443 4,038
Long-term debt 7,336 7,333
Deferred income taxes 415 507
Other liabilities 2,535 2,598
Total liabilities 14,729 14,476
Shareholders’ Equity    
Common stock 1,466 1,466
Additional paid-in capital 2,623 2,488
Retained earnings 22,481 22,501
Accumulated other comprehensive income (loss) (4,578) (4,273)
Unearned compensation (1) (2)
Treasury stock, at cost (22,104) (22,063)
Total Colgate-Palmolive Company shareholders’ equity (113) 117
Noncontrolling interests 454 441
Total equity 341 558
Total liabilities and equity $ 15,070 $ 15,034